Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
MINISTRY OF HELTH OF UKRAINENATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE
SI «NATIONAL SCIENTEFICCENTER «ACADEMIC M.D. STRAZHESKO INSTITUTE
OF CARDIOLOGY» NAMS OF UKRAINE»UKRAINIAN ASSOCIATION OF CARDILOGY
ASSOCIATION OF RESEACHERS OF UKRAINEUKRAINIAN ASSOCIATION OF PREVENTIVE
CARDIOLOGY AND REHABILITATIONALL-UKRAINIAN ASSOCIATION OF ARRHYTHMOLOGISTS
OF UKRAINEACUTE CARDIAC CARE ASSOTIATION
OF UKRAINEUKRAINIAN ANTIHYPERTENSIVE SOCIETY
UKRAINIAN HEART FAILURE ASSOCIATION
UKRAINIAN ATHEROSCLEROSIS SOCIETY
̲ͲÑÒÅÐÑÒÂÎ ÎÕÎÐÎÍÈ ÇÄÎÐÎÂ’ß ÓÊÐÀ¯ÍÈÍÀÖ²ÎÍÀËÜÍÀ ÀÊÀÄÅÌ²ß ÌÅÄÈ×ÍÈÕ ÍÀÓÊ ÓÊÐÀ¯ÍÈ
ÄÓ «ÍÀÖ²ÎÍÀËÜÍÈÉ ÍÀÓÊÎÂÈÉ ÖÅÍÒÐ «²ÍÑÒÈÒÓÒ ÊÀÐIJÎËÎò¯ ²ÌÅͲ ÀÊÀÄÅ̲ÊÀ
Ì.Ä. ÑÒÐÀÆÅÑÊÀ» ÍÀÌÍ ÓÊÐÀ¯ÍÈ»ÂÑÅÓÊÐÀ¯ÍÑÜÊÀ ÀÑÎÖ²ÀÖ²ß ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
ÀÑÎÖ²ÀÖ²ß ÄÎÑ˲ÄÍÈʲ ÓÊÐÀ¯ÍÈÂÑÅÓÊÐÀ¯ÍÑÜÊÀ ÀÑÎÖ²ÀÖ²ß ÏÐÅÂÅÍÒÈÂÍί
ÊÀÐIJÎËÎò¯ ÒÀ ÐÅÀÁ²Ë²ÒÀÖ²¯ÂÑÅÓÊÐÀ¯ÍÑÜÊÀ ÀÑÎÖ²ÀÖ²ß ÀÐÈÒÌÎËÎòÂ
ÓÊÐÀ¯ÍÈÂÑÅÓÊÐÀ¯ÍÑÜÊÀ ÀÑÎÖ²ÀÖ²ß Ç ÍŲÄÊËÀÄÍί
ÊÀÐIJÎËÎò¯ÂÑÅÓÊÐÀ¯ÍÑÜÊÀ ÀÍÒÈòÏÅÐÒÅÍÇÈÂÍÀ ÀÑÎÖ²ÀÖ²ßÂÑÅÓÊÐÀ¯ÍÑÜÊÀ ÀÑÎÖ²ÀÖ²ß ÔÀÕ²ÂÖ²Â Ç ÑÅÐÖÅÂί
ÍÅÄÎÑÒÀÒÍÎÑÒ²ÓÊÐÀ¯ÍÑÜÊÅ ÒÎÂÀÐÈÑÒÂÎ Ç ÀÒÅÐÎÑÊËÅÐÎÇÓ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY
ÏÐÎÃÐÀÌÀSCIENTIFIC PROGRAM
25–27 âåðåñíÿ 2019 ð.ÊȯÂ
25th–27th OF SEPTEMBER, 2019KYIV
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
2
SCIENTIFIC AND ORGANIZING COMMITTEE OF THE XX NATIONAL CARDIOLOGY CONGRESS OF UKRAINE
Presidium of the scientific and organizing committee:V.M. Kovalenko (co-chairman), V.I. Tzymbalyuk (co-chairman), K.M. Amosova, O.M. Bilovol, Yu.V. Voronenko, V.V. Lasorishinets, M.I. Lutay, O.M. Parkhomenko, Yu.M. Sirenko, O.S. Sychov, Yu.M. Sokolov, E.G. Nesukay
Members of the scientific and organizing committee:V.V. Bratus, L.L. Vavilova, O.P. Volosovets, L.G. Voronkov, T.I. Gavrilenko, M.M. Dolzhenko, I.M. Emets, V.M. Zhdan, O.A. Koval, S.M. Koval, S.M. Kozhukhov, O.V. Korkushko, V.M. Kornatskyi, O.I. Mitchenko, V.A. Mikhnyov, V.Z. Netiazhenko, O.S. Nikonenko, L.A. Mishchenko, M.V. Rishko, A.V. Rudenko, K.V. Rudenko, N.M. Seredyuk, M.Yu. Sokolov, T.V. Talaeva, V.K. Tashchuk, B.M. Todurov, M.D. Tronko, M.K. Furkalo, V.Yo. Tseluyko, V.O. Shumakov
Secretariat:L.L. Vavilova (chairman), V.M. Korzhenko, V.E. Piletskiy, O.M. Romanova, T.V. Getman, O.V. Sribna, R.G. Ivanets, M.A. Gulya-nytska, T.M. Movchanovska, M.P. Mostovyak
ÍÀÓÊÎÂÎ-ÎÐÃÀͲÇÀÖ²ÉÍÈÉ ÊÎ̲ÒÅÒ ÕX ÍÀÖ²ÎÍÀËÜÍÎÃÎ ÊÎÍÃÐÅÑÓ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
Ïðåçèä³ÿ íàóêîâî-îðãàí³çàö³éíîãî êîì³òåòó:Â.Ì. Êîâàëåíêî (ñï³âãîëîâà), Â.². Öèìáàëþê (ñï³âãîëîâà), Ê.Ì. Àìîñîâà, Î.Ì. Á³ëîâîë,Þ.Â. Âîðîíåíêî, Â.Â. Ëàçîðè-øèíåöü, Ì.². Ëóòàé, Î.Ì. Ïàðõîìåíêî, Þ.Ì. ѳðåíêî, Î.Ñ. Ñè÷îâ, Þ.Ì. Ñîêîëîâ, Î.Ã. Íåñóêàé
×ëåíè íàóêîâî-îðãàí³çàö³éíîãî îðãêîì³òåòó:Ë.Ë. Âàâ³ëîâà, Î.Ï. Âîëîñîâåöü, Ë.Ã. Âîðîíêîâ, Ò.². Ãàâðèëåíêî, Ì.Ì. Äîëæåíêî, ².Ì. ªìåöü, Â.Ì. Æäàí, Î.À. Êîâàëü, Ñ.Ì. Êîâàëü, Ñ.Ì.Êîæóõîâ, Î.Â. Êîðêóøêî, Â.Ì. Êîðíàöüêèé, Î.². ̳ò÷åíêî, Â.À. ̳õíüîâ, Â.Ç. Íåòÿæåíêî, Ë.À. ̳-ùåíêî, Ì.Â. гøêî, À.Â. Ðóäåíêî, Ê.Â. Ðóäåíêî, Í.Ì. Ñåðåäþê, Ì.Þ. Ñîêîëîâ, Ò.Â. Òàëàåâà, Â.Ê. Òàùóê, Á.Ì. Òîäóðîâ, Ì.Ä. Òðîíüêî, Ì.Ê. Ôóðêàëî, Î.Î.Õàíþêîâ, Â.É. Öåëóéêî, Â.Î.Øóìàêîâ
Ñåêðåòàð³àò: Ë.Ë. Âàâ³ëîâà (ãîëîâà), Ð.Ã. ²âàíåöü, Â.Ì. Êîðæåíêî, Â.Å. ϳëåöüêèé, Î.Ì.Ðîìàíîâà, Ò.Â. Ãåòüìàí, Î.Â. Ñð³áíà, Ì.À. Ãóëÿ-íèöüêà, Ò.Ì. Ìîâ÷àíîâñüêà, Ì.Ï. Ìîñòîâ’ÿê
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
3
Âåëüìèøàíîâíèé(-à) êîëåãî!̳í³ñòåðñòâî îõîðîíè çäîðîâ’ÿ Óêðà¿íè, Íàö³îíàëüíà àêàäåì³ÿ ìåäè÷íèõ íàóê Óêðà¿íè, Àñîö³àö³ÿ
êàðä³îëîã³â Óêðà¿íè, Ãðîìàäñüêà îðãàí³çàö³ÿ «Âñåóêðà¿íñüêà Àñîö³àö³ÿ àðèòìîëîã³â Óêðà¿íè», Àñîö³à-ö³ÿ äîñë³äíèê³â Óêðà¿íè, Âñåóêðà¿íñüêà àñîö³àö³ÿ ïðåâåíòèâíî¿ êàðä³îëî㳿 òà ðåàá³ë³òàö³¿, ÄÓ «Íà-ö³îíàëüíèé íàóêîâèé öåíòð «²íñòèòóò êàðä³îëî㳿 ³ìåí³ àêàäåì³êà Ì.Ä. Ñòðàæåñêà» ÍÀÌÍ Óêðà¿íè», Âñåóêðà¿íñüêà àñîö³àö³ÿ êàðä³îëîã³â Óêðà¿íè çàïðîøóþòü Âàñ âçÿòè ó÷àñòü ó ðîáîò³ XX Íàö³îíàëüíîãî êîíãðåñó êàðä³îëîã³â, ùî â³äáóäåòüñÿ â Êèºâ³ 25–27 âåðåñíÿ 2019 ð.
Îñíîâíå ïîñëàííÿ Êîíãðåñó — êîìîðá³äí³ñòü â êàðä³îëî㳿. Ïðîáëåìà áóäå ðîçãëÿíóòà ç ïîçèö³é ìóëüòèäèñöèïë³íàðíîãî ï³äõîäó äî âèçíà÷åííÿ òà ä³àãíîñòèêè êîìîðá³äíèõ ñòàí³â òà ìîæëèâèõ íà-ïðÿìê³â ë³êóâàííÿ.
Ó ðàìêàõ Êîíãðåñó áóäóòü ïðîâåäåí³ ñï³ëüíå çàñ³äàííÿ àðèòìîëîã³â êðà¿í Ñõ³äíî¿ òà Öåíòðàëü-íî¿ ªâðîïè, ñï³ëüíå çàñ³äàííÿ ªâðîïåéñüêîãî òîâàðèñòâà ç àòåðîñêëåðîçó, Óêðà¿íñüêîãî òîâàðèñòâà
ç àòåðîñêëåðîçó òà Ïîëüñüêî¿ ë³ï³äíî¿ àñîö³àö³¿.Âè çìîæåòå îçíàéîìèòèñÿ ç îñòàíí³ìè äîñÿãíåííÿìè íàóêè â ëåêö³ÿõ ïðîâ³äíèõ â÷åíèõ-êàðä³îëîã³â ç Ïîëüù³
(M. Banach — ïðåçèäåíò Ïîëüñêî¿ ë³ï³äíî¿ àñîö³àö³¿, M. Chudzik PhD — çàñòóïíèê äèðåêòîðà êîì³ñ³¿ ç îñâ³òè ªâðîïåé-ñüêî¿ àñîö³àö³¿ àðèòìîëîã³â), Ëèòâè (ïðîô. V. Sapoka — ãîëîâà êë³í³êè âíóòð³øí³õ õâîðîá, ñ³ìåéíî¿ ìåäèöèíè òà îíêîëî㳿 ïðè ìåäè÷íîìó ôàêóëüòåò³ ³ëüíþñüêîãî óí³âåðñèòåòó, ïðîô. Z. Petrulioniene–ïðåçèäåíò Òîâàðèñòâà àòåðîñêëåðîçó Ëèò-âè), ³ðìåí³¿ (ïðîô. Ñ.Â. Ãðèãîðÿí — ïðåçèäåíò ³ðìåíñüêî¿ àñîö³àö³¿ ðèòìó ñåðöÿ), ÑØÀ (â ðåæèì³ on-line Dr. Mikhail N. Kosiborod, MD — äèðåêòîð ãðóïè êàðä³îìåòàáîë³÷íèõ äîñë³äæåíü ²íñòèòóòó Ñâÿòîãî Ëóêè, Êàíçàñ-ѳò³).
Ñêëàäí³ êë³í³÷í³ âèïàäêè áóäóòü ïðåäñòàâëåí³ â ñåêö³¿ «Øêîëà ïðàêòèêóþ÷îãî ë³êàðÿ» òà «Êë³í³÷í³ àñïåêòè íåâ³äêëàä-íèõ ñòàí³â â êàðä³îëî㳿».
Òàêîæ ï³ä ÷àñ Êîíãðåñó äëÿ ë³êàð³â ³ç ñïåö³àëüíîñò³ «Çàãàëüíà ïðàêòèêà — ñ³ìåéíà ìåäèöèíà» áóäå ïðî÷èòàíî êóðñ ëåêö³é «Êàðä³îëîã³ÿ äëÿ ñ³ìåéíèõ ë³êàð³â» òà êóðñ «Áàçèñí³ îñíîâè àðèòìîëî㳿».
Âæå ñòàëî òðàäèö³ºþ ïðîâåäåííÿ êîíêóðñó íàóêîâèõ ðîá³ò ìîëîäèõ â÷åíèõ òà îáãîâîðåííÿ ñòåíäîâèõ äîïîâ³äåé. Çàâåðøèòüñÿ Êîíãðåñ Ãåíåðàëüíîþ àñàìáëåºþ Âñåóêðà¿íñüêî¿ àñîö³àö³¿ êàðä³îëîã³â Óêðà¿íè. Ìè âïåâíåí³, ùî Êîíãðåñ äàñòü ìîæëèâ³ñòü ò³ñíîãî íàóêîâîãî ñï³ëêóâàííÿ, ïðîôåñ³éíîãî çðîñòàííÿ òà ñîö³àëüíî¿
âçຠìî䳿 âñ³õ ó÷àñíèê³â. Ïðîòÿãîì öèõ äí³â ñï³ëêóâàííÿ äåëåãàò³â òà ãîñòåé Êîíãðåñó îá³öÿº áóòè ³íôîðìàòèâíèì òà êî-ðèñíèì.
Dear Colleague!National Academy of Medical Sciences of Ukraine, Ministry of Health of Ukraine, Ukrainian Association of Cardiology, SI «NSC
«Academic M.D. Strazhesko Institute of Cardiology» of National Academy of Medical Sciences of Ukraine» invite you to take part in the XX National Congress of Cardiologists which will be held in Kyiv on 25–27-th of September 2019.
The main message of the Congress is comorbidity in cardiology. The problem will be addressed from the standpoint of a mul-tidisciplinary approach to the definition and diagnosis of comorbidities and possible treatment trends.
In the frames of the Congress will be held the Joint Scientific Session of the European Society of Cardiology and Ukrainian Association of Cardiology, the Joint Meeting of arrhythmologists from the central and eastern Europe countries, Joint Meeting of European atherosclerosis Society and Polish Lipid Association, Joint session of the Ukraine Association of Cardioliogy.
You will have the possibility to get acquai n ted with the latest scientific achievements in lectures of the prominent sci-entists — cardiologists from Poland (M. Banach — President of Polish Lipid Association (PoLA), M. Chudzik PhD), Lithuania (prof. V. Sapoka — Head of Vilnius University Clinics of Internal Medicine, prof. Z. Petrulioniene), Armenia (prof. S.V. Grigo-ryan — President of Armenian Arrhythmological Association), USA (on-line Dr. Mikhail N. Kosiborod MD, — Director of the Cardio-metabolic Research Group at the St. Luke Institute, Kansas City).
The complex clinical events will be presented in the section : in assistance to the practicing doctor and clinical aspects of emer-gency situations in cardiology.
Also at the Congress for doctors on the specialty «General Practice — Family Medicine» will be read the course of lectures «Cardiology for Family Doctors» and the course «Basic Fundamentals of Arrhythmology».
It has already become the tradition to carry out the competition of the youg scientists’ work and the discussion of the poster reports.
The Congress will be ended by the General Assembly of the Ukraine Association of Cardiology.We are sure that the Congress wi ll give the possibility of tight commu ni cati ons, professional growth and social coopera-
tion of all participants. We hope that during these days the communication of the delegates and guests of the Congress would be very informative and useful.
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
4
ÇÀÃÀËÜÍÀ ²ÍÔÎÐÌÀÖ²ß
̳ñöå ïðîâåäåííÿ Ðîáîòà Êîíãðåñó ïðîâîäèòèìåòüñÿ â ÍÑÊ «Îë³ìï³éñüêèé» — 25–27 âåðåñíÿ 2019 ð.(âóë. Âåëèêà Âàñèëüê³âñüêà, 55)Ãîòåëü «Ðóñü» — 26 âåðåñíÿ 2019 ð.(âóë. Ãîñï³òàëüíà, 4)
Ðåºñòðàö³ÿ Ðåºñòðàö³ÿ äåëåãàò³â òà ó÷àñíèê³â:ÍÑÊ «Îë³ìï³éñüêèé» (2-é ïîâåðõ)25 âåðåñíÿ — ç 8:00 äî 18:0026 âåðåñíÿ — ç 8:00 äî 17:0027 âåðåñíÿ — ç 8:00 äî 15:00Ãîòåëü «Ðóñü» (1-é ïîâåðõ)26 âåðåñíÿ — ç 8:00 äî 18:00Çàðåºñòðîâàíèì ó÷àñíèêàì Êîíãðåñó áóäóòü íàäàí³ ïîðòôåëü äåëåãàòà, ÿêèé ì³ñòèòü çá³ðíèê òåç, ïðîãðàìó, ïîñ³áíèêè, ìåòîäè÷í³ ðåêîìåíäàö³¿, ñåðòèô³êàò ³ çàïðîøåííÿ äëÿ îòðèìàííÿ ëàí÷-áîêñó
Óðî÷èñòåâ³äêðèòòÿ
Óðî÷èñòå â³äêðèòòÿ XX Íàö³îíàëüíîãî êîíãðåñó êàðä³îëîã³â Óêðà¿íè â³äáóäåòüñÿ 25 âå-ðåñíÿ î 17:15 â ÍÑÊ «Îë³ìï³éñüêèé» (âóë. Âåëèêà Âàñèëüê³âñüêà, 55) ç ïðèâ³òàííÿ Íàö³-îíàëüíîãî àêàäåì³÷íîãî îðêåñòðó íàðîäíèõ ³íñòðóìåíò³â Óêðà¿íè
Ãåíåðàëüíà àñàìáëåÿ
Ãåíåðàëüíà Àñàìáëåÿ XX Íàö³îíàëüíîãî êîíãðåñó êàðä³îëîã³â Óêðà¿íè â³äáóäåòüñÿ 27 âåðåñíÿ î 13.15 â ÍÑÊ «Îë³ìï³éñüêèé», çàëà «Õîë ×åìï³îí³â»
Ïðî¿çä Ïðî¿çä äî ÍÑÊ «Îë³ìï³éñüêèé» òà Ãîòåëþ «Ðóñü» — ñòàíö³ÿ ìåòðî «Îë³ìï³éñüêà»
²íôîðìàö³ÿäëÿ äîïîâ³äà÷³â
Óñ³ çàëè îñíàùåí³ ìóëüòèìåä³éíèìè ïðîåêòîðàìè ³ íîóòáóêàìè. Íà êîìï’þòåðàõ âñòàíîâëåí³ îïåðàö³éíà ñèñòåìà Windows 7, MS Power Point 2010: Äîïîâ³äà÷àì íåîáõ³äíî íå ï³çí³øå í³æ çà 30 õâ äî ïî÷àòêó çàñ³äàííÿ íàäàòè ñâî¿ íîñ³¿ ³íôîðìàö³¿ (ôëåø-êàðòè, CD, DVD-äèñêè) â³ä-ïîâ³äàëüíîìó ç òåõí³÷íîãî ñóïðîâîäó â çàë³
Îðãêîì³òåò 03151, Êè¿â-151, âóë. Íàðîäíîãî îïîë÷åííÿ, 5, ÄÓ «ÍÍÖ «²íñòèòóò êàðä³îëî㳿 ³ìåí³ àêàäåì³êà Ì.Ä.Ñòðàæåñêà» ÍÀÌÍ Óêðà¿íè»Òåëåôîíè äëÿ äîâ³äîê: (044) 249-70-03, 275-66-22Ôàêñ: (044) 249-70-03, 275-42-09E-mail: [email protected]
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
5
ÃÅÍÅÐÀËÜͲ ÏÀÐÒÍÅÐÈ ÊÎÍÃÐÅÑÓ
SERVIER(Ôðàíö³ÿ)
BAYER(ͳìå÷÷èíà)
ÊÐÊÀ, ä. ä., Íîâî ìåñòî (Ñëîâåí³ÿ)
NOVARTIS(Øâåéöàð³ÿ)
ÄÀÐÍÈÖß (Óêðà¿íà)
PFIZER (ÑØÀ)
ARTERIUM(Óêðà¿íà)
BOEHRINGER INGELHEIM(ͳìå÷÷èíà)
ÃÎËÎÂͲ ÏÀÐÒÍÅÐÈ ÊÎÍÃÐÅÑÓ
ÊȯÂÑÜÊÈÉ Â²ÒÀ̲ÍÍÈÉ ÇÀÂÎÄ(Óêðà¿íà)
ÊÓÑÓÌ ÔÀÐÌ(Óêðà¿íà)
Astra Zeneca(Âåëèêà Áðèòàí³ÿ)
TAKEDA(ßïîí³ÿ)
ÒΠ«Ñàíîô³-Àâåíò³ñ Óêðà¿íà»
ÏÀÐÒÍÅÐÈ ÊÎÍÃÐÅÑÓ
ACINO (Øâåéöàð³ÿ), ASPEN PHARMA (²ðëàíä³ÿ), BERLIN-CHEMIE (ͳìå÷÷èíà), D-r REDDY’S (²íä³ÿ), EGIS Pharmaceuticals (Óãîðùèíà), GEDEON RICHTER (Óãîðùèíà), GRINDEKS (Ëàòâ³ÿ), MEDOCHEMIE LTD (ʳïð), OLFA (Ëàòâ³ÿ), PRO.MED.CS Praha a.s. (×åõ³ÿ), ROSTGROUP (Óêðà¿íà), WOERWAG PHARMA (ͳìå÷÷èíà), Áîðùàã³âñüêèé ÕÔÇ (Óêðà¿íà), ÇÄÐÀÂÎ (Óêðà¿íà), ̲ÊÐÎÕ²Ì (Óêðà¿íà), ÑÀÍÄÎÇ (ͳìå÷÷èíà/Øâåéöàð³ÿ), ÒΠ«Íîâî Íîðä³ñê Óêðà¿íà» (Äàí³ÿ), ÒΠ«Ôîðñ-Ôàðìà Äèñòðèáþøí» (Óêðà¿íà), ÒΠ«Øàéºð Óêðà¿íà» (÷àñòèíà êîìïàí³¿ TAKEDA), Þвß-ÔÀÐÌ (Óêðà¿íà)
ϳä ÷àñ ïðîâåäåííÿ Êîíãðåñó ïðàöþâàòèìóòü âèñòàâêè ë³êàðñüêèõ ïðåïàðàò³â ³ ìåäè÷íèõ âèðîá³â òà ïðèëàä³â ïðîâ³äíèõ êîìïàí³é Óêðà¿íè ³ ñâ³òó:
SERVIER (Ôðàíö³ÿ), BAYER (ͳìå÷÷èíà), ÊÐÊÀ, ä. ä., Íîâî ìåñòî, (Ñëîâåí³ÿ), NOVARTIS (Øâåéöàð³ÿ), ÄÀÐÍÈÖß (Óêðà¿ íà), PFIZER (ÑØÀ), ARTERIUM (Óêðà¿íà), Êè¿âñüêèé â³òàì³ííèé çàâîä (Óêðà¿íà), ÊÓÑÓÌ ÔÀÐÌ (Óêðà¿íà), Astra Zeneca (Âåëèêà Áðèòàí³ÿ), BOEHRINGER INGELHEIM (ͳìå÷÷èíà), TAKEDA (ßïîí³ÿ), ÒΠ«Ñàíîô³-Àâåíò³ñ Óêðà¿íà», MEDOCHEMIE LTD (ʳïð), ̲ÊÐÎÕ²Ì (Óêðà¿íà), ACINO (Øâåéöàð³ÿ), Þвß-ÔÀÐÌ (Óêðà¿íà), BERLIN-CHEMIE (ͳìå÷-÷èíà), ROSTGROUP (Óêðà¿íà), GEDEON RICHTER (Óãîðùèíà), GRINDEKS (Ëàòâ³ÿ), ÒΠ«Íîâî Íîðä³ñê Óêðà¿íà» (Äà-í³ÿ), OLFA (Ëàòâ³ÿ), ÑÀÍÄÎÇ (ͳìå÷÷èíà/Øâåéöàð³ÿ), PRO.MED.CS Praha a.s. (×åõ³ÿ), ÇÄÐÀÂÎ (Óêðà¿íà), D-r REDDY’S (²íä³ÿ), ÞÒÀÑ (Óêðà¿íà), Áîðùàã³âñüêèé ÕÔÇ (Óêðà¿íà), ASPEN PHARMA (²ðëàíä³ÿ), ALVOGEN (Óêðà¿íà), WOERWAG PHARMA (ͳìå÷÷èíà), ÒΠ«Ôîðñ-Ôàðìà Äèñòðèáþøí» (Óêðà¿íà), EGIS Pharmaceuticals (Óãîðùèíà), ÑÎÍÀ-ÔÀÐÌÅÊ-Ñ²Ì (Óêðà¿íà), ÒΠ«ÇÌ» (Óêðà¿íà), IMESÑ (Óêðà¿íà), ÓêðÒåëåÌåä (Óêðà¿íà), HOFFMANN-La ROCHE Ltd (Øâåéöàðñüêà Êîíôåäåðàö³ÿ), ÌÅÄ ÅÊÑ²Ì (Óêðà¿íà), ÔÀÐÊÎÑ (Óêðà¿íà), Ñàí Ôàðìà (Óêðà¿íà), ÊÀÐIJÎ˲ÒÀ (Ëèòâà), MUCOSPHARMA (ͳìå÷÷èíà), ÒΠ«Øàéºð Óêðà¿íà» (÷àñòèíà êîìïàí³¿ TAKEDA), SCHILLER AG (Óêðà¿íà), ÂÑÌ Óêðà¿íà.
²ÍÔÎÐÌÀÖ²ÉÍÅ ÇÀÁÅÇÏÅ×ÅÍÍß
«Óêðà¿íñüêèé êàðä³îëîã³÷íèé æóðíàë», Âèäàâíè÷èé ä³ì «ÌÎвÎÍ»: «Óêðà¿íñüêèé ìåäè÷íèé ÷àñîïèñ», Âèäàâíè÷èé ä³ì «ÇÀÑËÀÂÑÜÊÈÉ»: ãàçåòà «Íîâîñòè ìåäèöèíû è ôàðìàöèè», Âèäàâíèöòâî MEDIX: «Ìèñòåöòâî ë³êóâàííÿ», «Ë³êè Óêðà¿íè», «Ìåäè÷íà ãàçåòà «Çäîðîâ’ÿ Óêðà¿íè ÕÕ² ñòîð³÷÷ÿ», Âèäàâíè÷èé ä³ì «Çäîðîâ’ÿ Óêðà¿íè, Ìåäè÷í³ æóðíàëè»: «Ïðàêòè÷íà àíã³îëîã³ÿ», «Ðàö³îíàëüíà ôàðìàêîòåðàï³ÿ», Âèäàâíèöòâî «Ìåäêíèãà»: «Ïðàêòèêóþ÷èé ë³êàð», Æóðíàë íåâðîëî㳿 ³ì. Á.Ì. Ìàíüêîâñüêîãî, Èçäàòåëüñòâî «Ïðîôåññèîíàëüíûå èçäàíèÿ Âîñòî÷íàÿ Åâðîïà»: «Êàðäèîëîãèÿ: îò íàóêè ê ïðàêòèêå», «Óêðà¿íñüêèé ìåäè÷íèé â³ñíèê»: æóðíàë «Ôàðìàöåâò ïðàêòèê», ÒΠ«Â²Ò-À-ÏÎË» (Ñåðöå ³ ñó-äèíè), ªâðîïåéñüêà ôóíäàö³ÿ ðîçâèòêó ìåäèöèíè é îñâ³òè «ªâðîìåä», Îñâ³òíüî-³íôîðìàö³éíà îíëàéí-ïëàòôîðìà (accemedin.com), Åëåêòðîííèé íàóêîâî-ïðàêòè÷íèé æóðíàë ïðî êàðä³îëîã³þ www.webcardio.org; Óêðà¿íñüêèé êàðä³î-ëîã³÷íèé æóðíàë, ïîðòàë www.ukrcardio.org, www.strazhesko.org.ua, www.facebook.com/strazhesko/
ÐÎÇÊ
ËÀ
Ä Ç
ÀÑ
²ÄÀ
ÍÜ
ÕX
ÍÀ
Ö²Î
ÍÀ
ËÜÍ
ÎÃÎ
ÊÎ
ÍÃÐ
ÅÑÓ
ÊÀ
ÐIJÎ
ËÎ
òÂ
ÓÊ
ÐÀ¯Í
È
Ñåðåäà 25 âåðåñíÿÍ
ÑÊ «
ÎË
²ÌÏ
²ÉÑÜ
ÊÈ
É»
ÕÎË
×ÅÌ
ϲÎ
ͲÂ
Êîíô
åðåí
ö-ç
àëà
«ÑÏ
ÀÐÒ
À»
Êîíô
åðåí
ö-ç
àëà
«ÎÄ
²ÑÑÅ
É»
Êîíô
åðåí
ö-ç
àëà
«ÀË
ÜÒ²Ó
Ñ»Êî
íôåð
åíö
-çàë
à «Ñ
²Ò²Ó
Ñ»Êî
íôåð
åíö
-çàë
à «Ñ
Ïв
ÍÒ»
09:0
0–10
:00
ñ. 8
Ñï³ë
üíå
çàñ³
äàíí
ÿ ªâ
ðîïå
éñüê
îãî
òîâà
ðèñò
âà
ç àò
åðîñ
êëåð
îçó,
Óêð
à¿íñ
üêîã
î òî
âàðè
ñòâà
ç à
òåðî
-ñê
ëåðî
çó òà
Ïîë
üñüê
î¿ ë
³ï³ä
íî¿ à
ñîö³
àö³¿
(÷àñ
òèíà
ïåð
øà)
09:0
0–09
:30
ñ. 8
Ëåê
ö³ÿ
ïðî
ô. Ì
. Áàí
àõ. (
Ëîä
çü, Ï
îëüù
à)09
:30–
09:5
0 ñ.
8Ä
óìêà
ñïå
ö³à
ë³ñò
à10
:00–
13:2
0 ñ.
8–9
Íàó
êîâî
-ïðà
êòè÷
í³ ñ
èìïî
ç³óì
è
9:30
–13:
20 ñ
. 9–1
0Ë
åêö
³ÿ, ì
àéñò
åð-ê
ëà-
ñè, í
àóêî
âî-ï
ðàê-
òè÷í
³ ñèì
ïîç³
óìè,
êðóã
ë³ ñò
îëè
9:00
–12:
50 ñ
. 11
Ñåêö
³éíå
çàñ
³äàí
íÿÌ
àéñò
åð ê
ëàñ
Àðè
òìîë
îã³ÿ
: ùî
ïîâè
-íå
í çí
àòè
êîæ
åí ë
³êàð
äëÿ
ë³êà
ð³â
çà ñ
ïåö
³-àë
üí³ñ
òþ «
Çàãà
ëüíà
ïð
àêòè
êà —
ñ³ì
åéíà
ì
åäèö
èíà»
12:5
0–13
:20
ñ. 1
2Ê
ðóãë
èé ñò
³ë
9:00
–11:
00 ñ
. 13
Ñåêö
³éíå
çàñ
³äàí
íÿÖ
óêðî
âèé
ä³àá
åò11
:00–
11:2
0 ñ.
13
Äóì
êà ñ
ïåö
³àë³
ñòà
11:2
0–13
:20
ñ. 1
3–14
Ñåêö
³éíå
çàñ
³äàí
íÿÀ
êòóà
ëüí³
ïèò
àííÿ
ãå
íäåð
íî¿ ì
åäèö
èíè
9:00
–13:
20 ñ
. 15–
16Ñå
êö³é
íå ç
àñ³ä
àííÿ
Ñåðö
åâî-
ñóäè
ííà
â³-
çóàë
³çàö³
ÿ
9:00
–11:
40 ñ
. 16
Ñåêö
³éíå
çàñ
³äàí
íÿÑò
ðåñà
ñîö³
éîâà
í³ ê
îìîð
á³äí
³ ðî
çëàä
è çä
îðîâ
’ÿ ó
ïîñ
òðàæ
-äà
ëèõ
âíàñ
ë³äî
ê çá
ðîéí
îãî
êîíô
ë³êò
ó11
:40–
13:2
0 ñ.
17–
18Ñå
êö³é
íå ç
àñ³ä
àííÿ
Íàó
êîâî
-ä³à
ãíîñ
òè÷í
³ äî-
ñë³ä
æåí
íÿ â
êàð
ä³îë
îã³÷
íó
ïðàê
òèêó
13:2
0–14
:00
ÏÅÐ
ÅÐÂÀ
14.0
0–14
.40
ñ. 9
̳æ
äèñö
èïë³
íàðí
èé ê
ðóãë
èé ñò
³ëÌ
îæëè
âîñò
³ êîì
á³íî
âàíî
¿ àíò
èã³ï
åðòå
íçèâ
íî¿
òåðà
ﳿ à
ìëî
äèï³
í +
âàë
ñàðò
àí +
ã³äð
îõëî
ðîò³à
çèä
14.4
0–15
.20
ñ. 9
Íàó
êîâî
-ïðà
êòè÷
íèé
ñèì
ïîç³
óìÍ
îâ³ ì
îæëè
âîñò
³ àíò
èêîà
ãóëÿ
íòíî
¿ òåð
àﳿ
ó ïà
ö³ºí
-ò³â
ç Í
ÔÏ
òà Ã
ÊÑ15
.20–
16.5
0 ñ.
9–1
0Í
îâèí
è ç
ªâðî
ïåéñ
üêîã
î êî
íãðå
ñó–2
019
Îãë
ÿä ð
åêîì
åíäà
ö³é
ºâðî
ïåéñ
üêîã
î òî
âàðè
ñòâà
êà
ðä³î
ëîã³â
201
9 ð.
14:0
0–16
:40
ñ. 1
0–11
Íàó
êîâî
-ïðà
êòè÷
í³
ñèì
ïîç³
óìè,
êðó
ãë³
ñòîë
è, ï
ðîáë
åìí³
äî
ïîâ³
ä³
14:0
0–16
:30
ñ. 1
2Ñå
êö³é
íå ç
àñ³ä
àííÿ
Ëåê
ö³¿ ä
ëÿ ë
³êàð
³â
çà ñ
ïåö³
àëüí
³ñòþ
«Çà
-ãà
ëüíà
ïðà
êòèê
à —
ñ³-
ìåé
íà ì
åäèö
èíà»
16:3
0–16
:50
ñ. 1
13Ê
ðóãë
èé ñò
³ë
14:0
0–14
:30
ñ. 1
4Ê
ðóãë
èé ñò
³ë14
:30–
16:5
0 ñ.
14
Ñåêö
³éíå
çàñ
³äàí
íÿ
Êàðä
³îöå
ðåáð
àëüí
³ ïî
ðóø
åííÿ
: ïîø
óêè
êîì
îðá³
äíîñ
ò³
14:0
0–14
:40
ñ. 1
6Ê
ðóãë
èé ñ
ò³ë
Ïàö
³ºíò
ç òÿ
æêî
þ Ñ
Í: ô
îêóñ
íà
àêò
èâí³
é ä³
óðåò
è÷í³
é òå
ðàï³
¿14
:40–
16:4
0 ñ.
16
Ñåêö
³éíå
çàñ
³äàí
íÿÊî
ëåã³à
ëüí³
ð³ø
åííÿ
â ñ
òðà-
òåã³ÿ
õ ïð
îô³ë
àêòè
êè òà
ë³-
êóâà
ííÿ
ñåðö
åâî-
ñóäè
ííèõ
óñ
êëàä
íåíü
ïðè
ïðî
âåäå
íí³
ïðîò
èïóõ
ëèíí
î¿ òå
ðàï³
¿
14:0
0–16
:30
ñ. 1
8–19
Êîíê
óðñ
ìîë
îäèõ
â÷å
íèõ
16:5
0–17
:15
ÒÅÕ
Ͳ×
ÍÀ
ÏÅÐ
ÅÐÂÀ
ÍÑÊ
«Î
˲Ì
ϲÉ
ÑÜÊ
ÈÉ
» (Õ
ÎË
×ÅÌ
ϲÎ
ͲÂ
)
17:1
5 Óð
î÷èñ
òå â
³äêð
èòòÿ
Êîí
ãðåñ
óÍ
àãîð
îäæ
åííÿ
Ðàóò
äëÿ
âñ³
õ ó÷
àñíè
ê³â
Êîíã
ðåñó
×åòâåð 26 âåðåñíÿ
ÍÑÊ
«Î
˲Ì
ϲÉ
ÑÜÊ
ÈÉ
»Ãî
òåëü
«Ðó
ñü»
ÕÎË
×ÅÌ
ϲÎ
ͲÂ
Êîíô
åðåí
ö-ç
àëà
«ÑÏ
ÀÐÒ
À»
Êîíô
åðåí
ö-ç
àëà
«ÎË
²ÌÏ
²ß»
Êîíô
åðåí
ö-ç
àëà
«ÎÄ
²ÑÑÅ
É»
Êîíô
åðåí
ö-ç
àëà
«ÀË
ÜÒ²Ó
Ñ»Âå
ëèêà
êîí
ôåð
åíö
-çàë
à«E
», «
À»,
«B,
Ñ, D
»
9:00
-11:
20 ñ
. 19
Ïëå
íàðí
å çà
ñ³äà
ííÿ
Ãîñò
ðèé
êîðî
íàðí
èé
ñèíä
ðîì
òà ³í
ø³ í
åâ³ä
-êë
àäí³
ñòà
íè11
:20-
13:2
0 ñ.
20
Ïëå
íàðí
å çà
ñ³äà
ííÿ
Ïðà
êòè÷
í³ à
ñïåê
òè í
å-â³
äêëà
äíî¿
êàð
ä³îë
î㳿
³ êîì
îðá³
äí³ñ
òü(÷
àñòè
íà ï
åðø
à)
9:00
–11:
30 ñ
. 21–
22Ï
ëåíà
ðíå
çàñ³
äàíí
ÿÑò
àá³ë
üíà
³øåì
³÷íà
õâ
îðîá
à ñå
ðöÿ:
ä³à
-ãí
îñòè
êà, ñ
òðàò
èô³ê
à-ö³
ÿ ðè
çèêó
, ïðî
ô³ë
àê-
òèêà
, ë³ê
óâàí
íÿ11
:30–
13:2
0 ñ.
22
Ëåê
ö³ÿ
, êðó
ãë³ ñ
òîëè
9:00
–13:
20 ñ
. 23–
24Ì
àéñò
åð-ê
ëàñè
, êð
óãë³
ñòîë
è, ë
åêö
³ÿ,
àêòó
àëüí
à äè
ñêóñ
³ÿ
9:00
–11:
40 ñ
. 25
Ñåêö
³éíå
çàñ
³äàí
íÿØ
êîëà
ïðà
êòèê
óþ÷î
ãî
ë³êà
ðÿ (ê
ë³í³
÷í³ â
è-ïà
äêè)
11:4
0–12
:50
ñ. 2
5–26
Ñåêö
³éíå
çàñ
³äàí
íÿÍ
îâ³ ò
åíäå
íö³¿
â ë³
êóâà
íí³ ñ
åðöå
âî-
ñóäè
ííèõ
çàõ
âîðþ
-âà
íü. Ä
îêàç
îâà
ìåä
è-öè
íà òà
ðåê
îìåí
äàö³
¿
9:00
–11:
20 ñ
. 27
Ñåêö
³éíå
çàñ
³äàí
íÿÌ
óëüò
èôàê
òîðí
à êî
ðåêö
³ÿ ñ
åðöå
âî-ñ
óäèí
íîãî
ðèç
èêó
11:2
0–12
:30
ñ. 2
7Ñï
³ëüí
å çà
ñ³äà
ííÿ
ªâðî
ïåéñ
üêîã
î òî
âàðè
ñòâà
ç à
òå-
ðîñê
ëåðî
çó, Ó
êðà¿
íñüê
îãî
òîâà
ðèñò
âà ç
àòå
ðîñê
ëåðî
çó
òà Ï
îëüñ
üêî¿
ë³ï
³äíî
¿ àñî
ö³àö
³¿ (÷
àñòè
íà ä
ðóãà
)12
:30—
12:5
0 ñ.
27
Ïðî
áëåì
íà ä
îïîâ
³äü
12:5
0—13
:20
ñ. 2
7Ì
àéñò
åð ê
ëàñ
9:00
–9:3
0 ñ.
29
Ëåê
ö³ÿ
: Î.Ñ
. Ñè÷
îâ (Ê
è¿â)
9:30
-11:
45 ñ
. 29_
30Ñå
êö³é
íå ç
àñ³ä
àííÿ
Àíò
èòðî
ìáî
òè÷í
à òå
ðàï³
ÿ ó
õâî-
ðèõ
ç ô
³áðè
ëÿö³
ºþ ï
åðåä
ñåðä
ü11
:45-
13:2
0 ñ.
30
Ñï³ë
üíå
çàñ³
äàíí
ÿ êð
à¿í
Ñõ³ä
íî¿
òà Ö
åíòð
àëüí
î¿ ª
âðîï
èÀ
ðèòì
³¿ òà
ðàï
òîâà
ñåð
öåâà
ñì
åðòü
13:2
0–14
:00
ÏÅÐ
ÅÐÂÀ
×åòâåð 26 âåðåñíÿ
ÍÑÊ
«Î
˲Ì
ϲÉ
ÑÜÊ
ÈÉ
»Ãî
òåëü
«Ðó
ñü»
ÕÎË
×ÅÌ
ϲÎ
ͲÂ
Êîíô
åðåí
ö-ç
àëà
«ÑÏ
ÀÐÒ
À»
Êîíô
åðåí
ö-ç
àëà
«ÎË
²ÌÏ
²ß»
Êîíô
åðåí
ö-ç
àëà
«ÎÄ
²ÑÑÅ
É»
Êîíô
åðåí
ö-ç
àëà
«ÀË
ÜÒ²Ó
Ñ»Çà
ëàE,
AÇà
ëàB,
C, D
Çàëà F,
14:0
0–15
:45
ñ. 2
0Ï
ëåí
àðí
å çà
ñ³ä
àíí
ÿÏ
ðàêò
è÷í³
àñï
åêòè
íå-
â³äê
ëàäí
î¿ ê
àðä³
îëîã
³¿ ³ ê
îìîð
á³äí
³ñòü
(÷àñ
òèíà
äðó
ãà)
14:0
0–14
:45
ñ. 2
0Òå
ëåì
³ñò
Óêðà
¿íà
— Ñ
ØÀ
ÃÊÑ
³ öó
êðîâ
èé ä
³àáå
ò14
:45–
15:4
5 ñ.
20
Êðó
ãëè
é ñ
ò³ë,
ëåê
ö³ÿ
15:4
5–18
:15
ñ. 2
0–21
Ïëå
íàð
íå
çàñ³
äàí
íÿ
Ñï³
ëüíå
çàñ
³äàí
íÿ
Âñåó
êðà¿
íñüê
î¿ à
ñî-
ö³àö
³¿ ³í
òåðâ
åíö³
éíèõ
êà
ðä³î
ëîã³
â Óê
ðà¿í
è òà
Àñî
ö³àö
³¿ êà
ðä³î
õ³-
ðóðã
³â Ó
êðà¿
íè
14:0
0–14
:30
ñ. 2
2Ê
ðóãë
èé
ñò³
ëÀ
íòèã
³ïåð
òåíç
èâíà
òå
ðàï³
ÿ ó
õâîð
îãî
íà ö
óêðî
âèé
ä³àá
åò:
åôåê
òèâí
³ñòü
çàð
àäè
æèò
òÿ14
:30–
17:3
0 ñ.
22–
23Ï
ëåí
àðí
å çà
ñ³ä
àíí
ÿÀ
ðòåð
³àëü
íà ã
³ïåð
-òå
íç³ÿ
14:0
0–14
:30
ñ. 2
4Ì
àéñò
åð-ê
ëàñ
Âèïð
àâäà
í³ í
à䳿
àáî
íîâå
â ë
³êóâ
àíí³
ïàö
³ºíò
³â
³ç õ
ðîí³
÷íîþ
ñåð
öåâî
þ í
å-äî
ñòàò
í³ñò
þ ³
çáåð
åæåí
îþ
ôðà
êö³º
þ â
èêèä
ó14
:30–
18:0
0 ñ.
24–
25Ï
ëåí
àðí
å çà
ñ³ä
àíí
ÿÑ
åðöå
âà í
åäîñ
òàòí
³ñòü
14:0
0–14
:30
ñ. 2
6Ê
ðóãë
èé
ñò³
ë«Ä
²ÀÌ
ÀÍ
Ò» â
ï³ä
õîä³
äî
ïåð
ñîí³
ô³ê
îâàí
î-ãî
ë³ê
óâàí
íÿ ³ø
å쳿
ì³î
êðàä
à14
:30–
16:3
0 ñ.
26–
27Ï
ëåí
àðí
å çà
ñ³ä
àíí
ÿÊî
ìîð
á³äí
³ ñòà
íè
â êà
ðä³î
ëîã³
¿16
:30–
17:0
0 ñ.
27
Êðó
ãëè
é ñ
ò³ë
Ïåð
èïàð
òàëü
íà ê
àðä³
î-ì
³îïà
ò³ÿ
ç òî
÷êè
çîðó
êà
ðä³î
ëîãà
òà
ã³íå
êî-
ëîãà
: ä³à
ëîã
ïðîô
åñ³-
îíàë
³â17
:00–
17:2
0 ñ.
27
Ïðî
áëåì
íà
äîï
îâ³ä
üC
ó÷àñ
í³ ï
îçèö
³¿ ñò
à-òè
íîòå
ðàï³
¿ ó õ
âîðè
õ ç
êàðä
³îâñ
êóëÿ
ðíîþ
ïà
òîëî
㳺þ
14:0
0–17
:50
ñ. 2
8–29
Ïëå
íàð
íå
çàñ³
äàí
íÿ
Ëåã
åíåâ
à ã³
ïåðò
åíç³
ÿ â
êë³í
³÷íè
õ âè
ïàäê
àõ
14:0
0–16
:45
ñ. 3
0–31
Cåê
ö³é
íå
çàñ³
äàí
íÿ
Àðè
ò쳿
³ êîì
îð-
á³äí
³ñòü
16:4
5–17
:45
ñ. 3
1C
åêö
³éí
å çà
ñ³ä
àíÿ
Êë³í
³÷í³
âèï
àäêè
14:0
0–14
:30
ñ. 3
1Ê
ðóãë
èé
ñò³
ëÒå
ðàï³
ÿ ô
³áðè
ëÿ-
ö³¿ ï
åðåä
ñåðä
ü —
ª
âðîï
åéñü
ê³
ðåêî
ìåí
äàö³
¿ òà
âëà
ñíèé
äî-
ñâ³ä
14:3
0–15
:10
ñ. 3
1Ï
ðîáë
åìí
³ äî-
ïîâ³
ä³
15:1
0–17
:45
ñ. 3
2C
åêö
³éí
å çà
ñ³ä
àíÿ
²íòå
ðâåí
ö³éí
à àð
èòì
îëîã
³ÿ
14:0
0–17
:40
ñ. 3
2–33
Ìàé
ñòåð
-êë
àñè
Ïðà
êòè÷
í³
íàâè
÷êè
äëÿ
ë³êó
âàíí
ÿ õâ
îðèõ
³ç
ïîð
óøåí
-íÿ
ìè
ðèòì
ó òà
ïðî
â³ä-
íîñò
³ ñåð
öÿ
Ï’ÿòíèöÿ 27 âåðåñíÿ
ÍÑÊ
«Î
˲Ì
ϲÉ
ÑÜÊ
ÈÉ
»Õ
ÎË
×ÅÌ
ϲÎ
ͲÂ
Êîí
ôåð
åíö
-çàë
à «Î
IJÑ
ÑÅÉ
»Êî
íô
åðåí
ö-ç
àëà
«ÀË
ÜÒ²Ó
Ñ»
9:00
–9:3
0 ñ.
33
Ëåê
ö³ÿ
Î.À
. Êðè
êóíî
â9:
30–1
3:00
ñ. 3
3–34
Ïëå
íàð
íå
çàñ³
äàí
íÿ
Õâî
ðîáè
ì³î
êàðä
à, å
íäîê
àðäà
òà
êëàï
àí³â
ñåð
öÿ
9:00
–11:
30 ñ
. 34–
35Ï
ëåí
àðí
å çà
ñ³ä
àíí
ÿ²í
íîâà
ö³¿ ä
³àãí
îñòè
êè ò
à ë³
êóâà
ííÿ
àðòå
ð³àë
üíî¿
ã³ï
åðòå
í糿
10:5
0–11
:20
ñ. 3
5Ì
àéñò
åð-ê
ëàñ
Òåðà
ï³ÿ
õâîð
èõ í
à öó
êðîâ
èé ä
³àáå
ò 2
-ãî
òèïó
: ÿê
ïîêð
àùèò
è ñå
ðöåâ
î-ñó
äèí-
íèé
ïðîã
íîç
11:2
0–11
:30
ñ. 3
5Ä
óìêà
ñïå
ö³à
ë³ñò
àÌ
³ñöå
ïîä
â³éí
î¿ ³
ïîòð
³éíî
¿ êîì
á³íî
âàíî
¿ àíò
èã³ï
åðòå
íçèâ
íî¿ ò
åðàï
³¿ â
ñó÷à
ñ-íè
õ ñõ
åìàõ
ë³ê
óâàí
íÿ11
:30–
13:1
5 ñ.
35–
36Ñ
åêö
³éí
å çà
ñ³ä
àíí
ÿÁ³
îìàð
êåðè
ó ê
àðä³
îëîã
³¿
9:00
–12:
00 ñ
. 36
Ìàñ
òåð-
êëàñ
êàð
ä³î
ëîãà
ç í
åâðî
ëîãî
ì:
âðÿò
óºì
î Óê
ðà¿í
ó â³
ä ³í
ñóëü
ò³â
ðàçî
ì9:
30–1
3:00
ñ. 3
6–37
Ïëå
íàð
íå
çàñ³
äàí
íÿ
Àêò
óàëü
í³ ï
èòàí
íÿ ï
ðåâå
íòèâ
íî¿ ê
àðä³
îëîã
³¿ òà
ðåà
á³ë³
òàö³
¿
ÍÑÊ
«Î
˲Ì
ϲÉ
ÑÜÊ
ÈÉ
» (Õ
ÎË
×ÅÌ
ϲÎ
ͲÂ
)13
:15—
15:3
0 ñ.
34
Ãåí
åðàë
üíà
àñàì
áëåÿ
Çàêð
èòò
ÿ Êî
íãð
åñó
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
8
25 â
åðåñ
íÿ
(ñåð
åäà)
PROGRAM OF MEETINGS25-TH OF SEPTEMBER (WEDNESDAY)
NSK «OLYMPIYSKIY»
HALL OF CHAMPIONS9:00–10:00 Joint meeting of the European Atherosclerosis Society, Ukrainian Atherosclerosis Society and Polish Lipid AssociationModerators: prof. O.I. Mitchenko, prof. M.I. Lutay, prof.
M. Banach, prof. Z. Petrulioniene Part One
9:00–9:30 Lecture: Prof. M. Banakh., President of the Polish Mother’s Memorial Hospital Research Institute, President of the Polish Lipid Association (PoLA), EAS Advisor in Matters related to EU Relations, (Lodz, Poland)New aspects of hypolipidemic therapy
9:30–9:50 Opinion of the specialistDiagnosis and treatment of family hypercholesterolemia in Ukraine. The role of inhibitors of PCSK9
prof. O.I. Mitchenko (Kyiv) – 20 minDiscussion – 10 min
10:00–10:40 Scientific-practical symposiumPrimary and secondary prevention: is there a difference in approach?Participants: prof. O.Y. Zharinov, L.A. Mishchenko MD (Kyiv)
10:40–11:20 Scientific-practical symposiumAnticoagulation with NOAC in high CV risk: management in CAD and in nvAF patients
Participants: prof. O.S. Sychov (Kyiv), prof. O.A. Koval (Dni-pro)
11:20–12:00 Scientific-practical symposiumThe role of combined neprilysine/angiotensin II receptor blockade in realization of personalized treatment strategy in chronic heart failureParticipauts: prof. L.G. Voronkov, prof. O.M. Parkhomenko
(Kyiv)
12:00–12:40 Scientific-practical symposium 1. AH treatment for patient with T2D: evidence-based
choice
prof. S.A. Tykhonova (Odesa) – 10 min2. Patient with CHD and AH: practical aspects of treat-
mentO.I. Irkin MD (Kyiv) – 10 min
3. Combined antihypertensive therapy in patients with comorbiditiesL.A. Mishchenko MD (Kyiv) — 10 min
Discussion — 10 min
ÏÐÎÃÐÀÌÀ ÇÀѲÄÀÍÜ25 ÂÅÐÅÑÍß (ÑÅÐÅÄÀ)
ÍÑÊ «Î˲ÌϲÉÑÜÊÈÉ»
ÕÎË ×ÅÌϲÎͲÂ9:00–10:00 Ñï³ëüíå çàñ³äàííÿ ªâðîïåéñüêîãî òîâàðè-ñòâà ç àòåðîñêëåðîçó, Óêðà¿íñüêîãî òîâàðèñòâà ç àòåðî-ñêëåðîçó òà Ïîëüñüêî¿ ë³ï³äíî¿ àñîö³àö³¿ Ìîäåðàòîðè: ïðîô. Î.². ̳ò÷åíêî, ïðîô. Ì.². Ëóòàé, ïðîô.
Ì. Áàíàõ, ïðîô. Æ. Ïåòðóë³îí³íå ×àñòèíà ïåðøà
9:00–9:30 Ëåêö³ÿ: ïðîô. Ì. Áàíàõ (Ëîäçü, Ïîëüùà), Presi-dent of Polish Mother’s Memorial Hospital Research Institute, President of Polish Lipid Association (PoLA), EAS Advisor in Mat-ters related to EU Relations, Poland, Lodz
Íîâ³ àñïåêòè ã³ïîë³ï³äåì³÷íî¿ òåðàﳿ
9:30–9:50 Äóìêà ñïåö³àë³ñòàijàãíîñòèêà òà ë³êóâàííÿ ñ³ìåéíèõ ã³ïåðõîëåñòåðèíåì³é â Óêðà¿í³. Ðîëü ³íã³á³òîð³â PCSK9
ïðîô. Î.². ̳ò÷åíêî (Êè¿â) — 20 õâÎáãîâîðåííÿ — 10 õâ
10:00–10:40 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óìÏåðâèííà ³ âòîðèííà ïðîô³ëàêòèêà: ÷è º ð³çíèöÿ â ï³äõîäàõ?Ó÷àñíèêè: ïðîô. Î.É. Æàð³íîâ, ä.ì.í. Ë.À. ̳ùåíêî (Êè¿â)
10:40–11:20 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óìÀíòèêîàãóëÿíòíà òåðàï³ÿ ÍÎÀÊ ó ïàö³ºíò³â âèñîêîãî ñåðöåâî-ñóäèííîãî ðèçèêó: îñîáëèâîñò³ çàñòîñóâàííÿ ó õâîðèõ ³ç ñèíóñîâèì ðèòìîì òà çà íàÿâíîñò³ íÔÏ Ó÷àñíèêè: ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â), ïðîô.Î.À. Êîâàëü
(Äí³ïðî)
11:20–12:00 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óìÐîëü êîìá³íîâàíî¿ áëîêàäè íåïðèë³çèíó òà ðåöåïòîð³â àíã³îòåíçèíó ²² ó ðåàë³çàö³¿ ñòðàòå㳿 ïåðñîí³ô³êîâàíîãî ë³êóâàííÿ ïðè õðîí³÷í³é ñåðöåâ³é íåäîñòàòíîñò³Ó÷àñíèêè: ïðîô. Ë.Ã.Âîðîíêîâ, ïðîô. Î.Ì. Ïàðõîìåíêî
(Êè¿â)
12:00–12:40 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì1. Àíòèã³ïåðòåíçèâíà òåðàï³ÿ äëÿ ïàö³ºíò³â ç öóêðî-
âèì ä³àáåòîì 2-ãî òèïó: âèá³ð íà äîêàçîâèõ çàñà-äàõïðîô. Ñ.À. Òèõîíîâà (Îäåñà) — 10 õâ
2. Ïàö³ºíò ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ òà àðòåð³-àëüíîþ ã³ïåðòåí糺þ: ïðàêòè÷í³ àñïåêòè ë³êóâàííÿä.ì.í. Î.². ²ðê³í (Êè¿â) — 10 õâ
3. Êîìá³íîâàíà àíòèã³ïåðòåíçèâíà òåðàï³ÿ äëÿ ïàö³-ºíò³â ç êîìîðá³äíèìè ñòàíàìèä.ì.í. Ë.À. ̳ùåíêî (Êè¿â) — 10 õâ
Îáãîâîðåííÿ — 10 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
9
25th
of
Sept
embe
r (W
edne
sday
)
12:40–13:20 Scientific-practical symposium1. Does treatment of AH with beta-blockers depend
on stage of disease?prof. Yu.M. Sirenko (Kyiv) – 20 min
2. Metabolic agents in treatment of ischemic heart dis-ease: how to choose?prof. E.G. Nesukay (Kyiv) – 20 min
13:00–14:00 BREAK
14:00–14:40 Interdisciplinary Round tableFeasibility of combination antihypertensive therapy amlodipine + valsartan + hydrochlorothiazideParticipauts: prof. M. Banach (Poland, Lodz), L.A. Mishchenko
MD (Kyiv), Z.M. Kravchuk PhD (Kyiv)
14:40–15:20 Scientific-practical symposiumNew possibility anticoagulant therapy for treatment of patients with NAF and ACS1. Antithrombotic therapy after Acute Coronary Syn-
drome or PCI in Atrial Fibrillation
prof. O.S. Sychov(Kyiv) – 20 min2. Will the results of the AUGUSTUS study change the
guidelines for the management of patients with AF?O.I. Irkin MD (Kyiv) – 20 min
15:20–16:50 Hotline ESC 20192019 ESC GUIDELINES OVERVIEW
1. 2019 ESC Guidelines on Stable CAD
prof. Yu.M. Sirenko – 15 min2. 2019 ESC/EAS Guidelines on Dyslipidaemias
prof. O.I. Mitchenko – 15 min3. 2019 ESC Guidelines on Supraventricular Tachycardia
prof. O.S. Sychov – 15 min4. 2019 ESC Guidelines on Acute Pulmonary Embolism
prof. O.M. Parkhomenko – 15 min5. 2019 ESC/EASD Guidelines on Diabetes, Pre-diabetes,
and Cardiovascular Diseasesprof. E.G. Nesukay – 15 min
16:50–17:15 TECHNICAL BREAK
17:15 Grand opening of the congressCongratulations to the participants of the ÕX National Congress of Cardiologists of UkraineAwardingProblem lectureComorbidity and cardiovascular continuum — a new paradigm in cardiology Awarding
acad. of NAMS of Ukraine, prof. V.M. KovalenkoRout for all Congress members
CONFERENCE HALL «SPARTA»9:00–9:30 Lecture: prof. M.M. Oros (Uzhhorod)Myofascial syndrome as a cause of heart pain
12:40–13:20 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì1. ×è çàëåæèòü ë³êóâàííÿ Àà áåòà-áëîêàòîðîì â³ä ñòà-
䳿 çàõâîðþâàííÿ? ïðîô. Þ.Ì. ѳðåíêî (Êè¿â) — 20 õâ
2. Ìîäóëÿòîðè ìåòàáîë³çìó ó ë³êóâàíí³ ³øåì³÷íî¿ õâîðîáè ñåðöÿ: ÿê îáðàòè?ïðîô. Î.Ã. Íåñóêàé (Êè¿â) — 20 õâ
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–14:40 ̳æäèñöèïë³íàðíèé êðóãëèé ñò³ëÌîæëèâîñò³ êîìá³íîâàíî¿ àíòèã³ïåðòåíçèâíî¿ òåðàﳿ àìëîäèï³í + âàëñàðòàí + ã³äðîõëîðîò³àçèäÓ÷àñíèêè: ïðîô. Ì. Áàíàõ (Ëîäçü, Ïîëüùà), ä.ì.í. Ë.À. ̳-
ùåíêî, ê.á.í. Æ.Ì. Êðàâ÷óê (Êè¿â)
14:40–15:20 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óìÍîâ³ ìîæëèâîñò³ àíòèêîàãóëÿíòíî¿ òåðàﳿ ó ïàö³ºíò³â ç ÍÔÏ òà ÃÊÑ1. Àíòèòðîìáîòè÷íà òåðàï³ÿ ïàö³ºíò³â ç ÍÔÏ ï³ñëÿ ãî-
ñòðîãî êîðîíàðíîãî ñèíäðîìó àáî ÷åðåçøê³ðíîãî êîðîíàðíîãî âòðó÷àííÿ ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â) — 20 õâ
2. ×è çì³íÿòü ðåçóëüòàòè äîñë³äæåííÿ AUGUSTUS ðå-êîìåíäàö³¿ ç âåäåííÿ ïàö³ºíò³â ç ÔÏ?ä.ì.í. Î.². ²ðê³í (Êè¿â) — 20 õâ
15:20–16:50 Íîâèíè ç ªâðîïåéñüêîãî êîíãðåñó–2019 ÎÃËßÄ ÐÅÊÎÌÅÍÄÀÖ²É ªÂÐÎÏÅÉÑÜÊÎÃÎ ÒÎÂÀÐÈÑÒÂÀ ÊÀÐIJÎËÎò 2019 ð.1. Ðåêîìåíäàö³¿ ùîäî ñòàá³ëüíî¿ ³øåì³÷íî¿ õâîðîáè
ñåðöÿïðîô. Þ.Ì. ѳðåíêî — 15 õâ
2. Ðåêîìåíäàö³¿ ùîäî äèñë³ï³äå쳿ïðîô. Î.². ̳ò÷åíêî — 15 õâ
3. Ðåêîìåíäàö³¿ ùîäî íàäøëóíî÷êîâî¿ òàõ³êàð䳿ïðîô. Î.Ñ. Ñè÷îâ — 15 õâ
4. Ðåêîìåíäàö³¿ ùîäî ãîñòðî¿ ëåãåíåâî¿ åìáî볿ïðîô. Î.Ì. Ïàðõîìåíêî — 15 õâ
5. Ðåêîìåíäàö³¿ ùîäî ä³àáåòó, ïåðåää³àáåòó òà ñåðöåâî- ñóäèííèõ çàõâîðþâàíü ïðîô. Î.Ã. Íåñóêàé — 15 õâ
16:50–17:15 ÒÅÕͲ×ÍÀ ÏÅÐÅÐÂÀ
17:15 Óðî÷èñòå â³äêðèòòÿ êîíãðåñó³òàííÿ ó÷àñíèêàì ÕX Íàö³îíàëüíîãî êîíãðåñó êàðä³îëîã³â Óêðà¿íè ÍàãîðîäæåííÿÏðîáëåìíà äîïîâ³äüÊîìîðá³äí³ñòü òà ñåðöåâî-ñóäèííèé êîíòèíóóì — íîâà ïàðàäèãìà â êàðä³îëî㳿
àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ì. ÊîâàëåíêîÐàóò äëÿ âñ³õ ó÷àñíèê³â Êîíãðåñó
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÑÏÀÐÒÀ»9:00–9:30 Ëåêö³ÿ: ïðîô. Ì.Ì. Îðîñ (Óæãîðîä) ̳îôàñö³àëüíèé ñèíäðîì ÿê ïðè÷èíà áîëþ â ä³ëÿíö³ ñåðöÿ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
10
25 â
åðåñ
íÿ
(ñåð
åäà)
9:30–10:00 Master class (clinical analysis)Optimization of antithrombotic therapy in patients with NAF and ACSParticipanyts: O.M. Romanova PhD, O.I. Irkin MD (Kyiv)
10:00–10:30 Scientific-practical symposium1. Secondary arterial hypertension and fixed combina-
tions for monitoring blood pressureprof. Yu.M. Sirenko (Kyiv) – 15 min
2. Pseudoreflective hypertension, control of blood pres-sure in Ukraineprof. T.V. Kolesnyk (Dnipro) — 15 min
10:30–11:00 Master classEra of NOACs in anticoagulant treatment of VTE patients: from guidelines to the clinical practice
corr.-member of NAMS of Ukraine, prof. O.M. Parkhomenko (Kyiv)
11:00–11:30 Scientific-practical symposium1. The efficacy of statin therapy for the prevention of car-
diovascular disease: ROSOVOSTATINprof. Yu.M. Sirenko (Kyiv) – 15 min
2. Modern principles of hypolipidemic and antiplatelet therapy, taking into account current international rec-ommendationsL.A.Mishchenko MD (Kyiv) – 15 min
11:30–12:00 Master classAppreciation of the Omega-3 (840 mg) efficacy and safety in patients with heart rhythm disturbances on the IHD backgroundParticipanyts: prof. T.V. Talaeva, O.M. Romanova PhD (Kyiv)
12:00–12:50 Scientific-practical symposium1. Recent recommendations on the use of anticoagulant
therapyprof. O.S. Sychov (Kyiv) – 20 min
2. Clinical pharmacology of anticoagulant therapy
prof A.V. Zaichenko (Kyiv) – 20 minDiscussion — 10 min
12:50–13:20 Scientific-practical symposiumSecondary prevention of cardiovascular diseases: reality and new guidelinesParticipanyts: corr.-member of NAMS of Ukraine, prof.
O.M. Parkhomenko (Kyiv), prof. Î.À. Koval (Dnipro)
13:20–14:00 BREAK
14:00–14:40 Scientific-practical symposiumPreventing of athero-trombotic events in patients with coronary disease1. Adherence in ACS patients: when should we start
to fight?corr.-member of NAMS of Ukraine prof. O.M. Parkhomen-ko (Kyiv) – 20 min
9:30–10:00 Ìàéñòåð-êëàñ (êë³í³÷íèé ðîçá³ð)Îïòèì³çàö³ÿ àíòèòðîìáîòè÷íî¿ òåðàﳿ ó ïàö³ºíò³â ç ÍÔÏ òà ãîñòðèì êîðîíàðíèì ñèíäðîìîì Ó÷àñíèêè: ê.ì.í. Î.Ì. Ðîìàíîâà, ä.ì.í. Î.². ²ðê³í (Êè¿â)
10:00–10:30 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì 1. Âòîðèíí³ àðòåð³àëüí³ ã³ïåðòåí糿 ³ ô³êñîâàí³ êîìá³-
íàö³¿ äëÿ êîíòðîëþ ÀÒïðîô. Þ.Ì. ѳðåíêî (Êè¿â) — 15 õâ
2. Ïñåâäîðåçèñòåíòí³ ÀÃ, ïðîáëåìè êîíòðîëþ ÀÒ â Óêðà-¿í³ïðîô. Ò.Â. Êîëåñíèê (Äí³ïðî) — 15 õâ
10:30–11:00 Ìàéñòåð-êëàñÅðà ÍÎÀÊ â àíòèêîàãóëÿíòí³é òåðàﳿ ïàö³ºíò³â ³ç ÂÒÅ: â³ä ðåêîìåíäàö³é äî êë³í³÷íî¿ ïðàêòèêè
÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõîìåíêî (Êè¿â)
11:00–11:30 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì1. Åôåêòèâí³ñòü òåðàﳿ ñòàòèíàìè äëÿ ïðîô³ëàêòèêè
ñåðöåâî-ñóäèííèõ çàõâîðþâàíü: ÐÎÇÓÂÀÑÒÀÒÈÍïðîô. Þ.Ì. ѳðåíêî (Êè¿â) — 15 õâ
2. Ïðèíöèïè ã³ïîë³ï³äåì³÷íî¿ òà àíòèòðîìáîöèòàðíî¿ òåðàﳿ ç óðàõóâàííÿì ñó÷àñíèõ ì³æíàðîäíèõ ðå-êîìåíäàö³éä.ì.í. Ë.À. ̳ùåíêî (Êè¿â) — 15 õâ
11:30–12:00 Ìàéñòåð-êëàñÎö³íêà êë³í³÷íî¿ åôåêòèâíîñò³ òà áåçïåêè îìåãà-3 (840 ìã) ó õâîðèõ ç ïîðóøåííÿìè ðèòìó ñåðöÿ íà ôîí³ ³øåì³÷íî¿ õâîðîáè ñåðöÿÓ÷àñíèêè: ïðîô. Ò.Â. Òàëàºâà, ê.ì.í. Î.Ì. Ðîìàíîâà (Êè¿â)
12:00–12:50 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì1. Îñòàíí³ ðåêîìåíäàö³¿ ùîäî çàñòîñóâàííÿ àíòèêîà-
ãóëÿíòíî¿ òåðàﳿïðîô. Î.Ñ. Ñè÷îâ (Êè¿â) — 20 õâ
2. Êë³í³÷íà ôàðìàêîëîã³ÿ àíòèêîàãóëÿíòíèõ ïðåïà-ðàò³âïðîô. Ã.Â. Çàé÷åíêî (Êè¿â) — 20 õâ
Îáãîâîðåííÿ — 10 õâ
12:50–13:20 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì Âòîðèííà ïðîô³ëàêòèêà ñåðöåâî-ñóäèííèõ çàõâîðþâàíü: ðåàëüí³ñòü ³ íîâ³ ðåêîìåíäàö³¿Ó÷àñíèêè: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõîìåíêî
(Êè¿â), ïðîô. Î.À. Êîâàëü (Äí³ïðî)
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–14:40 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óìÇàïîá³ãàííÿ àòåðîòðîìáîòè÷íèì ïîä³ÿì ó ïàö³ºíò³â ç êîðîíàðíîþ õâîðîáîþ1. Ïðèõèëüí³ñòü äî òåðàﳿ ó ïàö³ºíò³â ç ãîñòðèì êîðî-
íàðíèì ñèíäðîìîì: êîëè ïî÷èíàòè áîðîòüáó÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõîìåíêî (Êè¿â) — 20 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
11
25th
of
Sept
embe
r (W
edne
sday
)
2. CAD pts: what should we do for preventing cardio-vascular events
prof. Mikhail Kosiborod (Kansas-city) – 20 min
14:40–15:20 Scientific-practical symposiumÑarnitine synthesis blocade in cardiovascular pathology and comorbid conditionsParticipanyts: prof. Virginijus Sapoka (Vilnius, Lithuania), prof.
L.G. Voronkov (Kyiv)
15:20–15:40 Professional`s point of viewDiastolic HF — a modern view of the problem
D.V. Ryabenko MD (Kyiv)
15:40–16:20 Round tableDonators of the cycle of tricarboxylic acids. Can they help?Participanyts: prof. T.V. Talaeva, O.I. Irkin MD, O.M. Romanova
PhD (Kyiv)
16:20–16:40 Opinion of the specialistVasoprotection in patients with coronary heart disease (CHD): possibilities for controlling the stability of coronary flow
prof. N.M. Seredyuk (Ivano-Frankivsk)
CONFERENCE HALL «ODISSEY»9:00-12:50 Section meetingMaster classARITHMOLOGY: WHAT SHOULD YOU KNOW EVERY DOCTORfor doctors in the specialty «General practice — family medicine»Moderators: G.M. Solovyan PhD, O.I. Frolov PhD
Welcome address – prof. O.S. Sychov (Kyiv) – 10 min1. Atrial fibrillation: diagnostics and features of treat-
mentO.M. Romanova (Kyiv) – 20 min
2. Does left ventricular hypertrophy critical factor for choosing of antiarrhythmic drug?A.O. Borodai (Kyiv) – 20 min
3. Selection of patients for invasive treatment of cardiac arrhythmiasS.V. Lisogub, O.S. Sychov, E.V. Mogilnitskii (Kyiv) — 20 min
4. Syncope caused by cardiac arrhythmias. Diagnosis and treatmentO.I. Frolov (Kyiv) — 20 min
5. Supraventricular tachycardias: modern methods in the diagnosis and treatmentG.M. Solovyan (Kyiv) — 20 min
6. Ventricular arrhythmias. Diagnostics and modern methods of treatment. Sudden cardiac death and its preventionYu.V. Zinchenko (Kyiv) — 20 min
2. Ïàö³ºíòè ç õðîí³÷íîþ êîðîíàðíîþ õâîðîáîþ: ùî ïîòð³áíî çðîáèòè äëÿ ïðîô³ëàêòèêè êàðä³îâàñ-êóëÿðíèõ ïîä³éïðîô. ̳õà³ë Êîñ³áîðîä (Êàíçàñ-ñ³ò³) — 20 õâ
14:40–15:20 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì Áëîêàäà ñèíòåçó êàðí³òèíó ïðè êàðä³îâàñêóëÿðí³é ïàòîëî㳿 òà êîìîðá³äíèõ ñòàíàõÓ÷àñíèêè: ïðîô. ³ðã³í³þñ Øàïîêà (³ëüíþñ, Ëèòâà), ïðîô.
Ë.Ã. Âîðîíêîâ (Êè¿â)
15:20–15:40 Ïîãëÿä ïðîôåñ³îíàëàijàñòîë³÷íà ñåðöåâà íåäîñòàòí³ñòü — ñó÷àñíèé ïîãëÿä íà ïðîáëåìó
ä.ì.í. Ä.Â. Ðÿáåíêî (Êè¿â)
15:40–16:20 Êðóãëèé ñò³ëÄîíàòîðè öèêëó òðèêàðáîíîâèõ êèñëîò. ×è ìîæóòü âîíè äîïîìîãòè?Ó÷àñíèêè: ïðîô. Ò.Â. Òàëàºâà, ä.ì.í. Î.². ²ðê³í, ê.ì.í.
Î.Ì. Ðîìàíîâà (Êè¿â)
16:20–16:40 Äóìêà ñïåö³àë³ñòàÂàçîïðîòåêö³ÿ ó ïàö³ºíò³â ³ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ (²ÕÑ): ìîæëèâîñò³ êîíòðîëþ ñòàá³ëüíîñò³ êîðîíàðíîãî êðîâîïëèíó
ïðîô. Í.Ì. Ñåðåäþê (²âàíî-Ôðàíê³âñüê)
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÎIJÑÑÅÉ»9:00-12:50 Ñåêö³éíå çàñ³äàííÿÌàéñòåð-êëàñÀÐÈÒÌÎËÎòß: ÙÎ ÏÎÂÈÍÅÍ ÇÍÀÒÈ ÊÎÆÅÍ Ë²ÊÀÐäëÿ ë³êàð³â çà ñïåö³àëüí³ñòþ «Çàãàëüíà ïðàêòèêà — ñ³ìåéíà ìåäèöèíà»Ìîäåðàòîðè: ê.ì.í. Ã.Ì. Ñîëîâ’ÿí, ê.ì.í. Î.². Ôðîëîâ
Âñòóïíå ñëîâî — ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â) — 10 õâ1. Ô³áðèëÿö³ÿ ïåðåäñåðäü: ä³àãíîñòèêà òà îñîáëèâîñò³
òåðàﳿ Î.Ì. Ðîìàíîâà (Êè¿â) — 20 õâ
2. Åõîêàðä³îãðàô³ÿ ó õâîðèõ ç àðèòì³ÿìè: çíà÷åííÿ ìåòîäó À.Î. Áîðîäàé (Êè¿â) — 20 õâ
3. ³äá³ð õâîðèõ äî ³íâàçèâíîãî ë³êóâàííÿ àðèòì³é ñåðöÿ Ñ.Â. Ëèçîãóá, Î.Ñ. Ñè÷îâ, ª.Â. Ìîãèëüíèöüêèé (Êè¿â) — 20 õâ
4. Ñèíêîïàëüí³ ñòàíè ïðè ïîðóøåííÿõ ðèòìó ñåðöÿ. ijàãíîñòèêà ³ ë³êóâàííÿ Î.². Ôðîëîâ (Êè¿â) — 20 õâ
5. Ñóïðàâåíòðèêóëÿðí³ òàõ³êàð䳿: ñó÷àñí³ ìåòîäè ä³à-ãíîñòèêè ³ ë³êóâàííÿÃ.Ì. Ñîëîâ’ÿí (Êè¿â) — 20 õâ
6. Øëóíî÷êîâ³ ïîðóøåííÿ ðèòìó ñåðöÿ. ijàãíîñòè-êà ³ ñó÷àñí³ ìåòîäè ë³êóâàííÿ. Ðàïòîâà êàðä³àëüíà ñìåðòü òà ¿¿ ïðîô³ëàêòèêàÞ.Â. dzí÷åíêî (Êè¿â) — 20 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
12
25 â
åðåñ
íÿ
(ñåð
åäà)
7. Features of arrhythmias management during preg-nancyM.Z. Cherednichenko PhD (Kyiv) – 20 min
8. Antithrombotic therapy for atrial fibrillation
T.V. Hetman (Kyiv) — 20 min9. Guidelines for the management of patients with car-
diac arrhythmias during cancer treatmentE.V. Mogilnitskii (Kyiv) – 20 min
10. Reabilitation of patients with arrhythmiasO.V. Sribna (Kyiv) – 20 min
Discussion — 15 min
12:50–13:20 Round tablePatients with ACS, AF and CH: how to treat such patients
Participators: O.I. Irkin MD, O.M. Romanova PhD (Kyiv)
13:20-14:00 BREAK
14:00–16:30 Section meeting LECTURES FOR DOCNORS ON THE SPECIALTY «GENERAL PRACTICE — FAMILY MEDICINE»Moderators: prof. M.M. Dolzhenko, prof. S.O. Andriyevska,
prof. M.M. Seliuk1. Possibilities of organoprotection of the triple com-
bined therapy of hypertensionK.Y. Egorov (Dnipro) – 15 min
2. The modern possibilities of treatment of chronic coro-nary syndrome or new — it is well forgotten oldM.M. Dolzhenko (Kyiv) – 15 min
3. Antihypertensive therapy for patients without a meta-bolic syndromeN.Yu. Osovska (Vinnytsia) – 15 min
4. Patient with AH and T2D: simple choice in complicated situationI.V. Davydova (Kyiv) – 15 min
5. Long-term surveillance programs for patients with high cardiovascular risk according to European guide-lines 2019S.O. Andriyevska (Odesa) – 15 min
6. Important components of T2D patients’ management in family doctor practiceN.M. Zherdiova (Kyiv) – 15 min
7. Modern view on the combination therapy of arterial hypertensionM.M. Seliuk (Kyiv) — 15 min
8. Program «Prostir without Stroke»: how to improve outcomes of anticoagulant therapy in nvAF patients
S.M. Koval (Kharkiv)— 15 min9. Treatment of tobacco dependence in patients with
CVDO.V. Sribna (Kyiv) — 15 min
7. Îñîáëèâîñò³ ë³êóâàííÿ ïîðóøåíü ðèòìó ñåðöÿ ó âà-ã³òíèõÌ.Ç. ×åðåäíè÷åíêî (Êè¿â) — 20 õâ
8. Àíòèòðîìáîòè÷íà òåðàï³ÿ ïðè ô³áðèëÿö³¿ ïåðåä-ñåðäüÒ.Â. Ãåòüìàí (Êè¿â) — 20 õâ
9. Ðåêîìåíäàö³¿ ç âåäåííÿ îíêîëîã³÷íèõ õâîðèõ ç àðèòì³ÿìèª.Â. Ìîãèëüíèöüêèé (Êè¿â) — 20 õâ
10. Ðåàá³ë³òàö³ÿ õâîðèõ ç àðèòì³ÿìèÎ.Â. Ñð³áíà (Êè¿â) — 20 õâ
Îáãîâîðåííÿ — 15 õâ
12:50–13:20 Êðóãëèé ñò³ëÏàö³ºíòè ç ãîñòðèì êîðîíàðíèì ñèíäðîìîì, ô³áðèëÿö³ºþ ïåðåäñåðäü òà ñåðöåâîþ íåäîñòàòí³ñòþ: ÿê ë³êóâàòè òàêèõ ïàö³ºíò³â Ó÷àñíèêè: ä.ì.í. Î.². ²ðê³í, ê.ì.í. Î.Ì. Ðîìàíîâà (Êè¿â)
13:20-14:00 ÏÅÐÅÐÂÀ
14:00-16:30 Ñåêö³éíå çàñ³äàííÿ ËÅÊÖ²¯ ÄËß Ë²ÊÀв ÇÀ ÑÏÅÖ²ÀËÜͲÑÒÞ «ÇÀÃÀËÜÍÀ ÏÐÀÊÒÈÊÀ — ѲÌÅÉÍÀ ÌÅÄÈÖÈÍÀ»Ìîäåðàòîðè: ïðîô. Ì.Ì. Äîëæåíêî, ïðîô. Ñ.Î. Àíäð³ºâ-
ñüêà, ïðîô. Ì.Ì. Ñåëþê 1. Ìîæëèâîñò³ îðãàíîïðîòåêòîðíî¿ ä³¿ ïîòð³éíî¿ êîì-
á³íîâàíî¿ òåðàﳿ àðòåð³àëüíî¿ ã³ïåðòåí糿Ê.Þ. ªãîðîâ (Äí³ïðî) — 15 õâ
2. Ñó÷àñí³ ìîæëèâîñò³ ë³êóâàííÿ õðîí³÷íîãî êîðîíàð-íîãî ñèíäðîìó, àáî Íîâå — öå äîáðå çàáóòå ñòàðåÌ.Ì. Äîëæåíêî (Êè¿â) — 15 õâ
3. Àíòèã³ïåðòåíçèâíà òåðàï³ÿ ó ïàö³ºíò³â áåç ìåòàáî-ë³÷íîãî ñèíäðîìóÍ.Þ. Îñîâñüêà (³ííèöÿ) — 15 õâ
4. Õâîðèé íà àðòåð³àëüíó ã³ïåðòåíç³þ òà öóêðîâèé ä³-àáåò 2-ãî òèïó: ïðîñòèé âèá³ð ó ñêëàäí³é ñèòóàö³¿².Â. Äàâèäîâà (Êè¿â) — 15 õâ
5. Äîâãîñòðîêîâ³ ïðîãðàìè ñïîñòåðåæåííÿ ïàö³ºíò³â âèñîêîãî êàðä³îâàñêóëÿðíîãî ðèçèêó â ñâ³òë³ ªâðî-ïåéñüêèõ ðåêîìåíäàö³é–2019Ñ.Î. Àíäð³ºâñüêà (Îäåñà) — 15 õâ
6. Âàæëèâ³ êîìïîíåíòè âåäåííÿ ïàö³ºíò³â ç öóêðîâèì ä³àáåòîì 2-ãî òèïó â ïðàêòèö³ ñ³ìåéíîãî ë³êàðÿÍ.Ì. Æåðäüîâà (Êè¿â) — 15 õâ
7. Ñó÷àñí³ ïîãëÿäè íà êîìá³íîâàíó òåðàï³þ àðòåð³-àëüíî¿ ã³ïåðòåí糿Ì.Ì. Ñåëþê (Êè¿â) — 15 õâ
8. Ïðîãðàìà «Ïðîñò³ð áåç ³íñóëüòó»: ÿê ï³äâèùèòè ðå-çóëüòàòèâí³ñòü àíòèêîàãóëÿíòíî¿ òåðàﳿ ó ïàö³ºíò³â ç ô³áðèëÿö³ºþ ïåðåäñåðäüÑ.Ì. Êîâàëü (Õàðê³â) — 15 õâ
9. ˳êóâàííÿ òþòþíîâî¿ çàëåæíîñò³ ó õâîðèõ ³ç ñåðöåâî- ñóäèííèìè çàõâîðþâàííÿìèÎ.Â. Ñð³áíà (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
13
25th
of
Sept
embe
r (W
edne
sday
)
16:30–16:50 Round tableContinuum of coronary heart disease: the role of personalized treatment strategiesPartcipants: corr.-member of NAMS of Ukraine, prof.
O.M. Parkhomenko, prof. L.G. Voronkov (Kyiv)
CONFERENCE HALL «ALTIUS»9:30–11:00 Section meeting DIABETES MELLITUSModerators: corr. member of NAMS of Ukraine, prof.
O.M. Parkhomenko, prof. V.M. Zhebel, L.K. Sokolova MD
9:00–9:30 Round tableModern global CaReMe trend: cardiologist and endocrinologist’s perspective on T2D patients with cardiovascular pathologyParticipants: corr. member of NAMS of Ukraine, prof.
O.M. Parkho menko (Kyiv), corr. member of NAMS of Ukraine, prof. B.M. Mankovskiy (Kyiv), prof.M.V. Vlasenko (Vinnytsia)
1. Modern approaches to decreasing of cardiovascular outcomes in patients with T2 diabetes mellitusO.M. Parkhomenko (Kyiv) – 15 min
2. Prognosis and modern correction of cardiovascular risk in patients with pre- and diabetesV.N. Zhebel (Vinnytsia) – 15 min
3. Strategic aspects of CHF treatment in patients with co-morbid conditionsM.M. Dolzhenko (Kyiv) – 15 min
10:15–10:45 Master classHeart failure in T2D patients
Participants: prof. L.G. Voronkov (Kyiv), L.K. Sokolova MD (Kyiv) Discussion — 15 min
11:00–11:20 Opinion of the specialistAchieving blood pressure control in isolated systolic hypertension: a portrait of the patient
prof. E.G. Nesukay (Kyiv)
11:20–13:20 Sectional sessionGENDER MEDICINE — CURRENT ISSUESModerators: prof. O.I. Mitchenko, corr.-Member of the NAMS
of Ukraine, prof. T.F. Tatarchuk1. Correction of insulin resistance at comorbidity with
hypothyroidism in womenV.I. Pankiv (Kyiv) — 15 min
2. Management of women with PCOS in the aspect of prevention of cardiovascular diseaseT.F. Tatarchuk, N.V. Kosey, T.M. Tutchenko (Kyiv) — 15 min
3. Arterial hypertension and insulin resistance in the for-mation of cardiovascular risk in womenO.I. Mitchenko, G.Ya. Ilyushina (Kyiv) — 15 min
16:30–16:50 Êðóãëèé ñò³ëÊîíòèíóóì ³øåì³÷íî¿ õâîðîáè ñåðöÿ: ðîëü ñòðàòå㳿 ïåðñîí³ô³êîâàíîãî ë³êóâàííÿÓ÷àñíèêè: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõîìåí-
êî, ïðîô. Ë.Ã. Âîðîíêîâ (Êè¿â)
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÀËÜÒ²ÓÑ»9:00–11:00 Ñåêö³éíå çàñ³äàííÿÖÓÊÐÎÂÈÉ Ä²ÀÁÅÒÌîäåðàòîðè: ÷ë.-êîð ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõî-
ìåíêî, ïðîô. Â.Ì. Æåáåëü, ä.ì.í. Ë.Ê. Ñîêîëîâà
9:00–9:30 Êðóãëèé ñò³ëÑó÷àñíà ñâ³òîâà òåíäåíö³ÿ CaReMe: ïîãëÿä êàðä³îëîãà òà åíäîêðèíîëîãà íà ïàö³ºíòà ç ÖÄ 2-ãî òèïó òà íàÿâí³ñòþ ñåðöåâî-ñóäèííî¿ ïàòîëî㳿Ó÷àñíèêè: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõîìåíêî
(Êè¿â), ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Á.Ì. Ìàíüêîâ-ñüêèé (Êè¿â), ïðîô. Ì.Â. Âëàñåíêî (³ííèöÿ)
1. Ñó÷àñí³ ï³äõîäè äî çíèæåííÿ ñåðöåâî-ñóäèííèõ óñêëàäíåíü ó õâîðèõ íà öóêðîâèé ä³àáåò 2-ãî òèïóÎ.Ì. Ïàðõîìåíêî (Êè¿â) — 15 õâ
2. Ïðîãíîç òà ñó÷àñíà êîðåêö³ÿ ñåðöåâî-ñóäèííîãî ðèçèêó ó õâîðèõ íà ïðå- òà ä³àáåòÂ. Ì. Æåáåëü (³ííèöÿ) — 15 õâ
3. Ñòðàòåã³÷í³ àñïåêòè ë³êóâàííÿ õðîí³÷íî¿ ñåðöåâî¿ íåäîñòàòíîñò³ ó õâîðîãî ç êîìîðá³äíèìè ñòàíàìèÌ.Ì. Äîëæåíêî (Êè¿â) — 15 õâ
10:15–10:45 Ìàéñòåð-êëàñÑåðöåâà íåäîñòàòí³ñòü ó õâîðèõ íà öóêðîâèé ä³àáåò 2-ãî òèïóÓ÷àñíèêè: ïðîô. Ë.Ã. Âîðîíêîâ, ä.ì.í. Ë.Ê. Ñîêîëîâà (Êè¿â)Îáãîâîðåííÿ — 15 õâ
11:00–11:20 Äóìêà ñïåö³àë³ñòà Øëÿõè äîñÿãíåííÿ êîíòðîëþ àðòåð³àëüíîãî òèñêó ïðè ³çîëüîâàí³é ñèñòîë³÷í³é àðòåð³àëüí³é ã³ïåðòåí糿: ïîðòðåò ïàö³ºíòà
ïðîô. Î.Ã. Íåñóêàé (Êè¿â)
11:20–13:20 Ñåêö³éíå çàñ³äàííÿ ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÃÅÍÄÅÐÍί ÌÅÄÈÖÈÍÈÌîäåðàòîðè: ïðîô. Î.². ̳ò÷åíêî, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè,
ïðîô. Ò.Ô. Òàòàð÷óê1. Êîðåêö³ÿ ³íñóë³íîðåçèñòåíòíîñò³ ïðè êîìîðá³äíîñò³
ç ã³ïîòèðåîçîì ó æ³íîê Â.². Ïàíüê³â (Êè¿â) — 15 õâ
2. Ìåíåäæìåíò æ³íîê ³ç ñèíäðîìîì ïîë³ê³ñòîçíèõ ÿº÷íèê³â â àñïåêò³ ïðîô³ëàêòèêè êàðä³îâàñêóëÿðíî¿ ïàòîëî㳿 Ò.Ô. Òàòàð÷óê, Í.Â. Êîcºé, Ò.Ì. Òóò÷åíêî (Êè¿â) — 15 õâ
3. Àðòåð³àëüíà ã³ïåðòåíç³ÿ òà ³íñóë³íîðåçèñòåíòí³ñòü ó ôîðìóâàíí³ ñåðöåâî-ñóäèííîãî ðèçèêó ó æ³íîê Î.². ̳ò÷åíêî, Ã.ß. ²ëþøèíà (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
14
25 â
åðåñ
íÿ
(ñåð
åäà)
4. Controversial provisions in the Guidelines of the ESC-2018 concerning the Cardiovascular Diseases during PregnancyV.I. Medvid (Kyiv) — 15 min
5. Prognostic value of sex hormones in women with ische mic heart diseaseG.S. Isayeva, V.I. Volkov (Kharkiv) – 15 min
6. High pulmonary hypertension in pregnant women: cardiological and perinatal aspects K.M. Duda (Kyiv) — 15 min
7. Newest therapeutic tendencies in the treatment of the effects of estrogen deficiencyO.Î. Efimenko (Kyiv) — 15 min
8. Gender features of arterial wall stiffness. Possibilities of correctionK.Yu. Egorov (Dnipro) — 15 min
13:20-14:00 BREAK
14:00–14:30 Round table Treatment of patients with NAF after stroke: a tandem of a neurologist and a cardiologistParticipants: Yu.V. Flomin PhD, T.V. Hetman PhD (Kyiv)
14:30–16:50 Section meetingCARDIOCERBRAL DISORDERS: SEARCH FOR COMORBIDENCE Moderators: L.A. Mishchenko MD, prof. S.M. Kuznetsova,
I.L. Revenko PhD1. Pathogenetic heterogeneity of ischemic stroke (funda-
mental and clinical aspects)S.M. Kuznetsova, N.V. Jumping (Kyiv) — 15 min2. Cardiac disturbances in the problem of cerebral stroke L.A. Dzyak (Dnipro) - 15 min
3. National plan of stroke management in UkraineYu.V. Flomin (Kyiv) — 15 min
4. Arterial hypertension and brain: how to prevent com-plicationsL.A. Mishchenko (Kyiv) — 15 min
5. Arterial hypertension and cognitive disturbancesN.Yu. Bachynska (Kyiv) — 15 min
6. Comparing of secondary prophylaxis after ischemic stroke and myocardial infarctionA.V. Yagenskyi (Lutsk) — 15 min
7. Acute stroke: practical recommendationsH.P. Pasechnic, Yu.M. Martynchuk (Kyiv) — 15 min
8. Emergency care of cardioembolic stroke: opportunities for endovascular technologyD.V. Shcheglov, S.V. Konotopchik, O.E. Sviridyuk (Kyiv) — 15 min
9. Cardioembolic stroke. Work on mistakesI.L. Revenko, V.M. Kornatskyi (Kyiv) — 15 min
10. Low risk atrial fibrillation patients. In which cases is anticoagulation?N.N. Nosånko (Kyiv) — 15 min
4. Êîíòðîâåðñ³éí³ ïîëîæåííÿ â Ðåêîìåíäàö³ÿõ ªâðî-ïåéñüêîãî òîâàðèñòâà êàðä³îëîã³â–2018 ùîäî âå-äåííÿ ñåðöåâî-ñóäèííèõ õâîðîá ó âàã³òíèõ Â.². Ìåäâ³äü (Êè¿â) — 15 õâ
5. Ïðîãíîñòè÷íà çíà÷óù³ñòü ð³âíÿ ñòàòåâèõ ãîðìîí³â ó æ³íîê ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ Ã.Ñ. ²ñàºâà, Â.². Âîëêîâ (Õàðê³â) — 15 õâ
6. Âèñîêà ëåãåíåâà ã³ïåðòåíç³ÿ ó âàã³òíèõ: êàðä³îëî-ã³÷í³ òà ïåðèíàòàëüí³ àñïåêòè Ê.Ì. Äóäà (Êè¿â) — 15 õâ
7. Íîâ³òí³ òåðàïåâòè÷í³ òåíäåíö³¿ â ë³êóâàíí³ íàñë³ä-ê³â åñòðîãåííîãî äåô³öèòó Î.Î. ªô³ìåíêî (Êè¿â) — 15 õâ
8. Ãåíäåðí³ îñîáëèâîñò³ æîðñòêîñò³ àðòåð³àëüíî¿ ñò³í-êè. Ìîæëèâîñò³ êîðåêö³¿ Ê.Þ. ªãîðîâ (Äí³ïðî) — 15 õâ
13:20-14:00 ÏÅÐÅÐÂÀ
14:00–14:30 Êðóãëèé ñò³ëÂåäåííÿ õâîðèõ ç ÍÔÏ ï³ñëÿ ïåðåíåñåíîãî ³íñóëüòó: òàíäåì íåâðîëîãà òà êàðä³îëîãàÓ÷àñíèêè: ê.ì.í. Þ.Â. Ôëîì³í, ê.ì.í. Ò.Â. Ãåòüìàí (Êè¿â)
14:30–16:50 Ñåêö³éíå çàñ³äàííÿÊÀÐIJÎÖÅÐÅÁÐÀËÜͲ ÏÎÐÓØÅÍÍß: ÏÎØÓÊÈ ÊÎÌÎÐÁ²ÄÍÎÑÒ²Ìîäåðàòîðè: ïðîô. Ñ.Ì. Êóçíåöîâà, ä.ì.í. Ë.À. ̳ùåíêî,
ê.ì.í. ².Ë. Ðåâåíüêî1. Ïàòîãåíåòè÷íà ãåòåðîãåíí³ñòü ³øåì³÷íîãî ³íñóëüòó
(ôóíäàìåíòàëüí³ òà êë³í³÷í³ àñïåêòè)Ñ.Ì. Êóçíåöîâà, Í.Â. Ñêà÷êîâà (Êè¿â) — 15 õâ
2. Êàðä³àëüí³ ïîðóøåííÿ â ïðîáëåì³ ìîçêîâîãî ³íñóëüòóË.À. Äçÿê (Äí³ïðî) — 15 õâ
3. Íàö³îíàëüíèé ïëàí ä³é áîðîòüáè ç ³íñóëüòîìÞ.Â. Ôëîì³í (Êè¿â) — 15 õâ
4. Àðòåð³àëüíà ã³ïåðòåíç³ÿ ³ ìîçîê: ÿê çàïîá³ãòè óñêëàäíåííÿìË.À. ̳ùåíêî (Êè¿â) — 15 õâ
5. Àðòåð³àëüíà ã³ïåðòåíç³ÿ òà êîãí³òèâí³ ïîðóøåííÿÍ.Þ. Áà÷èíñüêà (Êè¿â) — 15 õâ
6. Ïîð³âíÿííÿ åôåêòèâíîñò³ âòîðèííî¿ ïðîô³ëàêòèêè ï³ñëÿ ³øåì³÷íîãî ³íñóëüòó òà ³íôàðêòó ì³îêàðäàÀ.Â. ßãåíñüêèé (Ëóöüê) — 15 õâ
7. Ãîñòðèé ³íñóëüò: ïðàêòè÷í³ ðåêîìåíäàö³¿ Ã.Ï. Ïàñ³÷íèê, Þ.Ì. Ìàðòèí÷óê (Êè¿â) — 15 õâ
8. Íåâ³äêëàäíà äîïîìîãà ïðè êàðä³îåìáîë³÷íîìó ³í-ñóëüò³: ìîæëèâîñò³ åíäîâàñêóëÿðíèõ òåõíîëîã³éÄ.Â. Ùåãëîâ, Ñ.Â. Êîíîòîï÷èê, Î.ª. Ñâèðèäþê (Êè¿â) — 15 õâ
9. Êàðä³îåìáîë³÷íèé ³íñóëüò. Ðîáîòà íàä ïîìèëêàìè².Ë. Ðåâåíüêî, Â.Ì. Êîðíàöüêèé (Êè¿â) — 15 õâ
10. Ïàö³ºíòè ³ç 1 áàëîì ðèçèêó çà øêàëîþ CHA2DS2–VASc.  ÿêèõ âèïàäêàõ àíòèêîàãóëÿö³ÿ?Í.Ì. Íîñåíêî (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
15
25th
of
Sept
embe
r (W
edne
sday
)
CONFERENCE HALL «CITIUS»9:00-12:30 Sectional sessionCARDIOVASCULAR VISUALIZATIONModerators: acad. of NAMS of Ukraine, prof. V.M. Kovalenko,
prof. S.V. Fedkiv, prof. S.M.Furkalo, prof. Yu.I.Karpenko, prof. Yu.A. Ivaniv
1. Modern possibilities of MRI in the diagnosis of myo-carditisS.V. Fedkiv (Kyiv) — 15 min
2. Intravascular visualization in the implementation of coronary interventional proceduresS.M. Furkalo (Kyiv) — 15min
3. Radiofrequency ablation of the interventricular sep-tum in patients with hypertrophic cardiomyopathy Yu.I. Karpenko (Odesa) – 15 min
4. Diagnostic peculiarities and treatment of the left ven-tricular pseudoaneurysmsY.A. Ivaniv, L.V. Kulyk (Lviv) — 15 min
5. New methods of functional diagnosis and vizualiza-tion in evaluating specifi non-coronary myocardial pa-thology (cardiac transplant rejection)S.V. Potashev, S.V. Fedkiv, K.V. Rudenko — 15 min
6. Echocardiographic profiles of chronic heart failure with preserved ejection fraction
M.Yu. Kolesnyk (Zaporizhzhya) — 15 min7. The role of multimodality imaging in Fabry disease
E.G. Nesukay (Kyiv) — 15min8. EchoCG of myocardial pathology and ischemia: new pos-
sibilities and clinical experienceS.V. Potashev, S.V. Salo, A.Y. Gavrylishyn (Kyiv) — 15 min
9. Speckle tracking ECG in Non-coronary diseases diag-nosticsN.S. Polenova, E.G. Nesukay, E.Yu. Titov (Kyiv) — 15 õâ
10. Imaging methods in the differential diagnosis of hy-pertrophied myocardium N.D. Oryshchyn (Lviv) – 15 min
11. Preoperative ÑÒ/ÌRI planning for the surgical treat-ment of hypertrophic obstructive cardiomyopathy — contemporary approach S.V. Fedkiv, M.O. Tregubova, K.V. Rudenko (Kyiv) — 15 min
12. Carotid ultrasound: interpretation of conclusion and the keys in the diagnostic search for the cardiolo-gistN.N. Nosenko (Kyiv) — 15 min
13. Evaluation of the right heart in patients with pulmo-nary hypertensionE.Yu. Titov, N.S. Polenova, I.O. Zhyvylo (Kyiv) — 15 min
14. Pits and falls of pulmonary hypertension echocardio-graphic assessment L.Ì. Hrubyak (Kyiv) — 15 min
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «Ñ²Ò²ÓÑ»9:00–13:20 Ñåêö³éíå çàñ³äàííÿÑÅÐÖÅÂÎ-ÑÓÄÈÍÍÀ ²ÇÓÀ˲ÇÀÖ²ßÌîäåðàòîðè: àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ì. Êîâàëåí-
êî, ïðîô. Ñ.Â. Ôåäüê³â, ïðîô. Ñ.Ì. Ôóðêàëî, ïðîô. Þ.². Êàðïåíêî, ïðîô. Þ.À. ²âàí³â
1. Ñó÷àñí³ ìîæëèâîñò³ ÌÐÒ â ä³àãíîñòèö³ ì³îêàðäè-ò³âÑ.Â. Ôåäüê³â (Êè¿â) — 15 õâ
2. Âíóòð³øíüîñóäèííà â³çóàë³çàö³ÿ ïðè çä³éñíåíí³ êî-ðîíàðíèõ ³íòåðâåíö³éíèõ âòðó÷àíüÑ.Ì. Ôóðêàëî (Êè¿â) — 15 õâ
3. Ðàä³î÷àñòîòíà àáëÿö³ÿ ì³æøëóíî÷êîâî¿ ïåðåãîðîä-êè ó õâîðèõ ç ã³ïåðòðîô³÷íîþ êàðä³îì³îïàò³ºþÞ.². Êàðïåíêî (Îäåñà) — 15 õâ
4. Îñîáëèâîñò³ ä³àãíîñòèêè ³ ë³êóâàííÿ ïñåâäîàíåâ-ðèçì ë³âîãî øëóíî÷êàÞ.À. ²âàí³â, Ë.Â. Êóëèê (Ëüâ³â) — 15 õâ
5. Ðîëü íîâèõ ìåòîä³â ôóíêö³îíàëüíî¿ ä³àãíîñòèêè òà â³-çóàë³çàö³¿ â îö³íö³ ñïåöèô³÷íî¿ íåêîðîíàðîãåííî¿ ïà-òîëî㳿 ì³îêàðäà (â³äòîðãíåííÿ òðàíñïëàíòàòó ñåðöÿ)Ñ.Â. Ïîòàøåâ, Ñ.Â. Ôåäüê³â, Ê.Â. Ðóäåíêî (Êè¿â) — 15 õâ
6. Åõîêàðä³îãðàô³÷í³ ïîðòðåòè õðîí³÷íî¿ ñåðöåâî¿ íå-äîñòàòíîñò³ ç³ çáåðåæåíîþ ôðàêö³ºþ âèêèäó ë³âîãî øëóíî÷êàÌ.Þ. Êîëåñíèê (Çàïîð³ææÿ) — 15 õâ
7. Çíà÷åííÿ ìåòîä³â â³çóàë³çàö³¿ â ä³àãíîñòèö³ õâîðî-áè Ôàáð³Î.Ã. Íåñóêàé (Êè¿â) — 15 õâ
8. ÅõîÊà ³øå쳿 òà ïàòîëî㳿 ì³îêàðäà: íîâ³ ìîæëèâîñò³ òà äîñâ³ä çàñòîñóâàííÿÑ.Â. Ïîòàøåâ, Ñ.Â. Ñàëî, À.Þ. Ãàâðèëèøèí (Êè¿â) — 15 õâ
9. Ñïåêë-òðåê³íã-åõîÊà â ä³àãíîñòèö³ íåêîðîíàðíèõ çàõâîðþâàíü ñåðöÿÍ.Ñ. Ïîëåíîâà, Î.Ã. Íåñóêàé, ª.Þ. Ò³òîâ (Êè¿â) — 15 õâ
10. Ðîëü ìåòîä³â â³çóàë³çàö³¿ ó äèôåðåíö³àö³¿ ã³ïåðòðî-ô³¿ ì³îêàðäà ë³âîãî øëóíî÷êàÍ.Ä. Îðèùèí (Ëüâ³â) — 15 õâ
11. Ïåðåäîïåðàö³éíå ÊÒ/ÌÐÒ ïëàíóâàííÿ â õ³ðóðã³÷-íîìó ë³êóâàíí³ ã³ïåðòðîô³÷íî¿ êàðä³îì³îïàò³¿ — ñó-÷àñíèé ï³äõ³äÑ.Â. Ôåäüê³â, Ì.Î. Òðåãóáîâà, Ê.Â. Ðóäåíêî (Êè¿â) — 15 õâ
12. Óëüòðàçâóêîâå äîñë³äæåííÿ ñóäèí: ³íòåðïðåòàö³ÿ âèñíîâêó òà êëþ÷³ â ä³àãíîñòè÷íîìó ïîøóêó äëÿ êàðä³îëîãàÍ.Ì. Íîñåíêî (Êè¿â) — 15 õâ
13. Îö³íêà ôóíêö³¿ ïðàâèõ â³ää³ë³â ñåðöÿ ó õâîðèõ ç ëå-ãåíåâîþ ã³ïåðòåí糺þ ª.Þ. Ò³òîâ, Í.Ñ. Ïîëåíîâà, ².Î. Æèâèëî (Êè¿â) — 15 õâ
14. Ïðîáëåìè åõîêàðä³îãðàô³÷íî¿ îö³íêè ëåãåíåâî¿ ã³-ïåðòåí糿Ë. Ì. Ãðóáÿê (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
16
25 â
åðåñ
íÿ
(ñåð
åäà)
15. Radiology management of patients with congenitally corrected transposition of great arteriesYe.V. Stohova, N.M. Rudenko, T.A. Yalynska, R. Tammo, O.O. Motrechko (Kyiv) — 15 min
16. Äîïîâ³äü
13:20-14:00 BREAK
14:00–14:40 Round table Patient with severe heart failure: the active diuretic treatment in focusParticipants: prof. L.G. Voronkov, N.A.Tkach PhD (Kyiv)
14:40–16:40 Sectional sessionTEAM DECISIONS IN THE STRATEGIES OF PREVENTION AND THERAPY OF CARDIOVASCULAR COMPLICATIONS IN CANCER TREATMENTModerators: S.M. Kozhukhov MD, prof. I.A. Kryachok 1. Cardio-onco-hematology as a part of cardio-oncolo-
gy: current state and perspectivesS.M. Kozhukhov (Kyiv) – 20 min
2. Management strategies in patients with combination of cardiac and hematological toxicity in cancer treat-mentI.A. Kryachok (Kyiv) – 20 min
15:20–15:50 Round table: Thrombosis in cardio-oncology practice: necessity of cardiologist and oncohematologist collaborationÑardiologist’s point of view
S.M. Kozhukhov (Kyiv) Oncohematologist’s point of view
prof. I.A. Kryachok (Kyiv) Discussion
15:50–16:30 Clinical casesManagement of patients with cardiovascular complications of cancer treatment
1. Heart failure in cancer therapy — role of visualization and biomarkers
N.V. Dovganych (Kyiv) – 10 min2. Patient with combination of cardiovascular and he-
matological complications of cancer treatment — team decisionsI.B. Tytorenko (Kyiv) — 10 min
3. Arterial hypertension in cancer therapy
O.A. Yarynkina (Kyiv) – 10 minDiscussion — 10 min
CONFERENCE HALL «SPRINT»9:00–11:40 Section mettengSTRESS-ASSOCIATED COMBINED DISORDERS OF HEALTH IN ADOLESCENT ARMED CONFLICTModerators: prof. V.Ì. Kornatskii, prof. V.I. Osiodlo
15. Ðàä³îëîã³÷íèé ñóïðîâ³ä ïàö³ºíò³â ³ç âðîäæåíîþ êî-ðèãîâàíîþ òðàíñïîçèö³ºþ ìàã³ñòðàëüíèõ àðòåð³éÎ.Â. Ñòîãîâà, Í.Ì. Ðóäåíêî, Ò.À. ßëèíñüêà, Òàììî Ðààä, Î.Î. Ìîòðå÷êî (Êè¿â) — 15 õâ
16. Äîïîâ³äü13:20–14:00 ÏÅÐÅÐÂÀ
14:00–14:40 Êðóãëèé ñò³ëÏàö³ºíò ç òÿæêîþ ÑÍ: ôîêóñ íà àêòèâí³é ä³óðåòè÷í³é òåðàﳿÓ÷àñíèêè: ïðîô. Ë.Ã. Âîðîíêîâ, ê.ì.í. Í.À. Òêà÷ (Êè¿â)
14:40–16:40 Ñåêö³éíå çàñ³äàííÿÊÎËÅòÀËÜͲ вØÅÍÍß Â ÑÒÐÀÒÅòßÕ ÏÐÎÔ²ËÀÊÒÈÊÈ ÒÀ ˲ÊÓÂÀÍÍß ÑÅÐÖÅÂÎ-ÑÓÄÈÍÍÈÕ ÓÑÊËÀÄÍÅÍÜ ÏÐÈ ÏÐÎÂÅÄÅÍͲ ÏÐÎÒÈÏÓÕËÈÍÍί ÒÅÐÀϲ¯Ìîäåðàòîðè: ä.ì.í. Ñ.Ì. Êîæóõîâ, ïðîô. ².À. Êðÿ÷îê1. Êàðä³îîíêîãåìàòîëîã³ÿ ÿê ðîçä³ë êàðä³îîíêîëî㳿:
ñó÷àñíèé ñòàí òà ïåðñïåêòèâèÑ.Ì. Êîæóõîâ (Êè¿â) — 20 õâ
2. Îñîáëèâîñò³ êóðàö³¿ ïàö³ºíò³â ç ïîºäíàííÿì ïðî-ÿâ³â êàðä³àëüíî¿ òà ãåìàòîëîã³÷íî¿ òîêñè÷íîñò³ ïðè ïðîâåäåíí³ ë³êóâàííÿ çëîÿê³ñíèõ íîâîóòâîðåíü². À. Êðÿ÷îê (Êè¿â) — 20 õâ
15:20–15:50 Êðóãëèé ñò³ë Òðîìáîçè â êàðä³îîíêîëîã³÷í³é ïðàêòèö³: íåîáõ³äí³ñòü âçàºìî䳿 êàðä³îëîãà òà îíêîãåìàòîëîãàÏîãëÿä êàðä³îëîãà
ä.ì.í. Ñ.Ì. Êîæóõîâ (Êè¿â) Ïîãëÿä îíêîãåìàòîëîãà
ïðîô. ².À. Êðÿ÷îê (Êè¿â) Äèñêóñ³ÿ
15:50–16:30 Êë³í³÷í³ âèïàäêè Òàêòèêà âåäåííÿ ïàö³ºíò³â ³ç êàðä³îâàñêóëÿðíèìè óñêëàäíåííÿìè ïðè ïðîâåäåíí³ ïðîòèïóõëèííîãî ë³êóâàííÿ 1. Ñåðöåâà íåäîñòàòí³ñòü ïðè ïðîâåäåíí³ ïðîòè-
ïóõëèííîãî ë³êóâàííÿ — ðîëü ìåòîä³â â³çóàë³çàö³¿ òà á³î ìàðêåð³âÍ.Â. Äîâãàíè÷ (Êè¿â) — 10 õâ
2. Ïàö³ºíò ç ïîºäíàííÿì êàðä³îâàñêóëÿðíèõ òà ãåìà-òîëîã³÷íèõ óñêëàäíåíü ïðîòèïóõëèííî¿ òåðàﳿ — êîìàíäíèé ï³äõ³ä².Á. Òèòîðåíêî (Êè¿â) — 10 õâ
3. Àðòåð³àëüíà ã³ïåðòåíç³ÿ ïðè ïðîâåäåíí³ ïðîòèïóõ-ëèííîãî ë³êóâàííÿÎ.À. ßðèíê³íà (Êè¿â) — 10 õâ
Îáãîâîðåííÿ — 10 õâ
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÑÏвÍÒ»9:00–11:40 Ñåêö³éíå çàñ³äàííÿ ÑÒÐÅÑÀÑÎÖ²ÉÎÂÀͲ ÊÎÌÎÐÁ²ÄͲ ÐÎÇËÀÄÈ ÇÄÎÐÎÂ’ß Ó ÏÎÑÒÐÀÆÄÀËÈÕ ÂÍÀÑ˲ÄÎÊ ÇÁÐÎÉÍÎÃÎ ÊÎÍÔ˲ÊÒÓÌîäåðàòîðè: ïðîô. Â.Ì. Êîðíàöüêèé, ïðîô. Â.². Îñüîäëî
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
17
25th
of
Sept
embe
r (W
edne
sday
)
1. Features of the development and the course of stress-associated comorbid pathology in modern conditions of UkraineV.M. Kornatskyi, D.M. Moroz, L.O. Dyachenko (Kyiv) – 20 min
2. Peculiarities of the effect of combat psychic trauma on the cardiovascular system. Principles of diagnosis and managementA.P. Kazmirchuk, G.V. Myasnikov, A.P. Tchaikovsky (Kyiv) — 15 min
3. Post-traumatic stress disorder and cardiovascular dis-ease in combatantsV.I. Os�odlo (Kyiv) — 15 min
4. Complex analysis of cardiac rhythm variability as a cri-terion for assessing the effectiveness of medical and psychological rehabilitation of servicemen of UkraineV.V. Steblyuk (Kyiv) — 15 min
5. Post-traumatic stress disorder: somatic content
O.S. Chaban (Kyiv) — 15 min6. Rehabilitation of participants in armed conflict: mea-
sures and guaranteesA.H. Kyrychenko (Dnipro) — 15 min
7. Optimization of cardiological care of tertiary level in patients with stress-associated comorbid patho-logyA.M. Dorokhina (Kyiv) — 15 min
8. Psychotherapeutic help in cardiology practice
ZH.H. Adaricheva (Kyiv) — 15 min9. Correction of social-psychological maladjustment
in patients with arrhythmia and alexithymiaO.Y. Polishchuk (Chernivtsi) — 15 min
Discussion — 10 min
11:40–13:20 Section meeting SCIENTIFIC AND DIAGNOSTIC RESEARCH IN CARDIOLOGY PRACTICEModerators: prof. T.I. Gavrilenko, prof. O.V. Kuryata, prof.
O.M. Klimova1. The imbalance of cell cytokines in cardiovascular pa-
thologyT.I. Gavrilenko, N.O. Ryzhkova, L.V. Yakushko, O.A. Pid-gaina (Kyiv) – 15 min
2. Regulators of angiogenesis, endothelial dysfunction and activity of matrex metalloproteinases in the blood of patients with atrial fibrillation and chronic heart failureO.V. Kuryata, A.O. Tikhomirov, Y.S. Kushnir (Kyiv) – 15 min
3. Diagnostic criteria of inflammatory reactions in pa-tients with cardiovascular pathology in the context of obstructive pulmonary diseasesO.M. Klimova, O.V. Lovinska, K.O. Bychenko, G.M. Tim-chenko (Kharkiv) – 15 min
1. Îñîáëèâîñò³ ðîçâèòêó òà ïåðåá³ãó ñòðåñàñîö³éîâà-íî¿ êîìîðá³äíî¿ ïàòîëî㳿 â ñó÷àñíèõ óìîâàõ Óêðà¿-íèÂ.Ì. Êîðíàöüêèé, Ä.Ì. Ìîðîç, Ë.Î. Äÿ÷åíêî (Êè¿â) — 20 õâ
2. Îñîáëèâîñò³ âïëèâó áîéîâî¿ ïñèõ³÷íî¿ òðàâìè íà ñåðöåâî-ñóäèííó ñèñòåìó. Ïðèíöèïè ä³àãíîñòè-êè òà íàäàííÿ äîïîìîãèÀ.Ï. Êàçì³ð÷óê, Ã.Â. Ì’ÿñíèêîâ, À.Ï. ×àéêîâñüêèé (Êè¿â) — 15 õâ
3. Ïîñòòðàâìàòè÷íèé ñòðåñîâèé ðîçëàä ³ ñåðöåâî- ñóäèíí³ çàõâîðþâàííÿ â ó÷àñíèê³â áîéîâèõ ä³éÂ.². Îñüîäëî (Êè¿â) — 15 õâ
4. Êîìïëåêñíèé àíàë³ç âàð³àáåëüíîñò³ ñåðöåâîãî ðèò-ìó ÿê êðèòåð³é îö³íêè åôåêòèâíîñò³ ìåäèêî-ïñèõî-ëîã³÷íî¿ ðåàá³ë³òàö³¿ â³éñüêîâîñëóæáîâö³â Óêðà¿íèÂ.Â. Ñòåáëþê (Êè¿â) — 15 õâ
5. Ïîñòòðàâìàòè÷íèé ñòðåñîâèé ðîçëàä: ñîìàòè÷íå íàïîâíåííÿÎ.Ñ. ×àáàí (Êè¿â) — 15 õâ
6. Ðåàá³ë³òàö³ÿ ó÷àñíèê³â çáðîéíîãî êîíôë³êòó: çàõî-äè òà ãàðàíò³¿À.Ã. Êèðè÷åíêî (Äí³ïðî) — 15 õâ
7. Îïòèì³çàö³ÿ êàðä³îëîã³÷íî¿ äîïîìîãè òðåòèííîãî ð³âíÿ õâîðèì ³ç ñòðåñàñîö³éîâàíîþ êîìîðá³äíîþ ïàòîëî㳺þ À.Ì. Äîðîõ³íà (Êè¿â) — 15 õâ
8. Ïñèõîòåðàïåâòè÷íà äîïîìîãà ó êàðä³îëîã³÷í³é ïðàêòèö³ Æ.Ã. Àäàð³÷åâà (Êè¿â) — 15 õâ
9. Êîðåêö³ÿ ñîö³àëüíî-ïñèõîëîã³÷íî¿ äåçàäàïòàö³¿ ó ïà-ö³ºíò³â ³ç ïîðóøåííÿìè ðèòìó ñåðöÿ òà àëåêñèòè쳺þÎ.Þ. Ïîë³ùóê (×åðí³âö³) — 15 õâ
Îáãîâîðåííÿ — 10 õâ
11:40-13:20 Ñåêö³éíå çàñ³äàííÿÍÀÓÊÎÂÎ-IJÀÃÍÎÑÒÈ×Ͳ ÄÎÑ˲ÄÆÅÍÍß Â ÊÀÐIJÎËÎò×ÍÓ ÏÐÀÊÒÈÊÓÌîäåðàòîðè: ïðîô. Ò.². Ãàâðèëåíêî, ïðîô. Î.Â. Êóðÿòà,
ïðîô. Î.Ì. Êë³ìîâà1. Äèñáàëàíñ êë³òèííèõ öèòîê³í³â ïðè ñåðöåâî-
ñóäèíí³é ïàòîëî㳿Ò.². Ãàâðèëåíêî, Í.Î. Ðèæêîâà, Ë.Â. ßêóøêî, Î.À. ϳä-ãàéíà (Êè¿â) — 15 õâ
2. Ðåãóëÿòîðè àíã³îãåíåçó, åíäîòåë³àëüíî¿ äèñôóíêö³¿ òà àêòèâíîñò³ ìàòðèêñíèõ ìåòàëîïðîòå¿íàç ó êðî-â³ õâîðèõ ç ô³áðèëÿö³ºþ ïåðåäñåðäü òà õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþÎ.Â. Êóðÿòà, À.Î. Òèõîìèðîâ, Þ.Ñ. Êóøí³ð (Äí³ïðî) — 15 õâ
3. ijàãíîñòè÷í³ êðèòå𳿠çàïàëüíèõ ðåàêö³é ó õâîðèõ ³ç ñåðöåâî-ñóäèííîþ ïàòîëî㳺þ íà ôîí³ îáñòðóê-òèâíèõ çàõâîðþâàíü ëåãåíüÎ.Ì. Êë³ìîâà, Î.Â. Ëîâèíñüêà, Ê.Î. Áè÷åíêî, Ã.Ì. Òèì-÷åíêî (Õàðê³â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
18
25 â
åðåñ
íÿ
(ñåð
åäà)
4. The role of immunological biomarkers in predicting the clinical course of myocarditisS.V. Chernyuk, T.I. Gavrilenko, L.V. Yakushko, O.A. Pid-gaina (Kyiv) – 15 min
5. Influence of immunopathological reactions on the ef-fectiveness of resynchronization therapy in patients with heart failureO.V. Rasputnyak, V.P. Zalevsky, O.M. Lomakovsky, N.O. Rizhkova – 15 min
6. Use of laboratory research in the complex treatment of patients with ischemic heart disease, which pro-ceeds against the background of allergic dermatitisL.V. Kuznetsova (Kyiv) – 15 min
Discussion — 10 min
13:20–14:00 BREAK
14:00–16:30 Competition of the young investigatorsModerators: prof. M.I. Lytay, prof. L.M. Babii, prof. I.E. Maly-
novska, S.M. Kozhukhov MD, S.V. Chernyuk PhD 1. The biomarker growth differentiation factor 15 in the
5-year adverse events prediction in patients with acute coronary syndromeI.R. Vyshnevska (Kharkiv)
2. Clinical and functional predictors of quality of life in patients with stable ischemic heart disease and con-comitant chronic obstructive pulmonary disease
D.V. Didenko (Vinnytsia)3. Weight loss in patients with chronic heart failure: pre-
dictors and clinical and prognostic significance
K.V. Voitsekhovska (Kyiv)4. Predictors of atrial fibrillation recurrence after radio-
frequency ablation in patients with chronic heart fai-lureV.T. Zolotarova (Kharkiv)
5. The relationship between uric acid level with risk fac-tor in essential hypertensionL.S. Tymoshchuk (Kyiv)
6. Analysis of the hospitalization causes in patients with a permanent form of atrial fibrillation, arterial hyper-tension, stable coronary artery disease and heart fai-lureM.I. Yalovenko (Dnipro)
7. Predictors of renal function impairment in patients with resistant arterial hypertensionK.I. Serbeniuk (Kyiv)
8. Features of the reactions of individual leukocyte popu-lations to acute ischemic injury and the development of complications of acute myocardial infarctionO.V. Dovhan (Kyiv)
9. 10-rdichny dosv³d imposition of total cavalp-posses-sion at the party with functionally one slut sertsya
Yu.V. Poznyak (Kyiv)
4. Ðîëü ³ìóíîëîã³÷íèõ á³îìàðêåð³â ó ïðîãíîçóâàíí³ êë³í³÷íîãî ïåðåá³ãó ì³îêàðäèòóÑ.Â. ×åðíþê, Ò.². Ãàâðèëåíêî, Ë.Â. ßêóøêî, Î.À. ϳä-ãàéíà (Êè¿â) — 15 õâ
5. Âïëèâ ³ìóíîïàòîëîã³÷íèõ ðåàêö³é íà åôåêòèâí³ñòü ðåñèíõðîí³çàö³éíî¿ òåðàﳿ ó ïàö³ºíò³â ³ç ñåðöåâîþ íåäîñòàòí³ñòþÎ.Â. Ðàñïóòíÿê, Â.Ï. Çàëåâñüêèé, Î.Ì. Ëîìàêîâñüêèé, Í.Ð. Ðèæêîâà (Êè¿â) — 15 õâ
6. Âèêîðèñòàííÿ ëàáîðàòîðíèõ äîñë³äæåíü ïðè êîìï-ëåêñíîìó ë³êóâàíí³ õâîðèõ ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ íà ôîí³ àëåðãîäåðìàòîç³âË.Â. Êóçíºöîâà (Êè¿â) — 15 õâ
Îáãîâîðåííÿ — 10 õâ
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–16:30 Êîíêóðñ ìîëîäèõ â÷åíèõÌîäåðàòîðè: ïðîô. Ì.². Ëóòàé, ïðîô. Ë.Ì. Áàá³é, ïðîô.
².Å. Ìàëèíîâñüêà, ä.ì.í. Ñ.Ì. Êîæóõîâ, ê.ì.í. Ñ.Â. ×åðíþê1. Á³îìàðêåð ðîñòîâèé ôàêòîð äèôåðåíö³àö³¿ 15
â 5-ð³÷íîìó ïðîãíîçóâàíí³ íàñòàííÿ íåñïðèÿòëèâèõ ïîä³é ó ïàö³ºíò³â ³ç ãîñòðèì êîðîíàðíèì ñèíäðîìîì².Ð. Âèøíåâñüêà (Õàðê³â)
2. Êë³í³êî-ôóíêö³îíàëüí³ ïðåäèêòîðè ÿêîñò³ æèòòÿ ó ïàö³ºíò³â ³ç ñòàá³ëüíîþ ³øåì³÷íîþ õâîðîáîþ ñåð-öÿ òà ñóïóòí³ì õðîí³÷íèì îáñòðóêòèâíèì çàõâîðþ-âàííÿì ëåãåíüÄ.Â. ijäåíêî (³ííèöÿ)
3. Âòðàòà ìàñè ò³ëà ó ïàö³ºíò³â ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþ: ïðåäèêòîðè òà êë³í³êî-ïðîãíîñòè÷-íå çíà÷åííÿÊ.Â. Âîéöåõîâñüêà (Êè¿â)
4. Ïðåäèêòîðè ðåöèäèâó ô³áðèëÿö³¿ ïåðåäñåðäü ï³ñ-ëÿ ðàä³î÷àñòîòíî¿ àáëÿö³¿ ó ïàö³ºíò³â ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþÒ.Â. Çîëîòàðüîâà (Õàðê³â)
5. Âçàºìîçâ’ÿçîê ð³âíÿ ñå÷îâî¿ êèñëîòè ç ôàêòîðàìè ðèçèêó ïðè åñåíö³àëüí³é àðòåð³àëüí³é ã³ïåðòåí糿Ë.Ñ. Òèìîùóê (Êè¿â)
6. Ôàêòîðè ðèçèêó ðåãîñï³òàë³çàö³é ó õâîðèõ ³ç ô³á-ðèëÿö³ºþ ïåðåäñåðäü, àðòåð³àëüíîþ ã³ïåðòåí糺þ, ³øåì³÷íîþ õâîðîáîþ ñåðöÿ òà õðîí³÷íîþ ñåðöå-âîþ íåäîñòàòí³ñòþÌ.². ßëîâåíêî (Äí³ïðî)
7. Ïðåäèêòîðè ïîã³ðøåííÿ ôóíêö³¿ íèðîê ó õâîðèõ íà ðåçèñòåíòíó àðòåð³àëüíó ã³ïåðòåíç³þÊ.². Ñåðáåíþê (Êè¿â)
8. Îñîáëèâîñò³ ðåàêö³¿ îêðåìèõ ïîïóëÿö³é ëåéêîöèò³â íà ãîñòðå ³øåì³÷íå óøêîäæåííÿ ³ ðîçâèòîê óñêëàä-íåíü ãîñòðîãî ³íôàðêòó ì³îêàðäàÎ.Â. Äîâãàíü (Êè¿â)
9. 10-ð³÷íèé äîñâ³ä íàêëàäàííÿ òîòàëüíîãî êàâà-ïóëüìîíàëüíîãî ñïîëó÷åííÿ ó ïàö³ºíò³â ³ç ôóíêö³î-íàëüíî ºäèíèì øëóíî÷êîì ñåðöÿÞ.Â. Ïîçíÿê (Êè¿â)
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
19
26th
of
Sept
embe
r (T
hurs
day)
10. Arterial hypertension and connective tissue dysplasia
N.O. Rak (Lviv)11. Modern views and perspectives of the use of meta-
bolic therapy in patients with arterial hypertensionM.I. Prokosa (Lviv)
12. Role changes intestine micribiom in the pathogenesis of paroxysmal forms of AF in patients with CADI.O. Melnychuk (Kiev)
26-TH OF SEPTEMBER (THURSDAY)NSC «OLYMPIYSKIY»
HALL OF CHAMPIONS9:00-11:20 Plenary sessionACUTE CORONARY SYNDROME AND OTHER URGENT STATESModerators: corr. member of NAMS of Ukraine, prof.
O.M. Parkhomenko, prof. T.V. Talaeva, prof. V.K. Tashchuk 1. ACS in young patients: clinical and instrumental pecu-
liaritiesO.M. Parkhomenko, Ya.M. Lutay, O.I. Irkin, D.O. Belyi (Kyiv) – 20 min
2. Clinical realization of modern treatment pathways correction in ACS patients
V.K. Tashchuk (Chernivtsi) — 15 õâ3. Decongestion as a main goal of acute decompensated
HF treatmentK.M. Amosova, A.B. Bezrodnyi, Yu.V. Rudenko (Kyiv) – 15 min
4. Traditional and additional criteria for risk stratification of ACS patientsO.A. Koval, O.S. Schukina, A.S. Skoromna (Dnipro) – 15 min
5. ACS in elderly and senile patients. Diagnosis and treat-mentV.Z. Netiazhenko (Kyiv) – 15 min
6. Clinical and prognostic value of atrial fibrillation in ACS patientsV.Yo. Tseluyko, F. Ben Salem, O.E. Matuzok (Kharkiv) – 15 min
7. Influence of individual cardiorehabilitation program on atherosclerosis dynamics and restoration of work capacity after myocardial infarctionV.O. Shumakov, I.E. Malynovska, L.M. Babii, N.P. Teresh-chenko, A.Yu. Rybak, O.B. Kuchmenko (Kyiv) – 15 min
8. Role of blood monocytes subpopulations assessment in patients with acute myocardial infarctionT.V. Talaeva, O.M. Parkhomenko, I.V. Tretiak, O.M. Dov-gan (Kyiv) – 15 min
9. Risk Factor Stratification is a strategic stage in the treatment of NSTEMI patientsYu.M. Sokolov, M.Yu. Sokolov, Yu.V. Nechiporenko, I.V. Tarapon (Kyiv) – 15 min
10. Àðòåð³àëüíà ã³ïåðòåíç³ÿ òà äèñïëàç³ÿ ñïîëó÷íî¿ òêàíèíèÍ.Î. Ðàê (Ëüâ³â)
11. Ñó÷àñí³ ïîãëÿäè òà ïåðñïåêòèâè çàñòîñóâàííÿ ìåòà-áîë³÷íî¿ òåðàﳿ ó õâîðèõ íà àðòåð³àëüíó ã³ïåðòåíç³þÌ.². Ïðîêîñà (Ëüâ³â)
12. Ðîëü çì³í ì³êðîá³îìó êèøå÷íèêó â ïàòîãåíåç³ ïà-ðîêñèçìàëüíî¿ ôîðìè ÔÏ ó õâîðèõ íà ²ÕѲ.Î. Ìåëüíè÷óê (Êè¿â)
26 ÂÅÐÅÑÍß (×ÅÒÂÅÐ)ÍÑÊ «Î˲ÌϲÉÑÜÊÈÉ»
ÕÎË ×ÅÌÏIÎÍIÂ09:00–11:20 Ïëåíàðíå çàñ³äàííÿÃÎÑÒÐÈÉ ÊÎÐÎÍÀÐÍÈÉ ÑÈÍÄÐÎÌ ÒÀ ²Íز ÍŲÄÊËÀÄͲ ÑÒÀÍÈÌîäåðàòîðè: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõî-
ìåíêî, ïðîô. Ò.Â. Òàëàºâà, ïðîô. Â.Ê. Òàùóê1. Ãîñòðèé êîðîíàðíèé ñèíäðîì ó îñ³á ìîëîäîãî â³êó:
êë³í³êî-³íñòðóìåíòàëüí³ õàðàêòåðèñòèêèÎ.Ì. Ïàðõîìåíêî, ß.Ì. Ëóòàé, Î.². ²ðê³í, Ä.Î. Á³ëèé (Êè¿â) — 20 õâ
2. Êë³í³÷íà ðåàë³çàö³ÿ ïàòîãåíåòè÷íèõ åôåêò³â ñó-÷àñíîãî ë³êóâàííÿ õâîðèõ íà ãîñòðèé êîðîíàðíèé ñèíä ðîìÂ.Ê. Òàùóê (×åðí³âö³) — 15 õâ
3. Äåêîíãåñò³ÿ ÿê òåðàïåâòè÷íà ö³ëü ë³êóâàííÿ ãîñòðî¿ äåêîìïåíñîâàíî¿ ñåðöåâî¿ íåäîñòàòíîñò³Ê.Ì. Àìîñîâà, À.Á. Áåçðîäíèé, Þ.Â. Ðóäåíêî (Êè¿â) — 15 õâ
4. Òðàäèö³éí³ òà äîäàòêîâ³ êðèòå𳿠ñòðàòèô³êàö³¿ õâî-ðèõ íà ãîñòðèé êîðîíàðíèé ñèíäðîìÎ.À. Êîâàëü, Î.Ñ. Ùóê³íà, À.Ñ. Ñêîðîìíà (Äí³ïðî) — 15 õâ
5. Ãîñòðèé êîðîíàðíèé ñèíäðîì â îñ³á ïîõèëîãî ³ ñòà-ðå÷îãî â³êó. ijàãíîñòèêà òà ë³êóâàííÿÂ.Ç. Íåòÿæåíêî (Êè¿â) — 15 õâ
6. Êë³í³÷íå ³ ïðîãíîñòè÷íå çíà÷åííÿ ô³áðèëÿö³¿ ïå-ðåäñåðäü ó õâîðèõ íà ãîñòðèé êîðîíàðíèé ñèíäðîìÂ.É. Öåëóéêî, Ô. Áåí Ñàëåì, Î.Å. Ìàòóçîê (Õàðê³â) — 15 õâ
7. Âïëèâ ³íäèâ³äóàëüíèõ ïðîãðàì êàðä³îðåàá³ë³òàö³¿ íà äèíàì³êó àòåðîñêëåðîçó ³ â³äíîâëåííÿ ïðàöå-çäàòíîñò³ ï³ñëÿ ïåðåíåñåíîãî ³íôàðêòó ì³îêàðäàÂ.Î. Øóìàêîâ, ².Å. Ìàëèíîâñüêà, Ë.Ì. Áàá³é, Í.Ï. Òå-ðåùåíêî, À.Þ. Ðèáàê, Î.Á. Êó÷ìåíêî (Êè¿â) — 15 õâ
8. Çíà÷èì³ñòü âèçíà÷åííÿ ñóáïîïóëÿö³é ìîíîöèò³â êðîâ³ ó õâîðèõ íà ãîñòðèé ³íôàðêò ì³îêàðäàÒ.Â. Òàëàºâà, Î.Ì. Ïàðõîìåíêî, ².Â. Òðåòÿê, Î.Ì. Äîâ-ãàíü (Êè¿â) — 15 õâ
9. Ñòðàòèô³êàö³ÿ çà ôàêòîðàìè ðèçèêó — ñòðàòåã³÷íèé åòàï ë³êóâàííÿ NSTEMI ïàö³ºíò³âÞ.Ì. Ñîêîëîâ, Ì.Þ. Ñîêîëîâ, Þ.Â. Íå÷èïîðåíêî, ².Â. Òàðàïîí — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
20
26 â
åðåñ
íÿ
(÷åò
âåð)
11:20-13:20 Plenary sessionPRACTICAL ASPECTS OF EMERGENCY CARDIOLOGY AND COMORBIDITY Part OneModerators: corr. member of NAMS of Ukraine, prof.
O.M. Parkhomenko, corr. member of NAMS of Ukraine, prof. V.Z. Netiazhenko, O.I. Irkin MD
11:20–12:20 Round tableACS without ST elevation: modern possibilities of diagnostics and treatment in patients with comorbiditiesParticipants: O.M. Parkhomenko, O.I. Irkin, Ya.M. Lutay (Kyiv)
12:20–13:20 Scientific-practical symposiumFrom emergency treatment to secondary prevention in heart failure patientsParticipants: O.I. Irkin, Ya.M. Lutay, O.M. Parkhomenko (Kyiv)
13:20–14:00 BREAK
14:00–15:45 Plenary sessionPRACTICAL ASPECTS OF EMERGENCY CARDIOLOGY AND COMORBIDITY Part Two
14:00–14:45 Bridge Ukraine — USA ACS and diabetes mellitusParticipants: M. Kosiborod (USA), O.M. Parkhomenko (Kyiv)
14:45–15:15 Round table Updated ESC recommendations 2019 on management of Pulmonary Embolism
Participants: Ya.M. Lutay (Kyiv), V.Yo. Tseluyko (Kharkiv)
15:15–15:45 Lecture: corr. member of NAMS of Ukraine, prof. V.Z. Netiazhenko (Kyiv)Emergency care management strategy in patients with ACS, PE, Stroke and comorbidities
15:45–18:15 Plenary session JOINT SESSION OF THE ALL-UKRAINIAN ASSOCIATION OF INTERVENTIONAL CARDIOLOGISTS OF UKRAINE AND ASSOCIATION OF CARDIOCSURGES OF UKRAINEÌîäåðàòîðè: corr. member of NAMS of Ukraine, prof. Y.M. So-
kolov, acad. of NAMS of Ukraine, prof. A.V. Rudenko, prof. M.Yu. Sokolov
1. Prospects for the development of Interventional Car-diology in the world and in UkraineYu.M. Sokolov (Kyiv) — 20 min
2. Coronary Surgery. Trends in development, joint con-cept with interventional cardiologyA.V. Rudenko (Kyiv) — 20 min
11:20–13:20 Ïëåíàðíå çàñ³äàííÿÏÐÀÊÒÈ×Ͳ ÀÑÏÅÊÒÈ ÍŲÄÊËÀÄÍί ÊÀÐIJÎËÎò¯ ² ÊÎÌÎÐÁ²ÄͲÑÒÜ ×àñòèíà ïåðøà Ìîäåðàòîðè: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Î.Ì. Ïàðõî-
ìåíêî, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ç. Íåòÿæåíêî, ä.ì.í. Î.². ²ðê³í
11:20–12:20 Êðóãëèé ñò³ëÃîñòðèé êîðîíàðíèé ñèíäðîì áåç åëåâàö³¿ ñåãìåíòà ST: ñó÷àñí³ ìîæëèâîñò³ ä³àãíîñòèêè òà ë³êóâàííÿ â óìîâàõ êîìîðá³äíîñò³Ó÷àñíèêè: Î.Ì. Ïàðõîìåíêî, Î.². ²ðê³í, ß.Ì. Ëóòàé (Êè¿â)
12:20–13:20 Íàóêîâî-ïðàêòè÷íèé ñèìïîç³óì³ä ë³êóâàííÿ ãîñòðîãî ñòàíó äî âòîðèííî¿ ïðîô³ëàêòèêè ñåðöåâî¿ íåäîñòàòíîñò³Ó÷àñíèêè: Î.². ²ðê³í, ß.Ì. Ëóòàé, Î.Ì. Ïàðõîìåíêî (Êè¿â)
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–15:45 Ïëåíàðíå çàñ³äàííÿÏÐÀÊÒÈ×Ͳ ÀÑÏÅÊÒÈ ÍŲÄÊËÀÄÍί ÊÀÐIJÎËÎò¯ ² ÊÎÌÎÐÁ²ÄͲÑÒÜ×àñòèíà äðóãà
14:00-14:45 Òåëåì³ñò Óêðà¿íà — ÑØÀÃÊÑ ³ öóêðîâèé ä³àáåòÓ÷àñíèêè: Ì. Êîñ³áîðîä (ÑØÀ), Î.Ì. Ïàðõîìåíêî (Êè¿â)
14:45–15:15 Êðóãëèé ñò³ëÎíîâëåí³ ðåêîìåíäàö³¿ ªâðîïåéñüêîãî òîâàðèñòâà êàðä³îëîã³â 2019 ðîêó ùîäî âåäåííÿ õâîðèõ íà òðîìáîåìáîë³þ ëåãåíåâî¿ àðòåð³¿Ó÷àñíèêè: ß.Ì. Ëóòàé (Êè¿â), Â.É. Öåëóéêî (Õàðê³â)
15:15–15:45 Ëåêö³ÿ: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ç. Íå-òÿæåíêî (Êè¿â)Ïîñë³äîâí³ñòü ë³êàðñüêèõ çàõîä³â ïðè íàäàíí³ óðãåíòíî¿ ìåäè÷íî¿ äîïîìîãè õâîðèì ç ãîñòðèì êîðîíàðíèì ñèíäðîìîì, òðîìáîåìáî볺þ ëåãåíåâî¿ àðòå𳿠òà ãîñòð³ ïîðóøåííÿ ìîçêîâîãî êðîâîîá³ãó ïðè êîìîðá³äíèõ ñòàíàõ
15:45–18:15 Ïëåíàðíå çàñ³äàííÿ ÑϲËÜÍÅ ÇÀѲÄÀÍÍß ÂÑÅÓÊÐÀ¯ÍÑÜÊί ÀÑÎÖ²ÀÖ²¯ ²ÍÒÅÐÂÅÍÖ²ÉÍÈÕ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÒÀ ÀÑÎÖ²ÀÖ²¯ ÊÀÐIJÎÕ²ÐÓÐò ÓÊÐÀ¯ÍÈÌîäåðàòîðè: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Þ.Ì. Ñîêîëîâ,
àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. À.Â. Ðóäåíêî, ïðîô. Ì.Þ. Ñî-êîëîâ
1. Ïåðñïåêòèâè ðîçâèòêó ³íòåðâåíö³éíî¿ êàðä³îëî㳿 â ñâ³ò³ òà Óêðà¿í³Þ.Ì. Ñîêîëîâ (Êè¿â) — 20 õâ
2. Êîðîíàðíà õ³ðóðã³ÿ. Òåíäåíö³¿ ðîçâèòêó, ñï³ëüíà êîíöåïö³ÿ ç ³íòåðâåíö³éíî¿ êàðä³îëî㳺þÀ.Â. Ðóäåíêî (Êè¿â) — 20 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
21
26th
of
Sept
embe
r (T
hurs
day)
3. Development dynamics of Regional Reperfusion Net-works in Ukraine. Data of PCI Registry and analysis of the last three years activity (2015–2018)
M.Yu. Sokolov (Kyiv) — 20 min4. Successful experience of organization of Regional re-
perfusion network. Where to begin the program in the clinic for percutaneous reperfusion therapy of AMII.V. Danilchuk (Vinnytsia) — 15 min
5. Organization of Reperfusion Center with a large vo-lume of patients. Experience of Kharkiv and Kharkiv regionV.P. Konos (Kharkiv) — 15 min
6. Features of the intracoronary thrombus structure in STEMI patients. Morphology and Clinical PracticeD.I. Besh (Lviv) — 15 min
7. Experience of work of Donetsk and Lugansk regions on extraterritorial principle in the treatment of pa-tients with acute ST segment elevation myocardial in-farction (STEMI): the development of a program of ur-gent stentingS.M. Getman (Kramatorsk) — 15 min
8. Current options for using FFR in clinical practice
A.V. Khokhlov (Kyiv) — 15 min9. Grafts stenting: The role of antiembolic devices
M.V. Shimanko (Kyiv) — 15 min
CONFERENCE HALL «SPARTA»9:00-11:30 Plenary sessionSTABLE ISCHEMIC HEART DISEASE: DIAGNOSIS, RISK STRATIFICATION, PREVENTION, TREATMENTModerators: prof. M.I. Lutay, prof. T.V. Talaeva, Yu.S. Ru-
dik MD
9:00-9:30 Lecture: prof. M.I. Lutay (Kyiv)Principles of rational pharmacotherapy for patients with stable coronary heart disease according to new recommendations1. Role of blood monocytes in atherogenesis
T.V. Talaeva (Kyiv) – 15 min2. Control of heart rate and blood pressure in patients
with coronary artery disease and arterial hyperten-sion. Experience of ambulatory treatment in Ukraine
M.I. Lutay (Kyiv) – 15 min 3. Diagnosis of stable forms coronary heart disease in pa-
tients with kidneys function reduction, the possibility of coronary arteries index calcificationO.V. Kuryata, V.G. Stryzheniy, O.V. Gorshkova, V.V. Se-menov (Dnipro) – 15 min
3. Äèíàì³êà ðîçâèòêó ðåã³îíàëüíèõ ðåïåðôóç³éíèõ ìåðåæ â Óêðà¿í³. Äàí³ Ðåºñòðó ïåðêóòàííèõ êîðî-íàðíèõ âòðó÷àíü òà àíàë³ç îñòàíí³õ òðüîõ ðîê³â ðî-áîòè (2015–2018 ðð.)Ì.Þ. Ñîêîëîâ (Êè¿â) — 20 õâ
4. Óñï³øíèé äîñâ³ä îðãàí³çàö³¿ Ðåã³îíàëüíî¿ ðåïåð-ôóç³éíî¿ ìåðåæ³. Ç ÷îãî ïî÷àòè ïðîãðàìó â êë³í³ö³ ç ïåðêóòàííî¿ ðåïåðôóç³éíî¿ òåðàﳿ ò̲.Â. Äàíèëü÷óê (³ííèöÿ) — 15 õâ
5. Ñèñòåìà îðãàí³çàö³¿ ðåïåðôóç³éíîãî öåíòðó ç âåëè-êèì îáñÿãîì ïàö³ºíò³â. Äîñâ³ä Õàðêîâà ³ Õàðê³âñüêî¿ îáëàñò³Â.Ï. Êîíîñ (Õàðê³â) — 15 õâ
6. Îñîáëèâîñò³ áóäîâè âíóòð³øíüîêîðîíàðíîãî òðîìáó ó STEMI ïàö³ºíò³â. Ìîðôîëîã³ÿ òà êë³í³÷íà ïðàêòèêàÄ.². Áåø (Ëüâ³â) — 15 õâ
7. Äîñâ³ä ðîáîòè Äîíåöüêî¿ òà Ëóãàíñüêî¿ îáëàñòåé çà åêñòðàòåðèòîð³àëüíèì ïðèíöèïîì ïðè ë³êóâàíí³ ïàö³ºíò³â ç ãîñòðèì ³íôàðêòîì ì³îêàðäà ç åëåâà-ö³ºþ ñåãìåíòà ST (STEMI): ðîçâèòîê ïðîãðàìè óð-ãåíòíîãî ñòåíòóâàííÿÑ.Ì. Ãåòüìàí (Êðàìàòîðñüê) — 15 õâ
8. Ôðàêö³éíèé ðåçåðâ êðîâîïëèíó: ñó÷àñíèé ñòàí ïðîáëåìè À.Â. Õîõëîâ (Êè¿â) — 15 õâ
9. Ïðèñòðî¿ ïðîòèåìáîë³÷íîãî çàõèñòó ïðè ñòåíòóâàí-í³ âåíîçíèõ øóíò³âÌ.Â. Øèìàíêî (Êè¿â) — 15 õâ
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÑÏÀÐÒÀ»9:00-11:30 Ïëåíàðíå çàñ³äàííÿÑÒÀÁ²ËÜÍÀ ²ØÅ̲×ÍÀ ÕÂÎÐÎÁÀ ÑÅÐÖß: IJÀÃÍÎÑÒÈÊÀ, ÑÒÐÀÒÈÔ²ÊÀÖ²ß ÐÈÇÈÊÓ, ÏÐÎÔ²ËÀÊÒÈÊÀ, ˲ÊÓÂÀÍÍßÌîäåðàòîðè: ïðîô. Ì.². Ëóòàé, ïðîô. Ò.Â. Òàëàºâà, ä.ì.í.
Þ.Ñ. Ðóäèê
9:00–9:30 Ëåêö³ÿ: ïðîô. Ì.². Ëóòàé (Êè¿â)Ïðèíöèïè ðàö³îíàëüíî¿ ìåäèêàìåíòîçíî¿ òåðàﳿ ïàö³ºíò³â ç³ ñòàá³ëüíîþ ³øåì³÷íîþ õâîðîáîþ ñåðöÿ ç îãëÿäó íà íîâ³ ðåêîìåíäàö³¿1. Ðîëü ìîíîöèò³â êðîâ³ â àòåðîãåíåç³
Ò.Â. Òàëàºâà (Êè¿â) — 15 õâ2. Êîíòðîëü ÷àñòîòè ñåðöåâèõ ñêîðî÷åíü òà àðòåð³àëü-
íîãî òèñêó ó ïàö³ºíò³â ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ ³ àðòåð³àëüíîþ ã³ïåðòåí糺þ. Äîñâ³ä àìáóëàòîðíîãî ë³êóâàííÿ â Óêðà¿í³Ì.². Ëóòàé (Êè¿â) — 15 õâ
3. ijàãíîñòèêà ñòàá³ëüíèõ ôîðì ³øåì³÷íî¿ õâîðîáè ñåðöÿ ïðè çíèæåíí³ ôóíêö³¿ íèðîê, ìîæëèâîñò³ ³í-äåêñó êàëüöèô³êàö³¿ êîðîíàðíèõ àðòåð³éÎ.Â. Êóðÿòà, Â.Ã. Ñòðèæåíèé, Î.Â. Ãîðøêîâà, Â.Â. Ñå-ìåíîâ (Äí³ïðî) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
22
26 â
åðåñ
íÿ
(÷åò
âåð)
4. IHD and low triiodothyronine syndrome
Yu.S. Rudik, S.M. Brewer (Kharkiv) – 15 min5. Criteria for diagnosis, risk stratification in patients
with coronary artery calcinosisI.P. Golikova (Kyiv) – 15 min
6. Arterial myocardial revascularization. Modern view. The experience of the one centerO.O. Zhurba (Cherkasy) – 15 min
7. Coronary artery disease without significant hemody-namic atherosclerotic lesions: strategies and tactics of the treatment O.O. Yakymenko, D.M. Sebov, V.A. Korotaieva (Odesa) — 15 min
8. Complete myocardium revascularization as a safe and effective method of coronary bypass surgery in pa-tients with multivessel coronary artery lesions
S.V. Verbanets, O.Yu. Pukass, G.I. Emets, O.S. Gurjeva, I.M. Emets (Kyiv) – 15 min
11:30–12:00 Round table1. Portrait of a cardiologic patient with resistant arterial
hypertension and metabolic syndromeprof. N.Y. Osovska (Vinnytsia)
2. Problematic issues for treatment of arterial hyperten-sion in oblique and agingprof. L.M. Yena (Kyiv)
12:00-12:20 Lecture: prof. V.Yo.Tseluyko (Kharkiv)The comorbid patient in cardiology – how to find answers on unresolved questions
12:20–12:50 Round tableCardioprotection of coronary artery disease from stable angina pectoris to myocardial infarctionParticipants: prof. V.K. Tashchuk (Chernivtsi), prof.
V.O. Shumakov (Kyiv)
12:50–13:20 Round table1. Place of cardioprotective therapy in the treatment
of acute forms of coronary artery disease and the pos-sibility of its intensification in modern timesprof. V.V. Batushkin (Kyiv)
2. Features of pharmacotherapy for arterial hypertension in elderly patientsprof. O.M. Barna (Kyiv)
13:20–14:00 BREAK
14:00-14:30 Round TableAntihypertensive treatment in T2D patient: efficacy for lifeParticipants: L.K.Sokolova MD (Kyiv), prof. S.A. Tikhonova (Odessa)
14:30–17:30 Plenary sessionARTERIAL HYPERTENSIONModerators: L.A. Mishchenko MD, prof. S.M. Koval, prof.
O.Y. Zharinov
4. ²øåì³÷íà õâîðîáà ñåðöÿ òà ñèíäðîì íèçüêîãî òðè-éîäòèðîí³íóÞ.Ñ. Ðóäèê, Ñ.Ì. Ïèâîâàð (Õàðê³â) — 15 õâ
5. Êðèòå𳿠ä³àãíîñòèêè, ñòðàòèô³êàö³¿ ðèçèêó ó ïàö³-ºíò³â ç êàëüöèíîçîì êîðîíàðíèõ àðòåð³é².Ï. Ãîë³êîâà (Êè¿â) — 15 õâ
6. Àðòåð³àëüíà ðåâàñêóëÿðèçàö³ÿ ì³îêàðäà. Ñó÷àñíèé ïîãëÿä. Äîñâ³ä îäíîãî öåíòðóÎ.Î. Æóðáà (×åðêàñè) — 15 õâ
7. ²øåì³÷íà õâîðîáà ñåðöÿ áåç ãåìîäèíàì³÷íî çíà-÷óùîãî àòåðîñêëåðîòè÷íîãî óðàæåííÿ êîðîíàðíèõ àðòåð³é: ñòðàòåã³ÿ ³ òàêòèêà ë³êóâàííÿÎ.Î. ßêèìåíêî, Ä.Ì. Ñåáîâ, Â.À. Êîðîòàºâà (Îäåñà) — 15 õâ
8. Ïîâíà àðòåð³àëüíà ðåâàñêóëÿðèçàö³ÿ ì³îêàðäà ÿê áåçïå÷íèé òà åôåêòèâíèé ìåòîä êîðîíàðíîãî øóíòóâàííÿ ó ïàö³ºíò³â ³ç áàãàòîñóäèííèì óðàæåí-íÿì â³íöåâèõ ñóäèí Ñ.Â. Âåðáàíåöü, Î.Þ. Ïóêàñ, Ã.². ªìåöü, Î.Ñ. Ãóð’ºâà, ².Ì. ªìåöü (Êè¿â) — 15 õâ
11:30-12:00 Êðóãëèé ñò³ë1. Ïîðòðåò êàðä³îëîã³÷íîãî ïàö³ºíòà ³ç ðåçèñòåíòíîþ àð-
òåð³àëüíîþ ã³ïåðòåí糺þ òà ìåòàáîë³÷íèì ñèíä ðîìîìïðîô. Í.Þ. Îñîâñüêà (³ííèöÿ)
2. Ïðîáëåìí³ ïèòàííÿ ë³êóâàííÿ àðòåð³àëüíî¿ ã³ïåð-òåí糿 â ïîõèëîìó òà ñòàðå÷îìó â³ö³ïðîô. Ë.Ì. ªíà (Êè¿â)
12:00–12:20 Ëåêö³ÿ: ïðîô. Â.É. Öåëóéêî (Õàðê³â)Êîìîðá³äíèé ïàö³ºíò â êàðä³îëî㳿 — â³äïîâ³ä³ íà íåâèð³øåí³ ïèòàííÿ
12:20–12:50 Êðóãëèé ñò³ëÊàðä³îïðîòåêö³ÿ ³øåì³÷íî¿ õâîðîáè ñåðöÿ â³ä ñòàá³ëüíî¿ ñòåíîêàð䳿 äî ³íôàðêòó ì³îêàðäàÓ÷àñíèêè: ïðîô. Â.Ê. Òàùóê (×åðí³âö³), ïðîô. Â.Î. Øóìà-
êîâ (Êè¿â)
12:50–13:20 Êðóãëèé ñò³ë1. ̳ñöå êàðä³îïðîòåêòîðíî¿ òåðàﳿ â ë³êóâàíí³ ãî-
ñòðèõ ôîðì ³øåì³÷íî¿ õâîðîáè ñåðöÿ ³ ìîæëèâîñò³ ¿¿ ³íòåíñèô³êàö³¿ â ñó÷àñíèé ÷àñïðîô. Â.Â. Áàòóøê³í (Êè¿â)
2. Îñîáëèâîñò³ ôàðìàêîòåðàﳿ àðòåð³àëüíî¿ ã³ïåð-òåí糿 ó ïàö³ºíò³â ë³òíüîãî â³êóïðîô. Î.Ì. Áàðíà (Êè¿â)
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–14:30 Êðóãëèé ñò³ëÀíòèã³ïåðòåíçèâíà òåðàï³ÿ ó õâîðîãî íà öóêðîâèé ä³àáåò: åôåêòèâí³ñòü çàðàäè æèòòÿÓ÷àñíèêè: ä.ì.í. Ë.Ê. Ñîêîëîâà (Êè¿â), ïðîô. Ñ.À. Òèõîíîâà (Îäåñà)
14:30–17:30 Ïëåíàðíå çàñ³äàííÿÀÐÒÅвÀËÜÍÀ òÏÅÐÒÅÍDzßÌîäåðàòîðè: ä.ì.í. Ë.À. ̳ùåíêî, ïðîô. Ñ.Ì. Êîâàëü,
ïðîô. Î.É. Æàð³íîâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
23
26th
of
Sept
embe
r (T
hurs
day)
1. Micro-RNA and problems of pathogenesis and treat-ment of essential arterial hypertensionS.M. Koval, I.O. Snigurska, K.O. Yushko (Kharkiv) — 15 min
2. Masked arterial hypertension – myth or reality? Re-sults of Ukrainian MAHNAT trial
L.A. Mishchenko (Kyiv) — 15 min3. Arterial hypertension and atrial fibrillation
O.Y. Zharinov (Kyiv) — 15 min4. New opportunities in treatment hypertensive and dia-
betic patientsL.K. Sokolova (Kyiv) — 15 min
5. Ñrisis management: arterial hypertension and women`s healthYu.V. Davydova (Kyiv) — 15 min
6. Gender aspects of arterial hypertensionM.M. Dolzhenko (Kyiv) — 15 min
7. International clinical protocols and own experience of hypertension management in pregnancyA.Yu. Limanska (Kyiv) — 15 min
8. Hypertensive damage of the organ of vision
Ya.A. Diomin, O.V. Nedzvetska (Kharkiv) — 15 min9. Secondary stroke prevention: What? How? When?
I.L. Revenko, V.M. Kornatskyi (Kyiv) — 15 min10. Nephroprotection in patients with arterial hyperten-
sionS.V. Kushnirenko (Kyiv) — 15 min
11. Treatment of patients with resistant arterial hyper-tension and kidney damage – does universal approach exist?O.O. Matova (Kyiv) -— 15 min
Discussion – 15 min
CONFERENCE HALL «OLYMPIA»9:00–9:30 Master classNew opportunities in antithrombotic treatment of patients with multifocal atherosclerosis
prof. V.Yo. Tseluyko (Kharkiv)
9:30–10:00 Lecture: prof. L.G. Voronkov (Kyiv)Patient with Chronic Heart Failure and Concomitant Anemia
10:00–10:30 Round table Actual questions of treatment of cardiac patients with concomitant endocrine pathologyParticipants: L.A. Mishchenko MD, L.K. Sokolova MD (Kyiv)
10:30–11:00 Actual discussionAntiplatelet and antithrombotic therapy in patients with stable coronary artery disease. Which way to choose?
1. ̳êðî-ÐÍÊ ³ ïðîáëåìè ïàòîãåíåçó òà ë³êóâàííÿ ïåðâèííî¿ àðòåð³àëüíî¿ ã³ïåðòåí糿Ñ.Ì. Êîâàëü, ².Î. Ñí³ãóðñüêà, Ê.Î. Þøêî (Õàðê³â) — 15 õâ
2. Ìàñêîâàíà àðòåð³àëüíà ã³ïåðòåíç³ÿ — ì³ô ÷è ðå-àëüí³ñòü? Ðåçóëüòàòè âñåóêðà¿íñüêîãî äîñë³äæåííÿ ÌÀÃÍÀÒË.À. ̳ùåíêî (Êè¿â) — 15 õâ
3. Àðòåð³àëüíà ã³ïåðòåíç³ÿ ³ ô³áðèëÿö³ÿ ïåðåäñåðäüÎ.É. Æàð³íîâ (Êè¿â) — 15 õâ
4. Íîâ³ ìîæëèâîñò³ â ë³êóâàíí³ õâîðèõ íà àðòåð³àëüíó ã³ïåðòåíç³þ òà öóêðîâèé ä³àáåòË.Ê. Ñîêîëîâà (Êè¿â) — 15 õâ
5. Àíòèêðèçîâèé ìåíåäæìåíò: àðòåð³àëüíà ã³ïåðòåí-ç³ÿ ³ æ³íî÷å çäîðîâ’ÿÞ.Â. Äàâèäîâà (Êè¿â) — 15 õâ
6. Ãåíäåðí³ àñïåêòè àðòåð³àëüíî¿ ã³ïåðòåí糿Ì.Ì. Äîëæåíêî (Êè¿â) — 15 õâ
7. ̳æíàðîäí³ êë³í³÷í³ ïðîòîêîëè òà âëàñíèé äîñâ³ä â ë³êóâàíí³ ã³ïåðòåí糿 ó âàã³òíèõÀ.Þ. ˳ìàíñüêà (Êè¿â) — 15 õâ
8. Óðàæåííÿ îðãàíà çîðó ïðè àðòåð³àëüí³é ã³ïåð-òåí糿Þ.À. Äüîì³í, Î.Â. Íåäçâåöüêà (Õàðê³â) — 15 õâ
9. Âòîðèííà ïðîô³ëàêòèêà ³íñóëüòó: Ùî? ßê? Êîëè?².Ë. Ðåâåíüêî, Â.Ì. Êîðíàöüêèé (Êè¿â) — 15 õâ
10. Çàõèñò íèðîê ó ïàö³ºíò³â ç àðòåð³àëüíîþ ã³ïåðòåí-糺þÑ.Â. Êóøí³ðåíêî (Êè¿â) — 15 õâ
11. ˳êóâàííÿ õâîðèõ íà ðåçèñòåíòíó àðòåð³àëüíó ã³-ïåðòåíç³þ ç óðàæåííÿì íèðîê — ÷è ³ñíóº óí³âåð-ñàëüíèé ï³äõ³ä?Î.Î. Ìàòîâà (Êè¿â) — 15 õâ
Îáãîâîðåííÿ — 15 õâ
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «Î˲Ìϲ߻9:00–9:30 Ìàéñòåð-êëàñÍîâ³ ìîæëèâîñò³ àíòèòðîìáîòè÷íî¿ òåðàﳿ ïàö³ºíò³â ³ç ìóëüòèôîêàëüíèì àòåðîñêëåðîçîì
ïðîô. Â.É Öåëóéêî (Õàðê³â)
9:30–10:00 Ëåêö³ÿ: ïðîô. Ë.Ã. Âîðîíêîâ (Êè¿â)Ïàö³ºíò ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþ òà ñóïóòíüîþ àíå쳺þ
10:00–10:30 Êðóãëèé ñò³ë�Àêòóàëüí³ ïèòàííÿ ë³êóâàííÿ êàðä³îëîã³÷íèõ ïàö³ºíò³â ³ç ñóïóòíüîþ åíäîêðèííîþ ïàòîëî㳺þÓ÷àñíèêè: ä.ì.í. Ë.À. ̳ùåíêî, ä.ì.í. Ë.Ê. Ñîêîëîâà (Êè¿â)
10:30–11:00 Àêòóàëüíà äèñêóñ³ÿÀíòèòðîìáîöèòàðíà é àíòèòðîìáîòè÷íà òåðàï³ÿ ó õâîðèõ ç³ ñòàá³ëüíîþ õâîðîáîþ êîðîíàðíèõ àðòåð³é. ßêèé øëÿõ îáðàòè?
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
24
26 â
åðåñ
íÿ
(÷åò
âåð)
ASA, clopidogrel. Dual therapy: ASA + clopidogrel, ASA + ticagrelor
Participants: prof. M.I. Lutay, corr. member of NAMS of Ukraine, prof. O.M. Parkhomenko (Kyiv)
11:00–11:30 Master classAntihypertensive therapy choice in chronic heart failure patient with preserved ejection fraction
prof. Radchenko D.M (Kyiv)
11:30–12:10 Round tableFeatures of diuretic therapy in comorbid patients with cardiac pathologyParticipants: prof. L.G. Voronkov, L.A. Mishchenko MD (Kyiv)
12:10–12:50 Round tableEmpowering your clinical decisions in treating patients with D2T
Participants: L.K. Sokolova MD (Kyiv), prof. B.N. Mankovsky (Kyiv), prof. O.A. Koval (Dnipro)
12:50–13:20 Master classDouble or triple antihypertensive therapy: who to whom?Participants: L.A. Mishchenko MD, O.O.Matova PhD (Kyiv)
13:20–14:00 BREAK
14:00–14:30 Master classJustified expectations or new in the treatment of patients with chronic heart failure with preserved ejection fractionParticipants: prof. V.Yo. Tseluyko (Kharkiv), prof. O.A. Koval
(Dnipro)*With the scientific support of the ACINO company.
14:30–18:00 Plenary session HEART FAILUREPresidium: prof. L.G. Voronkov, corr. member of NAMS
of Ukraine, prof. K.M. Amosova, corr.member of NAMS of Ukraine, prof. B.M. Todurov
14:00-15:00 Lecture: corr. member of NAMS of Ukraine, prof. K.M. Amosova (Kyiv) Heart failure with preserved ejection fraction: phantom or real syndrome with «own face»?
15:00-15:30 Lecture: corr.member of NAMS of Ukraine prof. B.M. Todurov (Kyiv)Contemporary approaches to cardiosurgical treatment of chronic heart failure patients
15:30-18:00 1. Cognitive dysfunction in chronic heart failure patients:
clinical, prognostic significance and rationale for cor-rectionL.G. Voronkov, A.S. Solonovich (Kyiv) –20 min
Àöåòèëñàë³öèëîâà êèñëîòà, êëîï³äîãðåëü. Ïîäâ³éíà òåðàï³ÿ: àöåòèëñàë³öèëîâà êèñëîòà + êëîï³äîãðåëü, àöåòèëñàë³öèëîâà êèñëîòà + ò³êàãðåëîðÓ÷àñíèêè: ïðîô. Ì.². Ëóòàé, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô.
Î.Ì. Ïàðõîìåíêî (Êè¿â)
11:00–11:30 Ìàéñòåð-êëàñÂèá³ð àíòèã³ïåðòåíçèâíî¿ òåðàﳿ ó ïàö³ºíòà ³ç ñåðöåâîþ íåäîñòàòí³ñòþ òà çáåðåæåíîþ ôðàêö³ºþ âèêèäó
ïðîô. Ã.Ä. Ðàä÷åíêî (Êè¿â)
11:30–12:10 Êðóãëèé ñò³ëÎñîáëèâîñò³ ä³óðåòè÷íî¿ òåðàﳿ ó êîìîðá³äíèõ ïàö³ºíò³â ç êàðä³àëüíîþ ïàòîëî㳺þÓ÷àñíèêè: ïðîô. Ë.Ã. Âîðîíêîâ, ä.ì.í. Ë.À. ̳ùåíêî (Êè¿â)
12:10–12:50 Êðóãëèé ñò³ëÐîçøèðåííÿ ìîæëèâîñòåé äëÿ âàøèõ êë³í³÷íèõ ð³øåíü ï³ä ÷àñ ë³êóâàííÿ ïàö³ºíò³â ³ç öóêðîâèì ä³àáåòîì 2-ãî òèïóÓ÷àñíèêè: ä.ì.í. Ë.Ê. Ñîêîëîâà (Êè¿â), ïðîô. Á.Í. Ìàíü-
êîâñüêèé (Êè¿â), ïðîô. Å.À. Êîâàëü (Äí³ïðî)
12:50–13:20 Ìàéñòåð-êëàñÏîäâ³éíà ÷è ïîòð³éíà àíòèã³ïåðòåíçèâíà òåðàï³ÿ: ùî êîìó?Ó÷àñíèêè: ä.ì.í. Ë.À. ̳ùåíêî, ê.ì.í. Î.Î. Ìàòîâà (Êè¿â)
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–14:30 Ìàéñòåð-êëàñÂèïðàâäàí³ íà䳿 àáî íîâå â ë³êóâàíí³ ïàö³ºíò³â ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþ ³ çáåðåæåíîþ ôðàêö³ºþ âèêèäóÓ÷àñíèêè: ïðîô. Â.². Öåëóéêî (Õàðê³â), ïðîô. Î.À. Êîâàëü
(ijïðî)�*Çà íàóêîâî¿ ï³äòðèìêè êîìïàí³¿ ACINO.
14:30–18:00 Ïëåíàðíå çàñ³äàííÿÑÅÐÖÅÂÀ ÍÅÄÎÑÒÀÒͲÑÒÜÏðåçèä³ÿ: ïðîô. Ë.Ã. Âîðîíêîâ, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè,
ïðîô. Ê.Ì. Àìîñîâà, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Á.Ì. Òîäóðîâ
14:30-15:00 Ëåêö³ÿ: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Ê.Ì. Àìîñîâà (Êè¿â)Ñåðöåâà íåäîñòàòí³ñòü ç³ çáåðåæåíîþ ôðàêö³ºþ âèêèäó: ôàíòîì ÷è ðåàëüíèé ñèíäðîì ³ç «âëàñíèì îáëè÷÷ÿì»?
15:00-15:30 Ëåêö³ÿ: ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Á.Ì. Òîäóðîâ (Êè¿â)Ñó÷àñí³ ï³äõîäè äî íàäàííÿ êàðä³îõ³ðóðã³÷íî¿ äîïîìîãè ïàö³ºíòàì ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþ
15:30-18:001. Êîãí³òèâíà äèñôóíêö³ÿ ó ïàö³ºíò³â ³ç õðîí³÷íîþ
ñåðöåâîþ íåäîñòàòí³ñòþ: êë³í³êî-ïðîãíîñòè÷íå çíà÷åííÿ òà îá´ðóíòóâàííÿ êîðåêö³¿Ë.Ã. Âîðîíêîâ, À.Ñ. Ñîëîíîâè÷ (Êè¿â) — 20 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
25
26th
of
Sept
embe
r (T
hurs
day)
2. Transcatheter method of aortic valve stenosisB.M. Todurov, M.V. Stan, A.V. Khokhlov (Kyiv) – 20 min
3. Practical aspects of biomarker diagnostics in chronic heart failureO.E. Berezin (Zaporizhia) – 20 min
4. Heart failure with left ventricular ejection fraction in intermediary rangeO.Y. Zharinov (Kyiv) – 20 min
5. Heart failure phenotype and renal dysfunctionO.V. Kuryata (Dnipro) – 20 min
6. The phenotypes of chronic heart failure in patients with ischemic heart disease and comorbidities with chronic obstructive pulmonary diseaseV.A. Potabashniy (Kriviy Rig) – 20 min
7. Catheter treatment of atrial fibrillation in patients with left ventricular systolic dysfunction
Y.V. Zinchenko, T.V. Mikhaleva (Kyiv) – 20 min
CONFERENCE HALL «ODISSEY»9:00–11:40 Section meeting SCHOOL FOR PRACTICING DOCTORS (Clinical cases)Moderators: prof. T.V. Kolesnyk, prof. M.M. Dolzhenko1. The new paradigms of treatment of patients with arte-
rial hypertension after revaskularisation of myocardiumM.M. Dolzhenko (Kyiv ) – 20 min
2. Anticoagulation therapy for atrial fibrillation. Clinical caseanalysisO.M. Romanova (Kyiv) – 20 min
3. Can a patient with ACS be «simple»? Realities and myths based on analysis of a clinical casesD.I. Besh (Lviv) – 20 min
4. Anxiety and depression in cardiologic patients: how to see an genuine face and who has to treat?T.V. Kolesnyk (Dnipro) – 20 min
5. Hypertension and the brain. Cerebroprotective effects of blockade of angiotensin receptors (and not only): world experience and own observationsS.O. Andriyevska (Odessa) – 20 min
6. The multiple dimensions of anti-ischemic therapy and the possibilities of a family doctor at the present stage: clinical analysisM.M. Seliuk (Kyiv) – 20 min
7. Features of the course and treatment of complete AV-blockade L.P. Soleiko, O.V. Soleiko, O.O. Krukova (Vinnytsia) — 20 min
Discussion — 20 min
11:40–12:50 Section meeting NEW TRENDS IN TREATMENT OF CARDIOVASCULAR DISEASES. PROOF MEDICINE AND RECOMMENDATIONS
Moderators: prof. M.I. Lutay, prof. V.Yo. Tseluyko
2. Òðàíñêàòåòåðíà ìåòîäèêà ñòåíîçó àîðòàëüíîãî êëàïàíàÁ.Ì. Òîäóðîâ, Ì.Â. Ñòàí, À.Â. Õîõëîâ (Êè¿â) — 20 õâ
3. Ïðàêòè÷í³ àñïåêòè á³îìàðêåðíî¿ ä³àãíîñòèêè ïðè ñåðöåâ³é íåäîñòàòíîñò³Î.ª. Áåðåç³í (Çàïîð³ææÿ) — 20 õâ
4. Ñåðöåâà íåäîñòàòí³ñòü ç ôðàêö³ºþ âèêèäó ë³âîãî øëóíî÷êà ó ïðîì³æíîìó ä³àïàçîí³Î.É. Æàð³íîâ, Î.À. ªïàí÷³íöåâà (Êè¿â) — 20 õâ
5. Ôåíîòèï ñåðöåâî¿ íåäîñòàòíîñò³ òà äèñôóíêö³ÿ íèðîê Î.Â. Êóðÿòà (Äí³ïðî) — 20 õâ
6. Ôåíîòèïè õðîí³÷íî¿ ñåðöåâî¿ íåäîñòàòíîñò³ ó ïàö³-ºíò³â ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ ³ êîìîðá³äíèì õðîí³÷íèì îáñòðóêòèâíèì çàõâîðþâàííÿì ëåãåíüÂ.À. Ïîòàáàøí³é (Êðèâèé гã) — 20 õâ
7. Åôåêòèâí³ñòü êàòåòåðíîãî ë³êóâàííÿ ô³áðèëÿö³¿ ïå-ðåäñåðäü ó õâîðèõ ³ç ñèñòîë³÷íîþ äèñôóíêö³ºþ ë³-âîãî øëóíî÷êàÞ.Â. dzí÷åíêî, Ò.Â. ̳õàëºâà (Êè¿â) — 20 õâ
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÎIJÑÑÅÉ» 9:00–11:40 Ñåêö³éíå çàñ³äàííÿØÊÎËÀ ÏÐÀÊÒÈÊÓÞ×ÎÃΠ˲ÊÀÐß (êë³í³÷í³ âèïàäêè)Ìîäåðàòîðè: ïðîô. Ò.Â. Êîëåñíèê, ïðîô. Ì.Ì. Äîë æåíêî1. Íîâ³ ïàðàäèãìè ë³êóâàííÿ õâîðèõ íà àðòåð³àëüíó
ã³ïåðòåíç³þ ï³ñëÿ ðåâàñêóëÿðèçàö³¿ ì³îêàðäàÌ.Ì. Äîëæåíêî (Êè¿â) — 20 õâ
2. Àíòèêîàãóëÿíòíà òåðàï³ÿ ïðè ô³áðèëÿö³¿ ïåðåä-ñåðäü. Êë³í³÷íèé ðîçá³ðÎ.Ì. Ðîìàíîâà (Êè¿â) — 20 õâ
3. ×è ìîæå ïàö³ºíò ç ÃÊÑ áóòè «ïðîñòèì»? Ðåà볿 òà ì³ôè íà ïðèêëàä³ êë³í³÷íîãî âèïàäêóÄ.². Áåø (Ëüâ³â) — 20 õâ
4. Òðèâîãà ³ äåïðåñ³ÿ ó êàðä³îëîã³÷íîãî ïàö³ºíòà: ÿê ïî-áà÷èòè ñïðàâæíº îáëè÷÷ÿ ³ õòî ïîâèíåí ë³êóâàòè?Ò.Â. Êîëåñíèê (Äí³ïðî) — 20 õâ
5. óïåðòåíç³ÿ òà ìîçîê. Öåðåáðîïðîòåêòîðí³ åôåêòè áëîêàäè ðåöåïòîð³â àíã³îòåíçèíó (³ íå ò³ëüêè): ñâ³-òîâèé äîñâ³ä òà âëàñí³ ñïîñòåðåæåííÿÑ.Î. Àíäð³ºâñüêà (Îäåñà) — 20 õâ
6. Áàãàòîãðàíí³ñòü àíòè³øåì³÷íî¿ òåðàﳿ: êë³í³÷íèé ðîçá³ð
Ì.Ì. Ñåëþê (Êè¿â) — 20 õâ7. Îñîáëèâîñò³ ïåðåá³ãó òà ë³êóâàííÿ ïîâíî¿ ÀV-
áëîêàäèË.Ï. Ñîëåéêî, Î.Â. Ñîëåéêî, Î.Î. Êðþêîâà (³ííèöÿ) — 20 õâ
Îáãîâîðåííÿ — 20 õâ
11:40-12:50 Ñåêö³éíå çàñ³äàííÿÍβ ÒÅÍÄÅÍÖ²¯  ˲ÊÓÂÀÍͲ ÑÅÐÖÅÂÎ-ÑÓÄÈÍÍÈÕ ÇÀÕÂÎÐÞÂÀÍÜ. ÄÎÊÀÇÎÂÀ ÌÅÄÈÖÈÍÀ ÒÀ ÐÅÊÎÌÅÍÄÀÖ²¯Ìîäåðàòîðè: ïðîô. Ì.². Ëóòàé, ïðîô. Â.É. Öåëóéêî
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
26
26 â
åðåñ
íÿ
(÷åò
âåð)
1. Recommendations for antithrombotic therapy in patients with stable coronary artery disease. Focus on high-risk patients, place of anticoagulantsM.I. Lutay (Kyiv) – 15 min
2. Systolic arterial hypertension, current approaches for treatmentV.Yo. Tseluyko (Kharkiv) – 15 min
3. A contemporary view on statin use for the prevention and treatment of cardiovascular diseasesO.O. Khanukov (Dnipro) – 15 min
4. Positions of bisoprolol in modern guidelines for the management of patients with CVD
L.N. Yakovleva (Kharkiv) – 15 min
12:50–13:20 Lecture: prof. L.G. Voronkov (Kyiv)Anticoagulant therapy in chronic stable ischemic heart disease
13:20–14:00 BREAK
14:00–14:30 Round table «DIAMOND» approach to personalized miokardial ischemia treatmentParticipants: O.M. Romanova PhD, O.I. Irkin MD (Kyiv)*With the scientific support of the ACINO company.
14:30–16:30 Plenary session COMMERCIAL STATES IN CARDIOLOGYModerators: acad. of NAMS Ukraine, prof. V.M. Kovalen-
ko, corr. member of NAMS of Ukraine, prof. V.Z. Neti-azhenko, prof. T.V. Talaeva
1. Comorbidity — announce a problemV.M. Kovalenko (Kyiv) – 10 min
2. Efficacy of treatment of patients with high coronary risk in Ukraine M.I. Lutay (Kyiv) – 15 min
3. Pathogenetic mechanisms of development of comor-bid conditionsT.V. Talaeva (Kyiv) – 15 min
4. Diagnosis and correction of hemostasis disorders in co-morbid conditionsV.Z. Netiazhenko (Kyiv) – 15 min
5. Comorbid state in patients with hypertension: strategy and tactics of patient’s management M.M. Dolzhenko (Kyiv) – 15 min
6. Hidden and obvious manifestations of iron deficiency anemiaA.Y. Lymanska (Kyiv) – 15 min
7. Problems of gastrointestinal safety in patients receiv-ing antiplatelet therapyM.Yu. Zak (Mykolaiv)– 15 min
1. Ðåêîìåíäàö³¿ ç àíòèòðîìáîòè÷íî¿ òåðàﳿ ïàö³ºíò³â ç³ ñòàá³ëüíîþ ³øåì³÷íîþ õâîðîáîþ ñåðöÿ. Ôîêóñ íà ïàö³ºíò³â âèñîêîãî ðèçèêó, ì³ñöå àíòèêîàãóëÿíò³âÌ.². Ëóòàé (Êè¿â) — 15 õâ
2. Ñèñòîë³÷íà àðòåð³àëüíà ã³ïåðòåíç³ÿ, ñó÷àñí³ ï³äõîäè äî ë³êóâàííÿÂ.É. Öåëóéêî (Õàðê³â) — 15 õâ
3. Ñó÷àñí³ óÿâëåííÿ ïðî ðîëü ñòàòèí³â ó ïðîô³ëàêòèö³ òà ë³êóâàíí³ ñåðöåâî-ñóäèííèõ çàõâîðþâàíüÎ.Î. Õàíþêîâ (Äí³ïðî) — 15 õâ
4. Ïîçèö³¿ á³ñîïðîëîëó â ñó÷àñíèõ ðåêîìåíäàö³ÿõ ç âå-äåííÿ ïàö³ºíò³â ³ç ñåðöåâî-ñóäèííèìè çàõâîðþ-âàííÿìè�Ë.Ì. ßêîâëºâà (Õàðê³â) — 15 õâ
12:50–13:20 Ëåêö³ÿ: ïðîô. Ë.Ã. Âîðîíêîâ (Êè¿â)Àíòèêîàãóëÿíòíà òåðàï³ÿ ó ïàö³ºíò³â ³ç õðîí³÷íîþ ñòàá³ëüíîþ ³øåì³÷íîþ õâîðîáîþ ñåðöÿ
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–14:30 Êðóãëèé ñò³ë«Ä²ÀÌÀÍÒ» ó ï³äõîä³ äî ïåðñîí³ô³êîâàíîãî ë³êóâàííÿ ³øå쳿 ì³îêàðäàÓ÷àñíèêè: ê.ì.í. Î.Ì. Ðîìàíîâà, ä.ì.í. Î.². ²ðê³í (Êè¿â) ��*Çà íàóêîâî¿ ï³äòðèìêè êîìïàí³¿ ACINO.
14:30–16:30 Ïëåíàðíå çàñ³äàííÿÊÎÌÎÐÁ²ÄͲ ÑÒÀÍÈ Â ÊÀÐIJÎËÎò¯Ìîäåðàòîðè: àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ì. Êîâàëåíêî,
÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ç. Íåòÿæåíêî, ïðîô. Ò.Â. Òàëàºâà
1. Êîìîðá³äí³ñòü — àíîíñ ïðîáëåìèÂ.Ì. Êîâàëåíêî (Êè¿â) — 10 õâ
2. Åôåêòèâí³ñòü ë³êóâàííÿ õâîðèõ âèñîêîãî êîðîíàð-íîãî ðèçèêó â Óêðà¿í³Ì.². Ëóòàé (Êè¿â) — 15 õâ
3. Ïàòîãåíåòè÷í³ ìåõàí³çìè ðîçâèòêó êîìîðá³äíèõ ñòàí³âÒ.Â. Òàëàºâà (Êè¿â) — 15 õâ
4. ijàãíîñòèêà òà êîðåêö³ÿ ïîðóøåíü ãåìîñòàçó ïðè êîìîðá³äíèõ ñòàíàõÂ.Ç. Íåòÿæåíêî (Êè¿â) — 15 õâ
5. Êîìîðá³äíèé ñòàí: ñòðàòåã³ÿ ³ òàêòèêà âåäåííÿ ïàö³-ºíòà ç àðòåð³àëüíîþ ã³ïåðòåí糺þÌ.Ì. Äîëæåíêî (Êè¿â) — 15 õâ
6. Ïðèõîâàí³ òà íàÿâí³ ïðîÿâè çàë³çîäåô³öèòíî¿ àíå-쳿 À.Þ. Ëèìàíñüêà (Êè¿â) — 15 õâ
7. Ïðîáëåìè ãàñòðî³íòåñòèíàëüíî¿ áåçïåêè ó ïàö³ºí-ò³â, ÿê³ îòðèìóþòü àíòèòðîìáîöèòàðíó òåðàï³þÌ.Þ. Çàê (Ìèêîëà¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
27
26th
of
Sept
embe
r (T
hurs
day)
8. Cardiotoxicity in patients with solid tumors during treatment with the use of different polychemotherapy schemesL.A. Ilnytska, V.E.Zhylchuk (Rivne) — 15 min
9. Arterial hypertension in rheumatoid arthritis as a clini-cal problemV.E. Kondratiuk (Kyiv) – 15 min
Discussion — 10 min
16:30–17:00 Round TablePeripartum cardiomyopathy from the point of view of a cardiologist and gynecologist: a dialogue of professionals
V.Y. Tseluyko (Kharkiv), Yu.V. Davydova (Kyiv)
17:00–17:20 Problem reportModern positions of statinoterapy for heart disease patients
prof. T.V. Kolesnyk (Dnipro)
CONFERENCE HALL «ALTIUS»9:00–11:20 Sectional sessionMULTIFACTORIAL CORRECTION OF CARDIOVASCULAR RISKModerators: prof. O.I. Mitchenko, acad. of NAMS of Ukraine
A.V. Rudenko, prof. T.V. Kolesnyk 1. Modern approaches to the treatment of patients with
arterial hypertension and obesityT.V. Kolesnyk (Dnipro) — 15 min
2. The surgical treatment of acquired heart disease of ischemic genesisA.V. Rudenko, S.A. Rudenko (Kyiv) — 15 min
3. The problem of resistance to therapy of cardiovascular diseases in the European recommendationsO.I. Mitchenko (Kyiv) — 15 min
4. Factors of cardiovascular risk and premature aging: are there points of contact?O.V. Kolesnikova, O.E. Zaprovalna (Kharkiv) — 15 min
5. The influence of individual and group medical patients education on the control of cardiovascular risk factors
G.S. Isayeva, L.A. Reznik, O.O. Buryakivska, M.M. Vovchenko, A.S. Shalimova (Kharkiv) — 15 min
6. Congestion of alpha-lipid acid in patients with high cardiovascular rhizic L.V. Zhuravlova (Kharkiv) — 15 hv
7. Arterial hypertension and brain. The view of the neu-rologistM.A. Treschinskaya (Kyiv) — 15 min
8. Circulating micro-RNA in coronary artery disease and type 2 diabetesS.A. Serik (Kharkiv) — 15 min
9. Cardiovascular and nephroprotective effects of block-ers renin-angiotensin system in clinical practiceV.Yu. Romanov (Kyiv) — 15 min
8. Êàðä³îòîêñè÷í³ñòü ó õâîðèõ ³ç ñîë³äíèìè ïóõëèíà-ìè ïðè ë³êóâàíí³ ³ç çàñòîñóâàííÿì ð³çíèõ ñõåì ïî-ë³õ³ì³îòåðàﳿË.À. ²ëüíèöüêà, Â.ª. Æèëü÷óê (гâíå) — 15 õâ
9. Àðòåð³àëüíà ã³ïåðòåíç³ÿ ïðè ðåâìàòî¿äíîìó àðò-ðèò³ ÿê êë³í³÷íà ïðîáëåìàÂ.ª. Êîíäðàòþê (Êè¿â) — 15 õâ
Îáãîâîðåííÿ — 10 õâ
16:30–17:00 Êðóãëèé ñò³ëÏåðèïàðòàëüíà êàðä³îì³îïàò³ÿ ç òî÷êè çîðó êàðä³îëîãà òà ã³íåêîëîãà: ä³àëîã ïðîôåñ³îíàë³â
Â.É. Öåëóéêî (Õàðê³â), Þ.Â. Äàâèäîâà (Êè¿â)
17:00–17:20 Ïðîáëåìíà äîïîâ³äüCó÷àñí³ ïîçèö³¿ ñòàòèíîòåðàﳿ ó õâîðèõ ³ç êàðä³îâàñêóëÿðíîþ ïàòîëî㳺þ
ïðîô. Ò.Â. Êîëåñíèê (Äí³ïðî)
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÀËÜÒ²ÓÑ»9:00–11:20 Ñåêö³éíå çàñ³äàííÿÌÓËÜÒÈÔÀÊÒÎÐÍÀ ÊÎÐÅÊÖ²ß ÑÅÐÖÅÂÎ-ÑÓÄÈÍÍÎÃÎ ÐÈÇÈÊÓÌîäåðàòîðè: ïðîô. Î.². ̳ò÷åíêî, àêàä. ÍÀÌÍ Óêðà¿íè
À.Â. Ðóäåíêî, ïðîô. Ò.Â. Êîëåñíèê 1. Ñó÷àñí³ ï³äõîäè äî ë³êóâàííÿ ïàö³ºíò³â ç àðòåð³àëü-
íîþ ã³ïåðòåí糺þ òà îæèð³ííÿì Ò.Â. Êîëåñíèê (Äí³ïðî) — 15 õâ
2. Õ³ðóðã³÷íå ë³êóâàííÿ íàáóòèõ âàä ñåðöÿ ³øåì³÷íîãî ãåíåçó À.Â. Ðóäåíêî, Ñ.À. Ðóäåíêî (Êè¿â) — 15 õâ
3. Ïðîáëåìà ðåçèñòåíòíîñò³ äî òåðàﳿ ñåðöåâî-ñóäèí-íèõ çàõâîðþâàíü ó ñâ³òë³ ªâðîïåéñüêèõ ðåêîìåíäàö³éÎ.². ̳ò÷åíêî (Êè¿â) — 15 õâ
4. Ôàêòîðè ñåðöåâî-ñóäèííîãî ðèçèêó ³ ïåðåä÷àñíå ñòàð³ííÿ: ÷è º òî÷êè äîòèêó?Î.Â. Êîëåñí³êîâà, Î.ª. Çàïðîâàëüíà (Õàðê³â) — 15 õâ
5. Âïëèâ ³íäèâ³äóàëüíîãî ³ ãðóïîâîãî íàâ÷àííÿ ïàö³-ºíò³â îñíîâàì ìåäè÷íèõ çíàíü íà êîíòðîëü ôàêòî-ð³â ñåðöåâî-ñóäèííîãî ðèçèêóÃ.Ñ. ²ñàºâà, Ë.À. Ðåçí³ê, Î.Î. Áóðÿê³âñüêà, Ì.Ì. Âîâ-÷åíêî, À.Ñ. Øàë³ìîâà (Õàðê³â) — 15 õâ
6. Çàñòîñóâàííÿ àëüôà-ë³ïîºâî¿ êèñëîòè ó ïàö³ºíò³â ç âèñîêèì êàðä³îâàñêóëÿðíèì ðèçèêîìË.Â. Æóðàâëüîâà (Õàðê³â) — 15 õâ
7. Àðòåð³àëüíà ã³ïåðòåíç³ÿ òà ìîçîê. Ïîãëÿä íåâðî-ëîãàÌ.À. Òðåù³íñüêà (Êè¿â) — 15 õâ
8. Öèðêóëþþ÷³ ì³êðî-ÐÍÊ ïðè ³øåì³÷í³é õâîðîá³ ñåð-öÿ òà öóêðîâîìó ä³àáåò³ 2-ãî òèïóÑ.À. Ñåð³ê (Õàðê³â) — 15 õâ
9. Êàðä³î- òà íåôðîïðîòåêòîðíèé åôåêò áëîêàòîð³â ðåí³í-àíã³îòåíçèíîâî¿ ñèñòåìè â êë³í³÷í³é ïðàêòèö³Â.Þ. Ðîìàíîâ (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
28
26 â
åðåñ
íÿ
(÷åò
âåð)
11:20–12:30 Joint meeting of the European Atheroscle-rosis Society , Ukrainian Atherosclerosis Society and Polish Lipid AssociationModerators: prof. O.I. Mitchenko, prof. M.I. Lutay, prof. Z. Pe-
trulioniene Part Two1. Actual questions of diagnosis and treatment of dyslip-
idemia in LithuaniaZ. Petrulioniene (Vilnius) – 15 min
2. The current strategy of prevention of atherosclerotic cardiovascular diseasesM.I. Lutay (Kyiv) — 15 min
3. Effect of ASK gastropathy on the effectiveness of hy-polipidemic therapy in patients with high cardiovascu-lar riskO.O. Klekot (Vinnytsia) — 15 min
4. Place of combined hypolipidemic therapy in the treat-ment of hypercholesterolemia in patients with high cardiovascular riskV.Yu. Romanov (Kyiv) – 15 min
Discussion — 10 min
12:30–12:50 Problem reportRamipril and treatment of high cardio-vascular risk patients
prof. Yu.M. Sirenko (Kyiv)
12:50–13:30 Master classCommon errors in the treatment of patients with atrial fibrillation
O.M. Romanova (Kyiv)
13:20–14:00 BREAK
14:00–17:50 Plenary sessionPULMONARY HYPERTENSION IN CLINICAL CASESModerators: prof. Yu.M. Sirenko, prof. G.D. Radchenko1. Idiopathic pulmonary arterial hypertension: clinical
case Yu.M. Sirenko (Kyiv) — 30 min
2. SAUDI Pulmonary Hypertension Registry: Compared to west registriesAbdullah Aldalaan (Riyadh, Kingdom of Saudi Arabia) — 40 min
3. Indication and contraindication to surgical treatment of congenital heart diseases: clinical cases
I.G. Lebid (Kyiv) — 30 min4. Pulmonary hypertension associated with left heart
diseases: clinical caseG.D. Radchenko (Kyiv) — 30 min
5. Pulmonary hypertension associated with lung dise-ases: clinical casesE.O. Merinkov (Kyiv) — 30 min
11:20–12:30 Ñï³ëüíå çàñ³äàííÿ ªâðîïåéñüêîãî òîâàðè-ñòâà ç àòåðîñêëåðîçó, Óêðà¿íñüêîãî òîâàðèñòâà ç àòåðî-ñêëåðîçó òà Ïîëüñüêî¿ ë³ï³äíî¿ àñîö³àö³¿ Ìîäåðàòîðè: ïðîô. Î.². ̳ò÷åíêî, ïðîô. Ì.². Ëóòàé, ïðîô.
Æ. Ïåòðóë³îí³íå ×àñòèíà äðóãà 1. Àêòóàëüí³ ïèòàííÿ ä³àãíîñòèêè òà ë³êóâàííÿ äèñë³-
ï³äå쳿 â Ëèòâ³Æ. Ïåòðóë³îí³íå (³ëüíþñ) — 15 õâ
2. Ñó÷àñíà ñòðàòåã³ÿ ïîïåðåäæåííÿ àòåðîñêëåðîòè÷-íèõ ñåðöåâî-ñóäèííèõ çàõâîðþâàíü Ì.². Ëóòàé (Êè¿â) — 15 õâ
3. Âïëèâ àñï³ðèí-³íäóêîâàíèõ ãàñòðîïàò³é íà åôåê-òèâí³ñòü ã³ïîë³ï³äåì³÷íî¿ òåðàﳿ ó õâîðèõ ç âèñî-êèì ñåðöåâî-ñóäèííèì ðèçèêîìÎ.Î. Êëåêîò (³ííèöÿ) — 15 õâ
4. ̳ñöå êîìá³íîâàíî¿ ã³ïîë³ï³äåì³÷íî¿ òåðàﳿ â ë³êó-âàíí³ ã³ïåðõîëåñòåðèíåì³é ó õâîðèõ âèñîêîãî ñåð-öåâî-ñóäèííîãî ðèçèêóÂ.Þ. Ðîìàíîâ (Êè¿â) — 15 õâ
Îáãîâîðåííÿ — 10 õâ
12:30–12:50 Ïðîáëåìíà äîïîâ³äüÐàì³ïðèë ³ ë³êóâàííÿ õâîðèõ ç âèñîêèì ñåðöåâî-ñóäèííèì ðèçèêîì
ïðîô. Þ.Ì. ѳðåíêî (Êè¿â)
12:50–13:20 Ìàéñòåð-êëàñÍàé÷àñò³ø³ ïîìèëêè ïðè êóðàö³¿ õâîðèõ ³ç ô³áðèëÿö³ºþ ïåðåäñåðäü
Î.Ì. Ðîìàíîâà (Êè¿â)
13:20–14:00 ÏÅÐÅÐÂÀ
14:00–17:50 Ïëåíàðíå çàñ³äàííÿËÅÃÅÍÅÂÀ òÏÅÐÒÅÍÇ²ß Â Ê˲Ͳ×ÍÈÕ ÂÈÏÀÄÊÀÕÌîäåðàòîðè: ïðîô. Þ.Ì. ѳðåíêî, ïðîô. Ã.Ä. Ðàä÷åíêî1. ²ä³îïàòè÷íà ëåãåíåâà àðòåð³àëüíà ã³ïåðòåíç³ÿ: êë³-
í³÷íèé âèïàäîêÞ.Ì. ѳðåíêî (Êè¿â) — 30 õâ
2. Ñàóä³âñüêèé ðåã³ñòð ëåãåíåâî¿ ã³ïåðòåí糿: ïîð³â-íÿííÿ ³ç ðåã³ñòðàìè çàõ³äíèõ êðà¿íÀáäóëà Àëäàëààí (гÿä, Êîðîë³âñòâî Ñàóä³âñüêî¿ Àðà-⳿) — 40 õâ
3. Ïîêàçàííÿ òà ïðîòèïîêàçàííÿ äëÿ îïåðàòèâíî-ãî ë³êóâàííÿ âðîäæåíèõ âàä ñåðöÿ: êë³í³÷í³ ïðè-êëàäè².Ã. Ëåá³äü (Êè¿â) — 30 õâ
4. Ëåãåíåâà ã³ïåðòåíç³ÿ, àñîö³éîâàíà ç ë³âèìè â³ää³-ëàìè ñåðöÿ: êë³í³÷íèé âèïàäîêÃ.Ä. Ðàä÷åíêî (Êè¿â) — 30 õâ
5. Ëåãåíåâà ã³ïåðòåíç³ÿ, àñîö³éîâàíà ³ç çàõâîðþâàí-íÿì ëåãåíü: êë³í³÷í³ âèïàäêè ª.Î. Ìåðèíêîâà (Êè¿â) — 30 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
29
26th
of
Sept
embe
r (T
hurs
day)
16:40–17:20 Master classChronic thromboembolic pulmonary hypertension: treatment options in clinical casesParticipants: I.O. Zhyvilo PhD (Kyiv), prof. L.V. Kulik (Lviv)
17:20–17:50 Satellite symposium Modern options of pharmacological treatment of pulmonary arterial hypertension patients1. Actual questions of pharmacological treatment of pul-
monary arterial hypertension in Ukraineprof. Yu.M. Sirenko (Kyiv) – 15 min
2. Riociguat – new possibilities in treatment of pulmo-nary arterial hypertension I.O. Zhyvilo PhD (Kyiv) – 15 min
*With the scientific support of the BAYER company.
HOTEL «RUS» (LARGE HALL)CONFERENCE-HALL «E», «À», «Â, Ñ, D»
9:00-9:30 Lecture: prof. Sychov O.S. (Kyiv)Management of patients with atrial fibrillation
9:30-11:45 Sectional sessionANTITHROMBOTIC TREATMENT IN PATIENTS WITH ATRIAL FIBRILATIONModerators: prof. O.Y. Zharinov, prof. S.M. Koval, prof.
V.K. Taschuk, prof. O.O. Khanukov, prof. V.Yo. Tseluyko, O.I. Irkin MD
1. Contemporary antithrombotic treatment in patients with diabetes mellitus and AFV.Yo. Tseluyko (Kharkiv) – 15 min
2. Peculiarities of anticoagulation in patients with non-valvular AF and chronic kidney disease
V.K. Taschuk (Chernivtsi), L.L. Vavilova (Kyiv) — 15 min3. Practical issues of management of patients with atrial
fibrillation and CAD with high ischemic and hemor-rhagic risksO.O. Khanukov (Dnipro) – 15 min
4. Solving of clinical issues with frail patients and non valvular AFO.Y. Zharinov (Kyiv) – 15 min
5. First results of implementation of the programme «Space without stroke» in KharkivS.M. Koval, I.O. Snigurska, T.G. Starchenko, M.Y. Penko-va, O.V. Mysnychenko, K.O. Yushko (Kharkiv) — 15 min
6. Results of studies of real clinical practice for NOAC: how to interpret correctly and implement in different clinical situations
O.I. Irkin (Kyiv) — 15 min
16:40–17:20 Ìàéñòåð-êëàñ Xðîí³÷íà òðîìáîåìáîë³÷íà ëåãåíåâà ã³ïåðòåíç³ÿ: âàð³àíòè ë³êóâàííÿ â êë³í³÷íèõ ïðèêëàäàõ Ó÷àñíèêè: ê.ì.í. I.O. Æèâèëî (Êè¿â), ïðîô. Ë.Â. Êóëèê (Ëüâ³â)
17:20–17:50 Ñàòåë³òíèé ñèìïîç³óì�Ñó÷àñí³ ìîæëèâîñò³ òà àêòóàëüí³ ïèòàííÿ ôàðìàêîòåðàﳿ ïàö³ºíò³â ç ËÀÃ1. Àêòóàëüí³ ïèòàííÿ ôàðìàêîòåðàﳿ ëåãåíåâî¿ àðòå-
ð³àëüíî¿ ã³ïåðòåí糿 â Óêðà¿í³ïðîô. Þ.Ì. ѳðåíêî (Êè¿â) — 15 õâ
2. гîöèãóàò — íîâ³ ìîæëèâîñò³ â ë³êóâàíí³ ïàö³ºíò³â ç ëåãåíåâîþ àðòåð³àëüíîþ ã³ïåðòåí糺þê.ì.í. ².Î. Æèâèëî (Êè¿â) — 15 õâ
*�Çà íàóêîâî¿ ï³äòðèìêè êîìïàí³¿ BAYER.
ÃÎÒÅËÜ «ÐÓÑÜ» (ÂÅËÈÊÀ ÇÀËÀ)ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «E», «À», «B, Ñ, D»
9:00-9:30 Ëåêö³ÿ: ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â)Òåðàï³ÿ õâîðèõ ³ç ô³áðèëÿö³ºþ ïåðåäñåðäü
9:30-11:45 Ñåêö³éíå çàñ³äàííÿÀÍÒÈÒÐÎÌÁÎÒÈ×ÍÀ ÒÅÐÀÏ²ß Ó ÕÂÎÐÈÕ ²Ç Ô²ÁÐÈËßÖ²ªÞ ÏÅÐÅÄÑÅÐÄÜÌîäåðàòîðè: ïðîô. Î.É. Æàð³íîâ, ïðîô. Ñ.Ì. Êîâàëü,
ïðîô. Â.Ê. Òàùóê, ïðîô. Î.Î. Õàíþêîâ, ïðîô. Â.É. Öå-ëóéêî, ä.ì.í. Î.². ²ðê³í
1. Ñó÷àñíà àíòèòðîìáîòè÷íà òåðàï³ÿ ó õâîðèõ íà ä³à-áåò ³ç ô³áðèëÿö³ºþ ïåðåäñåðäüÂ.É. Öåëóéêî (Õàðê³â) — 15 õâ
2. Îñîáëèâîñò³ àíòèêîàãóëÿíòíî¿ òåðàﳿ ó ïàö³ºíò³â ç íåêëàïàííîþ ô³áðèëÿö³ºþ ïåðåäñåðäü òà ïîðó-øåíîþ ôóíêö³ºþ íèðîêÂ.Ê. Òàùóê (×åðí³âö³), Ë.Ë. Âàâ³ëîâà (Êè¿â) — 15 õâ
3. Ïðàêòè÷í³ ïèòàííÿ âåäåííÿ ïàö³ºíò³â ³ç íåêëàïàííîþ ô³áðèëÿö³ºþ ïåðåäñåðäü òà ³øåì³÷íîþ õâîðîáîþ ñåðöÿ âèñîêîãî ³øåì³÷íîãî òà ãåìîðàã³÷íîãî ðèçèêóÎ.Î. Õàíþêîâ (Äí³ïðî) — 15 õâ
4. Âèð³øåííÿ êë³í³÷íèõ ïèòàíü âåäåííÿ îñëàáëåíèõ ïàö³ºíò³â ³ç íåêëàïàííîþ ô³áðèëÿö³ºþ ïåðåäñåðäüÎ.É. Æàð³íîâ (Êè¿â) — 15 õâ
5. Ïåðø³ ðåçóëüòàòè ðåàë³çàö³¿ Ïðîãðàìè «Ïðîñò³ð áåç ³íñóëüòó» â Õàðêîâ³Ñ.Ì. Êîâàëü, ².Î. Ñí³ãóðñüêà, Ò.Ã. Ñòàð÷åíêî, Ì.Þ. Ïåíü-êîâà, Î.Â. Ìèñíè÷åíêî, Ê.Î. Þøêî (Õàðê³â) — 15 õâ
6. Ðåçóëüòàòè äîñë³äæåíü ðåàëüíî¿ ïðàêòèêè çàñòî-ñóâàííÿ íîâèõ îðàëüíèõ àíòèêîàãóëÿíò³â: ÿê ïðà-âèëüíî ³íòåðïðåòóâàòè òà âèêîðèñòîâóâàòè â ð³çíî-ìàí³òíèõ êë³í³÷íèõ ñèòóàö³ÿõÎ.². ²ðê³í (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
30
26 â
åðåñ
íÿ
(÷åò
âåð)
7. Prevention of thromboembolic complications during radiofrequency catheter destruction of atrial fibrilla-tionO.V. Doronin, Yu.I. Suslina, A.Ñ. Reznik, M.Ñ. Meshkova (Kyiv) – 15 min
8. Anticoagulant administration in patients with NAF and coronary heart diseaseT.V. Hetman (Kyiv)
Discussion – 15 min
11:45-13:20 Joint session of the Central and Eastern Eu-rope countriesARRHYTHMIAS AND SUDDEN CARDIAC DEATHModerators: ðrof. O.S. Sychov (Êyiv), ðrof. M. Chudzik
(Poland), K.V. Rudenko MD (Kyiv), M.P. Kopytsya MD (Kharkiv)
1. Profilactics of sudenn cardiac death: status of prob-leme in UkraineO.S. Sychov (Êyiv) – 20 min
2. Prophylactic of sudden cardiac death — practical recom mendationM. Chudzik (Poland) – 20 min
3. Stratification risk of sudden cardiac death in patient with HCM. What’s new? K.V. Rudenko (Kyiv) – 20 min
4. The role of biochemical and electrophysiological mar-kers in prognostication of ventricular arrhythmias af-ter myocardial infarction
M.P. Kopytsya (Kharkiv) – 20 minDiscussion – 15 min
13:20-14:00 BREAK
HOTEL «RUS» (HALL Å, À)
14:00-16:45 Sectional sessionARRHYTHMIAS AND COMORBIDITYModerators: prof. A.M. Vasylenko, prof. M.V. Grebenik, prof.
I.P. Katerenchuk, prof. V.A. Potabashniy, prof. N.M. Sere-duk, M.P. Kopytsya
1. Rate-dependent complete left bundle branch block on the background of an abnormal origin of the left circumflex arteryN.M. Seredyuk (Ivano-Frankivsk) – 15 min
2. Disorders of rhythm and their treatment in comorbid patients with acute coronary syndromeM.V. Hrebenyk (Ternopil) – 15 min
3. Supraventricular and ventricular arrhythmias in critical ill and post-surgery – consensus EHRA 2019
V.A. Potabashniy, V.I. Fesenko (Kryvyi Rih) – 15 min4. Heart ritting and consequences in patients who have
adults infection myocardityA.M. Vasylenko, S.O. Sheyko (Kryvyi Rih) – 15 min
7. Ïðîô³ëàêòèêà òðîìáîåìáîë³÷íèõ óñêëàäíåíü ï³ä ÷àñ ïðîâåäåííÿ ðàä³î÷àñòîòíî¿ êàòåòåðíî¿ äåñòðóê-ö³¿ ô³áðèëÿö³¿ ïåðåäñåðäüÎ.Â. Äîðîí³í, Þ.². Ñóñëèíà, À.Ñ. Ðåçí³ê, Ì.Ñ. ̺øêîâà (Êè¿â) — 15 õâ
8. Ïðèçíà÷åííÿ àíòèêîàãóëÿíòà ó ïàö³ºíò³â ç ÍÔÏ òà ²ÕÑÒ.Â. Ãåòüìàí (Êè¿â)
Îáãîâîðåííÿ — 15 õâ
11:45–13:20 Ñï³ëüíå çàñ³äàííÿ êðà¿í Ñõ³äíî¿ òà Öåíò-ðàëüíî¿ ªâðîïèÀÐÈÒ̲¯ ÒÀ ÐÀÏÒÎÂÀ ÑÅÐÖÅÂÀ ÑÌÅÐÒÜÌîäåðàòîðè: ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â), ïðîô. Ì. Õóäçèê
(Ïîëüùà), ä.ì.í. Ê.Â. Ðóäåíêî (Êè¿â ) ä.ì.í. Ì.Ï. Êîïè-öÿ (Õàðê³â)
1. Ïðîô³ëàêòèêà ðàïòîâî¿ ñåðöåâî¿ ñìåðò³: ñòàí ïðî-áëåìè â Óêðà¿í³Î.Ñ. Ñè÷îâ (Êè¿â) — 20 õâ
2. Ïðîô³ëàêòèêà ðàïòîâî¿ ñåðöåâî¿ ñìåðò³ — ïðàêòè÷-í³ ðåêîìåíäàö³¿Ì. Õóäçèê (Ïîëüùà) — 20 õâ
3. Ñòðàòèô³êàö³ÿ ðèçèêó ðàïòîâî¿ ñåðöåâî¿ ñìåðò³ ïðè ã³ïåðòðîô³÷í³é êàðä³îì³îïàò³¿. Ùî íîâîãî? Ê.Â. Ðóäåíêî (Êè¿â) — 20 õâ
4. Ðîëü á³îõ³ì³÷íèõ òà íå³íâàçèâíèõ åëåêòðîô³ç³îëî-ã³÷íèõ ìàðêåð³â â ïðîãíîçóâàíí³ âèíèêíåííÿ æèò-òºâî íåáåçïå÷íèõ øëóíî÷êîâèõ àðèòì³é ó õâîðèõ ï³ñëÿ ïåðåíåñåíîãî ³íôàðêòó ì³îêàðäàÌ.Ï. Êîïèöÿ (Õàðê³â) — 20 õâ
Îáãîâîðåííÿ – 15 õâ
13:20–14:00 ÏÅÐÅÐÂÀ
ÃÎÒÅËÜ «ÐÓÑÜ» (ÇÀËÀ Å, À)
14:00-16:45 Cåêö³éíå çàñ³äàííÿÀÐÈÒ̲¯ ² ÊÎÌÎÐÁ²ÄͲÑÒÜÌîäåðàòîðè: ïðîô. À.Ì. Âàñèëåíêî, ïðîô. Ì.Â. Ãðåáåíèê,
ïðîô. ².Ï. Êàòåðåí÷óê, ïðîô. Â.À. Ïîòàáàøí³é, ïðîô. Í.Ì. Ñåðåäþê, ä.ì.í. Ì.Ï. Êîïèöÿ
1. ×àñòîòíî-çàëåæíà ïîâíà áëîêàäà ë³âî¿ í³æêè ïó÷êà óñà çà íàÿâíîñò³ àíîìàëüíîãî â³äõîäæåííÿ îãèíà-þ÷î¿ ã³ëêè ë³âî¿ êîðîíàðíî¿ àðòåð³¿Í.Ì. Ñåðåäþê (²âàíî-Ôðàíê³âñüê) — 15 õâ
2. Ïîðóøåííÿ ðèòìó òà ¿õ ë³êóâàííÿ ó êîìîðá³äíèõ õâîðèõ ç ãîñòðèì êîðîíàðíèì ñèíäðîìîìÌ.Â. Ãðåáåíèê (Òåðíîï³ëü) — 15 õâ
3. Ñóïðàâåíòðèêóëÿðí³ òà âåíòðèêóëÿðí³ àðèò쳿 ïðè êðèòè÷íèõ ñòàíàõ ³ ï³ñëÿîïåðàö³éíîìó ïåð³îä³ — ðåêîìåíäàö³¿ EHRA 2019 ð.Â.À. Ïîòàáàøí³é, Â.². Ôåñåíêî (Êðèâèé гã) — 15 õâ
4. Ïîðóøåííÿ ðèòìó ñåðöÿ òà ïðîâ³äíîñò³ ó ïàö³ºíò³â, ÿê³ ïåðåíåñëè ³íôåêö³éíèé ì³îêàðäèòÀ.Ì. Âàñèëåíêî, Ñ.Î. Øåéêî (Êðèâèé гã) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
31
26th
of
Sept
embe
r (T
hurs
day)
5. Effectiveness of the long term treatment with propafe-none in management of ventricular extrasystoliaI.P. Katerenchuk, O.I. Katerenchuk (Poltava) – 15 min
6. Application of anti-arrhythmic drugs 1 C class for an-tirecession therapy in patients with atrial fibrillation and comorbid statesO.M. Romanova (Kyiv) – 15 min
7. Assessment of cardiac arrhythmias and heart rate variability in patients with myocarditisV.M. Kovalenko, E.G. Nesukay, R.M. Kirichenko (Kyiv) – 15 min
8. Effect of asymptomatic hyperuricemia correction in patients with atrial fibrillationD.M. Sebov, V.A. Korotaieva, O.M. Kobeleva (Odesa) – 15 min
9. New predictors of ventricular fibrillation and sudden cardiac death A.I. Vytrichovski (Ivano-Frankivsk) – 15 min
10. Òhe effect of antiretroviral therapy on cardiac arrhyth-mias in HIV-infected patientsV.A. Vasylenko, A.M. Vasylenko (Kryvyi Rih) – 15 min
Discussion – 15 min
16:45-17:45 Sectional sessionCLINICAL CASESModerators: L.I. Vasilieva PhD, S.O. Pravosudovich PhD1. Brugada Syndrom
S.V. Lyzohub, E.V. Mogilnitskii, L.O. Shabilianova (Kyiv) – 15 min
2. Transcatheter destruction of substrate of left ventricu-lar tachycardia in patient with aortic and mitral me-chanical prosthetic valves with the use of transseptal approachS.O. Pravosudovich, O.B. Bondarenko, L.L. Belmas, D.A. Misiura, L.D. Sushenko (Dnipro) – 15 min
3. Can we use MRI to determine final diagnosis in pa-tient with long term interventricular conduction dis-orders?L.I. Vasilieva, I.V. Marchuk (Dnipro) – 15 min
Discussion — 15 min
HOTEL «RUS» (HALL B, C, D)
14:00-14:30 Round table Management of atrial fibrillation — European guidelines and personal experienceParticipants: prof. O.S. Sychov (Kyiv), prof. O.O. Khanukov
(Dnipro)
14:30-14:50 Problem reportTreatment of atrial fibrillation in routine clinical practice
Participants: prof. V.Yo. Tseluyko, O.O. Romanenko (Kharkiv)
14:50-15:10 Problem reportMeldonium application åxperience in patients with ventricular arrhythmias of ischemic genesis
prof. S.V. Grigoryan (Yerevan, Armenia)
5. Åôåêòèâí³ñòü òðèâàëîãî ïðèéîìó ïðîïàôåíîíó ó ë³êóâàíí³ øëóíî÷êîâî¿ åêñòðàñèñòî볿².Ï. Êàòåðåí÷óê, Î.². Êàòåðåí÷óê (Ïîëòàâà) — 15 õâ
6. Çàñòîñóâàííÿ àíòèàðèòì³÷íèõ ïðåïàðàò³â 1Ñ êëàñó äëÿ ïðîòèðåöèäèâíî¿ òåðàﳿ ó ïàö³ºíò³â ³ç ô³áðè-ëÿö³ºþ ïåðåäñåðäü òà êîìîðá³äíèìè ñòàíàìèÎ.Ì. Ðîìàíîâà (Êè¿â) — 15 õâ
7. Îö³íêà àðèòì³é ñåðöÿ òà âàð³àáåëüíîñò³ ñåðöåâîãî ðèòìó â ïàö³ºíò³â ç ì³îêàðäèòîìÂ.Ì. Êîâàëåíêî, Î.Ã. Íåñóêàé, Ð.Ì. Êèðè÷åíêî (Êè¿â) — 15 õâ
8. Âïëèâ êîðåêö³¿ àñèìïòîìàòè÷íî¿ ã³ïåðóðèêå쳿 ó ïàö³ºíò³â ç ô³áðèëÿö³ºþ ïåðåäñåðäüÄ.Ì. Ñåáîâ, Â.À. Êîðîòàºâà, Î.Ì. Êîáåëåâà (Îäåñà) — 15 õâ
9. Íîâ³òí³ ïðåäèêòîðè ïîÿâè ô³áðèëÿö³¿ øëóíî÷ê³â òà ðàïòîâî¿ ñåðöåâî¿ ñìåðò³À.². Âèòðèõîâñüêèé (²âàíî-Ôðàíê³âñüê) — 15 õâ
10. Âïëèâ àíòèðåòðîâ³ðóñíî¿ òåðàﳿ íà ïîðóøåííÿ ðèòìó ñåðöÿ ó ²Ë-³íô³êîâàíèõ ïàö³ºíò³âÂ.À. Âàñèëåíêî, À.Ì. Âàñèëåíêî (Êðèâèé гã) — 15 õâ
Îáãîâîðåííÿ — 15 õâ
16:45-17:45 Cåêö³éíå çàñ³äàííÿÊ˲Ͳ×Ͳ ÂÈÏÀÄÊÈÌîäåðàòîðè: ê.ì.í. Ë.². Âàñèëüºâà, ê.ì.í. Ñ.Î. Ïðàâîñóäîâè÷ 1. Ñèíäðîì Áðóãàäà
Ñ.Â. Ëèçîãóá, ª.Â. Ìîãèëüíèöüêèé, Ë.Î. Øàá³ëüÿíîâà (Êè¿â) — 15 õâ
2. Òðàíñêàòåòåðíà äåñòðóêö³ÿ ñóáñòðàòó ë³âîøëóíî÷-êîâî¿ òàõ³êàð䳿 ó ïàö³ºíòà ç ìåõàí³÷íèìè ïðîòåçà-ìè àîðòàëüíîãî òà ì³òðàëüíîãî êëàïàí³â ç âèêîðèñ-òàííÿì òðàíññåïòàëüíîãî äîñòóïóÑ.Î. Ïðàâîñóäîâè÷, Î.Á. Áîíäàðåíêî, Ë.Ë. Áåëüìàñ, Ä.À. Ìèñþðà, Ë.Ä. Ñóùåíêî (Äí³ïðî) — 15 õâ
3. ×è ìîæëèâî âñòàíîâèòè ê³íöåâèé ä³àãíîç çà äîïî-ìîãîþ ÌÐÒ õâîðîìó ç äîâãîòðèâàëèì ïîðóøåííÿì âíóòð³øíüîøëóíî÷êîâî¿ ïðîâ³äíîñò³ ñåðöÿ?Ë.². Âàñèëüºâà, ².Â. Ìàð÷óê (Äí³ïðî) — 15 õâ
Îáãîâîðåííÿ — 15 õâ
ÃÎÒÅËÜ «ÐÓÑÜ» (ÇÀËÀ B, C, D)
14:00-14:30 Êðóãëèé ñò³ëÒåðàï³ÿ ô³áðèëÿö³¿ ïåðåäñåðäü — ªâðîïåéñüê³ ðåêîìåíäàö³¿ òà âëàñíèé äîñâ³äÓ÷àñíèêè: ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â), ïðîô. Î.Î. Õàíþêîâ
(Äí³ïðî)
14:30-14:50 Ïðîáëåìíà äîïîâ³äü˳êóâàííÿ ô³áðèëÿö³¿ ïåðåäñåðäü ó ïîâñÿêäåíí³é êë³í³÷í³é ïðàêòèö³Ó÷àñíèêè: ïðîô. Â.É. Öåëóéêî, Î.Î. Ðîìàíåíêî (Õàðê³â)
14:50-15:10 Ïðîáëåìíà äîïîâ³äüÄîñâ³ä çàñòîñóâàííÿ ìåëüäîí³þ ó õâîðèõ ³ç øëóíî÷êîâîþ àðèò쳺þ ³øåì³÷íîãî ãåíåçó
ïðîô. Ñ.Â. Ãðèãîðÿí (ªðåâàí, ³ðìåí³ÿ)
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
32
26 â
åðåñ
íÿ
(÷åò
âåð)
15:10-17:45 Sectional sessionINTERVENTIONAL ARRHYTHMOLOGYModerators: prof. O.V. Bilchenko, prof. Yu.I. Karpenko, prof.
O.S. Stychinski, V.P. Zalevski
15:10-15:30 Problem reportPhysiological stimulation of the heart in patients with heart failure. Modern approaches
B.B. Kravchuk PhD (Kyiv), prof. Y.I. Karpenko (Odessa)1. Catheter treatment of atrial tachycardias in patients
with congenital heart diseasesP.A. Almis, O.S. Stychinski, N.V. Melnik, A.V. Topchii, A.V. Pokanevich, A.V. Kovalchuk, O.S. Didus (Kyiv) – 15 min
2. Clinical features and pharmacotherapy in two-years prognosis in patients after atrial fibrillation and atrial flutter radiofrequency ablationO.V. Bilchenko (Kharkiv) – 15 min
3. Cryo-balloon ablation in elderly, in whom is it appro-priateA. Berkowitsch, E. Akkaya, S. Zaltsberg, A. Hain, J. Hjut-ter, K. Weipert, T. Neumann, M. Kuniss (Bad Nauheim, Germany) – 15 min
4. Anticoagulant treatment in rhythm restoring proce-duresY.I. Karpenko (Odessa) – 15 min
5. Ablation of atrial fibrillation is effective, but how to improve its result?D.E. Volkov, D.O. Lopin (Kharkiv) – 15 min
6. Treatment of atrial macro-reentry tachycardiasT.V. Kravchenko, E.S. Akobirov, S.I. Estrin (Kharkiv) – 15 min
7. Predictors of atrial fibrillation in patients after ablation of typical atrial flutter
S.V. Lyzohub, A.O. Borodai, S.I. Deyak, O.S. Sychov (Kyiv) – 15 min
8. Transcatheter left atrial appendage occlusion as an al-ternative for stroke prevention for patients with atrial fibrillationK. Boyko (Kyiv) – 15 min
Discussion – 15 min
HOTEL «RUS» (HALL F)
14:00–17:40 Master-classesPRACTICAL SKILLS FOR MANAGEMENT OF PATIENTS WITH RHYTHM AND CONDUCTION DISORDERS
14:00-14:40 Management of patients with pacemakers and defibrillators
S.V. Lisogub (Kyiv) – 40 min
14:40–14:45 BREAK
14:45–15:25 Anticoagulation in patients with non-valvu-lar atrial fibrillation
prof. O.S. Sychov (Kyiv) – 40 min
15:10-17:45 Cåêö³éíå çàñ³äàííÿ²ÍÒÅÐÂÅÍÖ²ÉÍÀ ÀÐÈÒÌÎËÎÃ²ß Ìîäåðàòîðè: ïðîô. Î.Â. Á³ëü÷åíêî, ïðîô. Þ.². Êàðïåíêî,
ïðîô. Î.Ñ. Ñòè÷èíñüêèé, Â.Ï. Çàëåâñüêèé
15:10-15:30 Ïðîáëåìíà äîïîâ³äüÔ³ç³îëîã³÷íà ñòèìóëÿö³ÿ ñåðöÿ ó õâîðèõ ³ç ñåðöåâîþ íåäîñòàòí³ñòþ. Ñó÷àñí³ ìîæëèâîñò³
ê.ì.í. Á.Á. Êðàâ÷óê (Êè¿â), ïðîô. Þ.². Êàðïåíêî (Îäåñà)1. Êàòåòåðíå ë³êóâàííÿ ïåðåäñåðäíèõ òàõ³êàðä³é
ó õâîðèõ ³ç âðîäæåíèìè âàäàìè ñåðöÿÏ.À. Àëüì³ç, Î.Ñ. Ñòè÷èíñüêèé, Í.Â. Ìåëüíèê, À.Â. Òîï÷³é, À.Â. Ïîêàíåâè÷, À.Â. Êîâàëü÷óê, Î.Ñ. ij-äóñü (Êè¿â) — 15 õâ
2. Êë³í³÷í³ õàðàêòåðèñòèêè òà ôàðìàêîòåðàï³ÿ ó äâî-ð³÷íîìó ïðîãíîç³ ñòàíó ïàö³ºíò³â ï³ñëÿ ðàä³î÷àñòîò-íî¿ àáëÿö³¿ ô³áðèëÿö³¿ òà òð³ïîò³ííÿ ïåðåäñåðäüÎ.Â. Á³ëü÷åíêî(Õàðê³â) — 15 õâ
3. Êð³îáàëîííà àáëÿö³ÿ â ïàö³ºíò³â ïîõèëîãî â³êó, êîìó âîíà ïîêàçàíàÀ. Áåðêîâè÷, Å. Àêàÿ, Ñ. Çàëüöáåðã, À. Õåéí, É. Õþò-òåð, Ê. Âàéïåðò, Ò. Íîéìàí, Ì. Êóíí³ñ (Áàä Íàóõàéì, ͳìå÷÷èíà) — 15 õâ
4. Àíòèêîàãóëÿíòíà òåðàï³ÿ ïðè ïðîöåäóðàõ â³äíîâ-ëåííÿ ðèòìó Þ.². Êàðïåíêî (Îäåñà) — 15 õâ
5. Àáëÿö³ÿ ô³áðèëÿö³¿ ïåðåäñåðäü åôåêòèâíà, àëå ÿê ïîë³ïøèòè ¿¿ ðåçóëüòàò?Ä.ª. Âîëêîâ, Ä.Î. Ëîï³í (Õàðê³â) — 15 õâ
6. ˳êóâàííÿ ïåðåäñåðäíèõ macro-reentry òàõ³êàðä³éÒ.Â. Êðàâ÷åíêî, ª.Ñ. Àêîá³ðîâ, Ñ.². Åñòð³í (Õàðê³â) — 15 õâ
7. Ïðåäèêòîðè âèíèêíåííÿ ô³áðèëÿö³¿ ïåðåäñåðäü ó ïàö³ºíò³â ï³ñëÿ àáëÿö³¿ òèïîâîãî òð³ïîò³ííÿ ïå-ðåäñåðäüÑ.Â. Ëèçîãóá, À.Î. Áîðîäàé, Ñ.². Äåÿê, Î.Ñ. Ñè÷îâ (Êè¿â) — 15 õâ
8. Òðàíñêàòåòåðíå çàêðèòòÿ âóøêà ë³âîãî ïåðåäñåðäÿ ÿê àëüòåðíàòèâà â ïðîô³ëàêòèö³ ³íñóëüòó ó ïàö³ºíò³â ³ç ô³áðèëÿö³ºþ ïåðåäñåðäüÊ.Ñ. Áîéêî (Êè¿â) — 15 õâ
Îáãîâîðåííÿ — 15 õâ
ÃÎÒÅËÜ «ÐÓÑÜ» (ÇÀËÀ F)
14:00–17:40 Ìàéñòåð-êëàñèÏÐÀÊÒÈ×Ͳ ÍÀÂÈ×ÊÈ ÄËß Ë²ÊÓÂÀÍÍß ÕÂÎÐÈÕ ²Ç ÏÎÐÓØÅÍÍßÌÈ ÐÈÒÌÓ ÒÀ ÏÐβÄÍÎÑÒ² ÑÅÐÖß
14:00–14:40 Âåäåííÿ õâîðèõ ³ç êàðä³îñòèìóëÿòîðàìè òà äåô³áðèëÿòîðàìè
Ñ.Â. Ëèçîãóá (Êè¿â) — 40 õâ
14:40–14:45 ÏÅÐÅÐÂÀ
14:45–15:25 Àíòèêîàãóëÿíòíà òåðàï³ÿ ó õâîðèõ ³ç íå-êëàïàííîþ ô³áðèëÿö³ºþ ïåðåäñåðäü
ïðîô. Î.Ñ. Ñè÷îâ (Êè¿â) — 40 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
33
26th
of
Sept
embe
r (T
hurs
day)
15:25-15:30 BREAK
15:30–16:10 Cardiopulmonary resuscitationO.I. Irkin MD (Kyiv) – 40 min
16:10–16:15 BREAK
16:15–16:55 Arrhythmias and comorbidityO.M. Romanova PhD (Kyiv) – 40 min
16:55–17:00 BREAK
17:00–17:40 Should we treat patients with asymptomatic cardiac arrthythmias?
A.O. Borodai MD (Kyiv) – 40 min
27-TH OF SEPTEMBER (FRIDAY)
CHAMPIONS HALL 9:00–9:30 Lecture: prof. O.A. Krikunov (Kyiv)Principles of antibiotic therapy of infective endocarditis
9:30–13:00 Plenary sessionDISEASESS OF MYOCARDIUM, ENDOCARDIUM AND HEART VALVESPresidium: acad. of NAMS of Ukraine, prof. V.M. Kovalenko,
prof. I.M. Emets, prof. E.G. Nesukay, prof.V.Y. Tseluyko, O.A. Krikunov MD
1. Myocarditis — problems and possible ways to resolve themV.M. Kovalenko (Kyiv) – 25 min
2. X-PANT Aortic Valve: TAVI’s first experience in Ukraine
I.M. Emets (Kyiv) – 20 min3. Mechanisms of formation and ways of overcoming
cardiac failure in cardiomyopathies: European recom-mendations 2019 E.G. Nesukay (Kyiv) – 15 min
4. The clinical case: myocarditisprof. V.Yo. Tseluyko, assoc. N.Ye. Mishchuk (Kharkiv) – 15 min
5. Clinical manifestations and treatment of infective en-docarditis caused by antibiotic-resistant pathogens
O.A. Krikunov (Kyiv) – 15 min6. Dilatational cardiomyopathy: forgotten illness
D.V. Ryabenko (Kyiv) – 15 min7. Morfofunctional bases for the formation of cardiac
output V.P. Zakharova, O.M. Trembovetska, O.V. Rudenko (Kyiv) – 15 min
8. Modern possibilities of diagnosis of myocarditis in UkraineS.V. Chernyuk (Kyiv) – 15 min
9. Problems of differential diagnostics of left ventricular hypertrophy in modern cardiologyN.S. Titova (Kyiv) – 15 min
15:25–15:30 ÏÅÐÅÐÂÀ
15:30–16:10 Êàðä³îðåàí³ìàö³ÿä.ì.í. Î.². ²ðê³í (Êè¿â) — 40 õâ
16:10–16:15 ÏÅÐÅÐÂÀ
16:15–16:55 Àðèò쳿 ³ êîìîðá³äí³ñòüê.ì.í. Î.Ì. Ðîìàíîâà (Êè¿â) — 40 õâ
16:55–17:00 ÏÅÐÅÐÂÀ
17:00–17:40 ×è ïîòð³áíî ë³êóâàòè áåçñèìïòîìí³ àðèò-쳿 ñåðöÿ
ä.ì.í. À.Î. Áîðîäàé (Êè¿â) — 40 õâ
27 ÂÅÐÅÑÍß (Ï’ßÒÍÈÖß)
ÕÎË ×ÅÌϲÎͲ 9:00–9:30 Ëåêö³ÿ: ïðîô. Î.À. Êðèêóíîâ (Êè¿â) Ïðèíöèïè àíòèá³îòèêîòåðàﳿ ³íôåêö³éíîãî åíäîêàðäèòó
9:30–13:00 Ïëåíàðíå çàñ³äàííÿÕÂÎÐÎÁÈ Ì²ÎÊÀÐÄÀ, ÅÍÄÎÊÀÐÄÀ ÒÀ ÊËÀÏÀͲ ÑÅÐÖß Ïðåçèä³ÿ: àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ì. Êîâàëåíêî,
ïðîô. ².Ì. ªìåöü, ïðîô. Î.Ã. Íåñóêàé, ïðîô. Â.É. Öå-ëóéêî, ä.ì.í. Î.À. Êðèêóíîâ
1. ̳îêàðäèò — ïðîáëåìè òà ìîæëèâ³ øëÿõè ¿õ âèð³-øåííÿÂ.Ì. Êîâàëåíêî (Êè¿â) — 25 õâ
2. Àîðòàëüíèé êëàïàí X-PANT: ïåðøèé äîñâ³ä TAVI â Óêðà¿í³ ².Ì. ªìåöü (Êè¿â) — 20 õâ
3. Ìåõàí³çìè ôîðìóâàííÿ òà øëÿõè ïîäîëàííÿ ñåð-öåâî¿ íåäîñòàòíîñò³ ïðè êàðä³îì³îïàò³ÿõ: ªâðîïåé-ñüê³ ðåêîìåíäàö³¿–2019Î.Ã. Íåñóêàé (Êè¿â) — 15 õâ
4. Êë³í³÷íèé âèïàäîê: ì³îêàðäèòïðîô. Â.É. Öåëóéêî, äîö. Í.ª. ̳ùóê (Õàðê³â) — 20 õâ
5. Êë³í³÷í³ ïðîÿâè òà ë³êóâàííÿ ³íôåêö³éíîãî åíäî-êàðäèòó, ùî âèêëèêàíèé ðåçèñòåíòíèìè äî àíòè-á³îòèê³â çáóäíèêàìèÎ.À. Êðèêóíîâ (Êè¿â) — 15 õâ
6. Äèëàòàö³éíà êàðä³îì³îïàò³ÿ: çàáóòà õâîðîáàÄ.Â. Ðÿáåíêî (Êè¿â) — 15 õâ
7. Ìîðôîôóíêö³îíàëüí³ îñíîâè ôîðìóâàííÿ ñåðöå-âîãî âèêèäóÂ.Ï. Çàõàðîâà, Î.Ì. Òðåìáîâåöüêà, Î.Â. Ðóäåíêî (Êè¿â) — 15 õâ
8. Ñó÷àñí³ ìîæëèâîñò³ ä³àãíîñòèêè ì³îêàðäèòó â Óêðà-¿í³Ñ.Â. ×åðíþê (Êè¿â) — 15 õâ
9. Ïðîáëåìè äèôåðåíö³éíî¿ ä³àãíîñòèêè ã³ïåðòðîô³¿ ë³âîãî øëóíî÷êà ó ñó÷àñí³é êàðä³îëî㳿Í.Ñ. Ò³òîâà (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
34
27 â
åðåñ
íÿ
(ï’ÿ
òíè
öÿ)
10. AL amyloidosis in the practice of a cardiologist: diag-nostic possibilities and prospects for treatmentA.S. Kozlyuk, Y.Y. Giresh, Ye.B. Yershova (Kyiv) – 15 min
11. Short- and long-term outcomes of surgical treatment of aortic valve disease: which strategy to prefer?
O.S. Gurjeva, S.V. Varbanets, O.M. Romaniuk, Yu.I. Klymyshyn, Ye.O. Artemenko, Z. Abdurahmanov, N.M. Rudenko, I.M. Emets (Kyiv) – 15 min
13:15-15:30 General assambly with the participation of Ministry of Health of Ukraine, NAMS of Ukraine, Ukrainian Association of Cardiology and Ukrainian Association of Cardio-Surgeons, Main Specialists of NAMS of Ukraine and Experts of Ministry of Health of UkrainePresidium: acad. of NAMS of Ukraine, prof. V.M. Kovalen-
ko, acad. of NAMS of Ukraine, prof. V.I. Tsymbalyuk, acad. of NAMS of Ukraine, prof. V.V. Lazorishinets, acad. of NAMS of Ukraine O.M. Bilovol, acad. of NAMS of Ukraine, prof. Yu.V. Voronenko, prof. I.D. Shkro-banetz, N.A. Ostropoletz, corr.-member of NAMS of Ukraine, prof. K.M. Amosova, corr.-member of NAMS of Ukraine, prof. B.M. Todurov, prof. I.M. Emetz, prof. Yu.M. Sirenko, prof. O.S. Sychov, prof. M.Yu. Sokolov, prof. S.O. Andriyevska, K.V. Rudenko MD, S.S. Pavlik, I.F. Shumeyko PhD, L.G. Pumpinets
1. Problem ReportNational strategy for the prevention and treatment of cardiovascular disease: new perspectives
Acad. of NAMS of Ukraine, prof. V.M. Kovalenko2. Report of the President of the Ukrainian Association of Cardiology3. Awarding4. Approval of new regulatory documents5. Adoption of the resolutionClosing of the Congress
CONFERENCE HALL «ODISSEY»9:00-11:30 Plenary sessionACTUAL QUESTIONS IN DIAGNOSIS AND TREATMENT OF ARTERIAL HYPERTENSIONModerators: prof. Yu.M. Sirenko, prof. S.M. Koval
9:00-10:501. Combination antihypertensive therapy — basis for
treatment of hypertensive patientsYu.M. Sirenko (Kyiv) — 20 min
2. If it possible to increase the treatment effectiveness in patients with arterial hypertension and decrease the drug adverse effect rate in the same time?S.M. Koval, I.O. Snigurska, K.O. Yushko, M.Y. Penkova, O.V. Mysnychenko (Kharkiv) — 15 õâ
3. Resistant and refractory hypertension: differences in treatment strategyO.L. Rekovetz (Kyiv) — 15min
10. AL àì³ëî¿äîç ó ïðàêòèö³ êàðä³îëîãà: ìîæëèâîñò³ ä³àãíîñòèêè ³ ïåðñïåêòèâè ë³êóâàííÿÀ.Ñ. Êîçëþê, É.É. óðåø, ª.Á. ªðøîâà (Êè¿â) — 15 õâ
11. Áåçïîñåðåäí³ òà â³ääàëåí³ ðåçóëüòàòè õ³ðóðã³÷íèõ âòðó÷àíü íà àîðòàëüíîìó êëàïàí³: ÿê³é òàêòèö³ íà-äàòè ïåðåâàãó? Î.Ñ. Ãóð’ºâà, Ñ.Â. Âàðáàíåöü, Î.Ì. Ðîìàíþê, Þ.². Êëè-ìèøèí, ª.Î. Àðòåìåíêî, Ç. Àáäóðàõìàíîâ, Í.Ì. Ðó-äåíêî, ².Ì. ªìåöü (Êè¿â) — 15 õâ
13:15-15:30 Ãåíåðàëüíà àñàìáëåÿçà ó÷àñòþ ÌÎÇ Óêðà¿íè, ÍÀÌÍ Óêðà¿íè, Âñåóêðà¿íñüêî¿ àñîö³àö³¿ êàðä³îëîã³â Óêðà¿íè òà Àñîö³àö³¿ ñåðöåâî-ñóäèííèõ õ³ðóðã³â, ãîëîâíèõ ñïåö³àë³ñò³â ÍÀÌÍ Óêðà¿íè òà åêñïåðò³â ÌÎÇ Óêðà¿íè
Ïðåçèä³ÿ: àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ì. Êîâàëåí-êî, àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.². Öèìáàëþê, àêàä. ÍÀÌÍ, ïðîô. Â.Â. Ëàçîðèøèíåöü, àêàä. ÍÀÌÍ Óêðà¿íè Î.Ì. Á³ëîâîë, àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Þ.Â. Âîðîíåíêî, ïðîô. ².Ä. Øêðîáàíåöü, Í.À. Îñòðî-ïîëåöü, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Ê.Ì. Àìîñîâà, ÷ë.-êîð. ÍÀÌÍ Óêðà¿íè, ïðîô. Á.Ì. Òîäóðîâ, ïðîô. ².Ì. ªìåöü, ïðîô. Þ.Ì. ѳðåíêî, ïðîô. Î.Ñ. Ñè-÷îâ, ïðîô. Ì.Þ. Ñîêîëîâ, ïðîô. Ñ.Î. Àíäð³ºâñüêà, ä.ì.í. Ê.Â. Ðóäåíêî, Ñ.Ñ. Ïàâëèê, ê.ì.í. ².Ô. Øóìåéêî, Ë.Ã. Ïóìïèíåöü
1. Ïðîáëåìíà äîïîâ³äüÍàö³îíàëüíà ñòðàòåã³ÿ ïîïåðåäæåííÿ ³ ë³êóâàííÿ ñåðöåâî-ñóäèííèõ çàõâîðþâàíü: íîâ³ ïîãëÿäè
àêàä. ÍÀÌÍ Óêðà¿íè, ïðîô. Â.Ì. Êîâàëåíêî2. Çâ³ò Ïðåçèäåíòà Âñåóêðà¿íñüêî¿ àñîö³àö³¿ êàðä³îëîã³â Óêðà¿íè3. Íàãîðîäæåííÿ4. Çàòâåðäæåííÿ íîâèõ íîðìàòèâíèõ äîêóìåíò³â5. Ïðèéíÿòòÿ ðåçîëþö³¿Çàêðèòòÿ Êîíãðåñó
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÎIJÑÑÅÉ»9:00–11:30 Ïëåíàðíå çàñ³äàííÿ²ÍÍÎÂÀÖ²¯ IJÀÃÍÎÑÒÈÊÈ ÒÀ ˲ÊÓÂÀÍÍß ÀÐÒÅвÀËÜÍί òÏÅÐÒÅÍDz¯Ìîäåðàòîðè: ïðîô. Þ.Ì. ѳðåíêî, ïðîô. Ñ.Ì. Êîâàëü
9:00–10:50 1. Êîìá³íîâàíà àíòèã³ïåðòåíçèâíà òåðàï³ÿ — îñíîâà
ë³êóâàííÿ ïàö³ºíò³â ç àðòåð³àëüíîþ ã³ïåðòåí糺þÞ.Ì. ѳðåíêî (Êè¿â) — 20 õâ
2. ×è ìîæëèâî ï³äâèùèòè åôåêòèâí³ñòü ë³êóâàííÿ õâîðèõ íà àðòåð³àëüíó ã³ïåðòåíç³þ é îäíî÷àñíî çíèçèòè ÷àñòîòó ïîá³÷íèõ åôåêò³â ïðåïàðàò³â? Ñ.Ì. Êîâàëü, ².Î. Ñí³ãóðñüêà, Ê.Î. Þøêî, Ì.Þ. Ïåíü-êîâà, Î.Â. Ìèñíè÷åíêî (Õàðê³â) — 15 õâ
3. Ðåçèñòåíòíà òà ðåôðàêòåðíà ã³ïåðòåíç³ÿ: â³äì³ííîñ-ò³ òàêòèêè ë³êóâàííÿÎ.Ë. Ðåêîâåöü (Êè¿â) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
35
27th
of
Sept
embe
r (F
rida
y)
4. Women vs men: differences in arterial hypertension
G.D. Radchenko (Kyiv) – 15 min5. LV diastolic dysfunction in patients with AH and its
clinical consequencesO.O. Torbas (Kyiv) – 15 min
6. Evaluations of EchoCG data in patients with arterial hypertension
N.N. Nosenko (Kyiv) – 15 min7. Syndrome of obstructive sleep apnea
N.A. Krushynska (Kyiv) – 15 min
10:50-11:20 Master classTherapy for type 2 diabetes mellitus: how to improve cardiovascular outcome1. Diabetes and cardiovascular risks
Yu.M. Sirenko (Kyiv) — 15 min2. GLP-1 receptor agonist in cardiology practice: about
what can not be silent O. V. Zinich (Kyiv) — 15 min
10:50-11:30 Opinion of the specialistThe place of double and triple combined antihypertensive therapy in modern treatment regimens
prof. Yu.M. Sirenko (Kyiv) — 10 min
11:20–13:15 Section MettengBIOMARKERS IN CARDIOLOGYPresidium: prof. O.E. Berezin, prof. L.G. Voronkov, prof.
V.M. Zhebel1. The level of NT-proBNP as a predictor of atrial fibrilla-
tion in patients with acute coronary syndrome
V.I. Tseluyko, F. Ben Salem, Î.Å. Matuzok (Kharkiv) – 15 min
2. Chronic heart failure and «low triodothyronine» syn-drome: features of beta blockers treatment
I.S. Rudyk, S.M. Pyvovar, V.I. Galchynska, T.O. Chenchyk (Kharkiv) – 15 min
3. Diagnostic value of ST 2 in essential hypertension and the polymorphism of the encoding gene
V.M. Zhebel, O.M. Starzhynska, D.A. Bahrii, T.M. Kali-novska, A.O. Donec (Vinnitsya) – 15 min
4. Contemporary opportunities in IHD treatment person-alization by biomarker useV.Y. Zharinova, D.A. Bodretska, V.O. Tabakovich-Vazeba, I.S. Shapovalenko, G.G. Voinarovska (Kyiv) – 15 min
5. Apoptotic endothelial microvesicles as a predictor of CHF phenotypeO.E. Berezin, O.O. Kremzer, T.A. Samura (Zaporizhia) – 15 min
4. Ƴíêè ïðîòè ÷îëîâ³ê³â: îñîáëèâîñò³ àðòåð³àëüíî¿ ã³-ïåðòåí糿Ã.Ä. Ðàä÷åíêî (Êè¿â) — 15 õâ
5. ijàñòîë³÷íà äèñôóíêö³ÿ ËØ ó ïàö³ºíò³â ³ç Àà òà ¿¿ êë³-í³÷í³ íàñë³äêèÎ.Î. Òîðáàñ (Êè¿â) — 15 õâ
6. Ïðîòîêîë âèñíîâêó åõîÊà ó ïàö³ºíòà ç àðòåð³àëüíîþ ã³ïåðòåí糺þ — ùî ïîòð³áíî çíàòè ïðàêòèêóþ÷îìó ë³êàðþ Í.Í. Íîñåíêî (Êè¿â) — 15 õâ
7. Ñèíäðîì îáñòðóêòèâíîãî í³÷íîãî àïíîå ñíóÍ.À. Êðóøèíñüêà (Êè¿â) — 15 õâ
10:50–11:20 Ìàéñòåð-êëàñ Òåðàï³ÿ õâîðèõ íà öóêðîâèé ä³àáåò 2-ãî òèïó: ÿê ïîêðàùèòè ñåðöåâî-ñóäèííèé ïðîãíîç1. Öóêðîâèé ä³àáåò ³ ñåðöåâî-ñóäèíí³ ðèçèêè
Þ.Ì. ѳðåíêî (Êè¿â) — 15 õâ2. àðÃÏÏ-1 â ïðàêòèö³ êàðä³îëîãà: ïðî ùî íå ìîæíà
ìîâ÷àòè Î.Â. dzíè÷ (Êè¿â) — 15 õâ
11:20–11:30 Äóìêà ñïåö³àë³ñòà̳ñöå ïîäâ³éíî¿ ³ ïîòð³éíî¿ êîìá³íîâàíî¿ àíòèã³ïåðòåíçèâíî¿ òåðàﳿ â ñó÷àñíèõ ñõåìàõ ë³êóâàííÿ
ïðîô. Þ.Ì. ѳðåíêî (Êè¿â) — 10õâ
11:30-13:15 Ñåêö³éíå çàñ³äàííÿÁ²ÎÌÀÐÊÅÐÈ Ó ÊÀÐIJÎËÎò¯Ïðåçèä³ÿ: ïðîô. Î.ª. Áåðåç³í, ïðîô. Ë.Ã. Âîðîíêîâ, ïðîô.
Â.Ì. Æåáåëü1. гâåíü NT-proBNP, ÿê ïðåäèêòîð ðîçâèòêó ô³áðè-
ëÿö³¿ ïåðåäñåðäü ó õâîðèõ íà ãîñòðèé êîðîíàðíèé ñèíäðîìÂ.É. Öåëóéêî, Ô. Áåí Ñàëåì, Î.Å. Ìàòóçîê (Õàðê³â) — 15 õâ
2. Õðîí³÷íà ñåðöåâà íåäîñòàòí³ñòü ³ ñèíäðîì «íèçüêî-ãî òðèéîäòèðîí³íó»: îñîáëèâîñò³ ë³êóâàííÿ áëîêà-òîðàìè áåòà-àäðåíîðåöåïòîð³âÞ.Ñ. Ðóäèê, Ñ.Ì. Ïèâîâàð, Â.Þ. Ãàëü÷èíñüêà, Ò.Î. ×åí-÷èê (Õàðê³â) — 15 õâ
3. ijàãíîñòè÷íå çíà÷åííÿ ST 2 ïðè åñåíö³àëüí³é ã³ïåð-òåí糿 ç óðàõóâàííÿì ïîë³ìîðô³çìó ãåíà, ùî éîãî êîäóºÂ.Ì. Æåáåëü, Î.Ë. Ñòàðæèíñüêà, Ä.À. Áàãð³é, Ò.Ì. Êà-ëèíîâñüêà, À.Î. Äîíåöü (³ííèöÿ) — 15 õâ
4. Ñó÷àñí³ ìîæëèâîñò³ ³íäèâ³äóàëüíî¿ òåðàﳿ ³øåì³÷-íî¿ õâîðîáè ñåðöÿ ³ç âèêîðèñòàííÿì á³îìàðêåð³âÂ.Þ. Æàð³íîâà, Ä.À. Áîäðåöüêà, Â.Î. Òàáàêîâè÷-Âàöå-áà, ².Ñ. Øàïîâàëåíêî, Ã.Ã. Âîéíàðîâñüêà (Êè¿â) — 15 õâ
5. Àïîïòîòè÷í³ åíäîòåë³àëüí³ ì³êðîâåçèêóëè ÿê ïðå-äèêòîð ôåíoòèïó ÕÑÍÎ.ª. Áåðåç³í, Î.Î. Êðåìçåð, Ò.À. Ñàìóðà (Çàïîð³æ-æÿ) — 15 õâ
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGYXVII ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ XVII UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
36
27 â
åðåñ
íÿ
(ï’ÿ
òíè
öÿ)
36
6. Êë³í³êî-ïðîãíîñòè÷íå çíà÷åííÿ ì³êðîÐÍÊ-155 ó õâîðèõ íà ãîñòðèé ³íôàðêò ì³îêàðäàÎ.Î. Ñîïêî, Â.Å. Äîñåíêî, Î.Ì. Ïàðõîìåíêî (Êè¿â) — 15 õâ
7. Îäíîíóêëåîòèäíèé ïîë³ìîðô³çì Ò786Ñ ãåíà åíäî-òåë³àëüíî¿ NO ñèíòàçè: ðîëü ó ôîðìóâàíí³ ñåðöåâî¿ íåäîñòàòíîñò³ ï³ñëÿ ³íôàðêòó ì³îêàðäàÌ.Ï. Êîïèöÿ, Î.Â. Ïåòþí³íà, Î.ª. Áåðåç³í (Çàïîð³æ-æÿ) — 15 õâ
ÊÎÍÔÅÐÅÍÖ-ÇÀËÀ «ÀËÜÒ²ÓÑ»9:00–9:30 Ìàéñòåð-êëàñ êàðä³îëîãà ç íåâðîëîãîì: âðÿ-òóºìî Óêðà¿íó â³ä ³íñóëüò³â ðàçîìÓ÷àñíèêè: ä.ì.í. Ë.À. ̳ùåíêî, ê.ì.í. ².Ë. Ðåâåíüêî (Êè¿â)
9:30–13:00 Ïëåíàðíå çàñ³äàííÿÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÏÐÅÂÅÍÒÈÂÍί ÊÀÐIJÎËÎò¯ ÒÀ ÐÅÀÁ²Ë²ÒÀÖ²¯Ìîäåðàòîðè: ïðîô. Ë.Ì. Áàá³é, ïðîô. ².Å. Ìàëèíîâñüêà,
ïðîô. Â.Î. Øóìàêîâ 1. EUROASPIRE IV–V â Óêðà¿í³: ÷è çì³íèëèñÿ ïð³îðèòåòè
ëþäñòâà â ïðîô³ëàêòèö³ ñåðöåâî-ñóäèííèõ çàõâî-ðþâàíü?Ì.Ì. Äîëæåíêî (Êè¿â) — 15 õâ
2. Îñíîâí³ ïîñòóëàòè ñó÷àñíî¿ ïàðàäèãìè «Åï³äåì³î-ëîã³ÿ õðîí³÷íèõ íå³íôåêö³éíèõ çàõâîðþâàíü»Î.Î. Êâàøà, Î.Â. Ñð³áíà, ².Ï. Ñìèðíîâà (Êè¿â) — 15 õâ
3. ²íôàðêò ì³îêàðäà òà îö³íêà ðåçóëüòàò³â ïðè ñó÷àñ-íèõ ï³äõîäàõ äî ë³êóâàííÿ: äîñÿãíåííÿ òà íåâèð³-øåí³ ïðîáëåìèË.Ì. Áàá³é, Â.Î. Øóìàêîâ, Î.Ï. Ïîãóðåëüñüêà, Þ.Î. Õîìåíêî (Êè¿â) — 15 õâ
4. Óïîâ³ëüíåííÿ ðåìîäåëþâàííÿ ë³âîãî øëóíî÷-êà ó ïàö³ºíò³â, ùî ïåðåíåñëè ³íôàðêò ì³îêàðäà, íà åòàï³ ðåàá³ë³òàö³¿Â.Î. Øóìàêîâ — 15 õâ
5. Êàðä³îëîã³÷íà ðåàá³ë³òàö³ÿ ïàö³ºíò³â, ÿê³ ïåðåíåñëè Q-³íôàðêò ì³îêàðäà: åôåêòèâí³ñòü ô³çè÷íî¿ òà ìå-äèêàìåíòîçíî¿ ñêëàäîâèõ².Å. Ìàëèíîâñüêà, Â.Î. Øóìàêîâ, Í.Ì. Òåðåùåíêî, Î.Ì. Âîëîøèíà, Ë.Ï. Òåðåøêåâè÷ (Êè¿â) — 15 õâ
6. ²ííîâàö³éíà ïðîãðàìà êàðä³îðåàá³ë³òàö³¿ õâîðèõ íà ³íôàðêò ì³îêàðäà ç êîìîðá³äíîþ ïàòîëî㳺þÌ.². Øâåä, Ë.Â. Ëåâèöüêà, ².Á. Ëåâèöüêèé (Òåðíî-ï³ëü) — 15 õâ
7. Ìåòàáîë³÷íà òåðàï³ÿ ñåðöåâî-ñóäèííèõ çàõâîðþ-âàíü: ÷è âñ³ ìîæëèâîñò³ ìè âèêîðèñòîâóºìîÎ.Î. Õàíþêîâ (Äí³ïðî) — 15 õâ
8. ³äíîâëåííÿ ïàö³ºíò³â ï³ñëÿ êîðîíàðíîãî øóíòó-âàííÿ íà ïðàöþþ÷îìó ñåðö³ ç âèêîðèñòàííÿì ïðà-âî¿ øëóíêîâî-ñàëüíèêîâî¿ àðòåð³¿À.Â. Ãàáð³ºëÿí, Ò.Ì. Äîìàíñüêèé, Î.Â. Áåðåãîâèé, Â.Â. Áåëåéîâè÷, ².Â. Êóäëàé (Êè¿â) — 15 õâ
6. Clinical and prognostic value of microRNA-155 in pa-tients with acute myocardial infarction O.Î. Sopko, V.E. Dosenko, O.M. Parkhomenko (Kyiv) – 15 min
7. Oligonuctleotide polymorphism of endothelial NO-syntase T786C gene: the role in development of heart failure after myocardial infarctionM.P. Kopytsya, O.V. Petiunina, O.E. Berezin (Zapori-zhia) – 15 min
CONFERENCE HALL «ALTIVUS»9:00–9:30 Master class of a cardiologist with a neurolo-gist: Together we will save Ukraine from strokesParticipants: L.A. Mishchenko MD, I.L. Revenko PhD (Kyiv)
9:30-13:00 Plenary session CURRENT ISSUES OF PREVENTIVE CARDIOLOGY AND REHABILITATIONModerators: prof. L.M. Babii, prof. I.E. Malynovska, prof.
V.O. Shumakov1. EUROASPIRE IV-V in Ukraine: did priority of huma-
nity change in the prophylaxis of cardiovascular dis-ease?prof. M.M. Dolzhenko (Kyiv) – 15 min
2. The main postulates of the modern paradigm «Epide-miology of noncommunicable diseases»O.O. Kvasha, O.V. Sribna, I.P. Smyrnova (Kyiv) – 15 min
3. Myocardial infarction and estimation of results at modern approaches to treatment : achievement and unsolved problemsL.M. Babii, V.O. Schumakov, O.P. Pogurelskaya, Yu.O. Khomenko (Kyiv) – 15 min
4. Deceleration of left ventricle remodeling in patients after myocardial infarction during rehabilitation
V.O. Shumakov (Kyiv) – 15 min5. Cardiologic rehabilitation in patients after Q-myo-
cardial infarction: efficiency of physical and medicine components I.E. Malynovska, V.O. Shumakov, N.M. Tereshchenko, O.V. Voloshyna, L.P. Tereshkevych (Kyiv) – 15 min
6. Innovative program of cardio rehabilitation of patients with myocardial infarction and comorbid pathologyM.I. Shved, L.V. Levytska, I.B. Levytsky (Ternopil) – 15 min
7. Metabolic therapy for cardiovascular disease: are we using all the possibilitiesO.O. Khanukov (Dnipro) – 15 min
8. Recovery of patients after off pump coronary bypass surgery using right artery gastroepiploica
A.V. Gabriyelyan, T.M. Domanskiy, O.V. Beregovoy, V.V. Beleyovich, I.V. Kudlay (Kyiv) – 15 min
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
37
27th
of
Sept
embe
r (F
rida
y)
9. Îö³íêà îá³çíàíîñò³ ïàö³ºíò³â ó ïèòàííÿõ âòîðèííî¿ ïðîô³ëàêòèêè àòåðîñêëåðîòè÷íèõ ñåðöåâî-ñóäèí-íèõ çàõâîðþâàíüÑ.À. Òèõîíîâà (Îäåñà) — 15 õâ
10. Äîñâ³ä âïðîâàäæåííÿ ðåã³îíàëüíèõ ðåºñòð³â ïàö³-ºíò³â ï³ñëÿ ïåðåíåñåíîãî ²ÌË.Â. Ðàñïóò³íà (³ííèöÿ) — 15 õâ
11. ßê³ñòü æèòòÿ òà êîãí³òèâí³ ôóíêö³¿ ó õâîðèõ íà àðòå-ð³àëüíó ã³ïåðòåíç³þ: ÷è ìîæíà ïîêðàùèòè ðåçóëü-òàòè?Ò.À. Õîìàçþê, Â.Þ. Êðîòîâà (Äí³ïðî) — 15 õâ
12. Äîñâ³ä ë³êóâàííÿ óñêëàäíåíèõ ôîðì ³øåì³÷íî¿ õâîðîáè ñåðöÿ: ôîêóñ íà õðîí³÷íó ïîñò³íôàðêòíó àíåâðèçìó ñåðöÿ Î.Â. Ñîëåéêî (³ííèöÿ) — 15 õâ
13. Åôåêòèâíå ë³êóâàííÿ í³êîòèíîâî¿ çàëåæíîñò³ ç ïî-çèö³¿ äîêàçîâî¿ ìåäèöèíè².Ì. Âîëîøèíà (Êè¿â)
Îáãîâîðåííÿ — 15 õâ
9. Assessment of patients’ awareness of secondary pre-vention of atherosclerotic cardiovascular diseases
S.A. Tychonova (Odessa) – 15 min10. The experience of introducing regional registries
of patients after MIL.V. Rasputina (Vinnytsia) – 15 min
11. Quality of life and cognitive function in patients with arterial hypertension: can the results be improved?
T.A. Khomazyuk, V.Yu. Krotova (Dnipro) – 15 min 12. Experience in treating complicated forms of coronary
heart disease: focus on chronic post-infarction heart aneurysmO.V. Soleiko (Vinnytsia) – 15 min
13. Effective treatment of nicotine dependence from the point of view of evidence-based medicineI.M. Voloshyna (Kyiv)
Discussion – 15 min
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
38
25 â
åðåñ
íÿ
(ñåð
åäà)
ÑÒÅÍÄβ ÄÎÏβIJÑÅÐÅÄÀ, 25 ÂÅÐÅÑÍß
(ÎÁÃÎÂÎÐÅÍÍß ÄÎÏβÄÅÉ Ç 13:00 ÄÎ 14:00)ÀÐÈÒ̲¯ ÑÅÐÖß
Ìîäåðàòîðè: ä.ì.í. À.Î. Áîðîäàé, ä.ì.í. À.². Âèòðèõîâñüêèé, ä.ì.í. Þ.Â. dzí÷åíêî1. Ôóíêö³îíàëüíèé ñòàí åíäîòåë³þ ñóäèí òà ð³âåíü Ñ-ðåàêòèâíîãî ïðîòå¿íó ó ïàö³ºíò³â ç ô³áðèëÿ ö³ºþ ïåðåä-
ñåðäü òà ãîñòðèì ïîðóøåííÿì ìîçêîâîãî êðîâîîá³ãóÞ.Ñ. Êóøí³ð, Î.Â. Êóðÿòà, À.Î. Òèõîìèðîâ, Ò.Î. ³õðîâà, Ì.Ñ. ijáðîâà (Äí³ïðî)
2. Îö³íêà ïðèõèëüíîñò³ äî àíòèêîàãóëÿíòíî¿ òåðàﳿ ó õâîðèõ ç íåêëàïàííîþ ô³áðèëÿö³ºþ ïåðåäñåðäüË.Ì. Ñòð³ëü÷óê, Ë.À. ²ëüíèöüêà, ².Â. Øóìëÿíñüêèé, ².Â. Áîãäàí (гâíå)
3. Ïðåäèêòîðè â³äíîâëåííÿ ñèíóñîâîãî ðèòìó ó ïàö³ºíò³â ç ïåðñèñòåíòíèì òð³ïîò³ííÿì ïåðåäñåðäü ó êë³í³÷í³é ïðàêòèö³À.Â. Àêåð, Ó.Ï. ×åðíÿãà-Ðîéêî, Î.É. Æàð³íîâ (Ëüâ³â)
4. Ïðåäèêòîðè ðàííüîãî ðåöèäèâó àðèò쳿 ó ïàö³ºíò³â ç íåêëàïàííîþ ïåðñèñòåíòíîþ ô³áðèëÿö³ºþ ³ òð³ïîò³ííÿì ïåðåäñåðäü ï³ñëÿ êàðä³îâåðñ³¿Í.Ñ. Ïàâëèê, Ó.Ï. ×åðíÿãà-Ðîéêî, Î.É. Æàð³íîâ, Ñ.Ñ. Ïàâëèê, Â.Þ. ×åðêàâñüêèé (Ëüâ³â)
5. Ðèçèê ðîçâèòêó òðîìáîåìáîë³÷íèõ óñêëàäíåíü ó ïàö³ºíò³â ç ô³áðèëÿö³ºþ ïåðåäñåðäü, ùî ìàþòü îðãàí³çîâàí³ òðîìáîòè÷í³ ìàñè â ïåðåäñåðäÿõ, ïðè ïðîâåäåíí³ ïëàíîâî¿ åëåêòðî³ìïóëüñíî¿ òåðàﳿÑ.Î. Ïðàâîñóäîâè÷, Î.Á. Áîíäàðåíêî, Ë.Ë. Áåëüìàñ, Ä.À. Ìèñþðà, Ë.Ä. Ñóùåíêî, Í.Ï. Àíîñîâà, Ë.Ì. ßêîâëºâà, Ë.Â. Ìå-ëåùèê (Äí³ïðî)
6. Êë³í³÷í³ òà åõîêàðä³îãðàô³÷í³ ïîêàçíèêè ïàö³ºíò³â ³ç òð³ïîò³ííÿì ïåðåäñåðäü ï³ñëÿ ðàä³î÷àñòîòíî¿ àáëÿö³¿Ä.Þ. Ïàâëîâà, Ò.Â. Çîëîòàðüîâà, Ì.Ñ. Áðèíçà (Õàðê³â)
7. Îö³íêà ÷àñó â òåðàïåâòè÷íîìó ä³àïàçîí³ (TTR) ó ïàö³ºíò³â ³ç íåêëàïàííîþ ô³áðèëÿö³ºþ ïåðåäñåðäü, ÿê³ îòðè-ìóþòü âàðôàðèíÌ.². ßëîâåíêî, Î.Î. Õàíþêîâ, Ë.Â. Ñàïîæíè÷åíêî, ª.Ä. ªãóä³íà, Î.Ñ. Êàëàøíèêîâà (Äí³ïðî)
8. Êë³í³÷í³ îçíàêè ïàö³ºíò³â ç ô³áðèëÿö³ºþ òà òð³ïîò³ííÿì ïåðåäñåðäü â ïîºäíàíí³ ç àðòåð³àëüíîþ ã³ïåðòåí糺þ, ÿêèì áóëà âèêîíàíà ðàä³î÷àñòîòíà àáëÿö³ÿÂ.Î. Øòåëüìàõ, Ì.Ñ. Áðèíçà, Î.Â. Á³ëü÷åíêî, Ä.ª. Âîëêîâ (Õàðê³â)
9. Àtrial electrical heterogeneity in patients with mitral valve prolapseO.V. Dzekan, G.V. Dehtyaryova (Vinnytsia)
10. Âçàºìîçâ’ÿçîê ì³æ ïîäîâæåííÿì ³íòåðâàëó Q–T òà íàÿâí³ñòþ ìàêðî- òà ì³êðîâàñêóëÿðíèõ óñêëàäíåíü ó õâî-ðèõ íà öóêðîâèé ä³àáåò 2-ãî òèïó².². Îêòÿáðüîâà, Î.Ñ. Ìàõàðèíñüêà, Ì.Ì. Ëåáåäèíñüêà (Õàðê³â)
11. Ïîð³âíÿííÿ âïëèâó á³ñîïðîëîëó òà àì³îäàðîíó íà ïàðàìåòðè öèôðîâî¿ îáðîáêè åëåêòðîêàðä³îãðàìè çà äî-ïîìîãîþ ïðîãðàìíîãî êîìïëåêñó «ÑÌÀÐÒ-ÅÊûÏ.Ð. ²âàí÷óê, Â.Ê. Òàùóê, Ì.Â. Òàùóê (×åðí³âö³)
ÃÎÑÒÐÈÉ ÊÎÐÎÍÀÐÍÈÉ ÑÈÍÄÐÎÌÌîäåðàòîðè: ïðîô. Ë.Ì. Áàá³é, ä.ì.í. Î.². ²ðê³í, ñò.í.ñ. ß.Ì. Ëóòàé 1. Á³îìàðêåð-êåðîâàíà òåðàï³ÿ ïàö³ºíò³â ç ãîñòðèì ³íôàðêòîì ì³îêàðäà
ß.Â. óëüîâà, Ì.Ï. Êîïèöÿ, Þ.Â. Ðîä³îíîâà, ².Ì. Êóòÿ (Õàðê³â)2. Îïûò ðàáîòû Äîíåöêîé è Ëóãàíñêîé îáëàñòè ïî ýêñòðàòåððèòîðèàëüíîìó ïðèíöèïó ïðè ëå÷åíèè ïàöèåíòîâ
ñ îñòðûì èíôàðêòîì ìèîêàðäà ñ ïîäúåìîì ñåãìåíòà ST (STEMI): ðàçâèòèå ïðîãðàììû óðãåíòíîãî ñòåíòèðî-âàíèÿÑ.Í. Ãåòüìàí, Ä.Þ. Óçóí (Êðàìàòîðñê)
3. Âïëèâ àäåíîçèíâì³ñíîãî ïðåïàðàòó (ÀÒÌÒñ) ³ êîìá³íàö³¿ L-àðã³í³íó òà L-êàðí³òèíó íà ðåçóëüòàòè ÅÊà òà åõîÊÃ- äîñë³äæåíü ó íåðåâàñêóëÿðèçîâàíèõ õâîðèõ ç³ STEMI/NSTEMIÍ.Ì. Ñåðåäþê, Ì.Â. Ôåäîð÷åíêî, Ð.Â. Ïåòðîâñüêèé, Î.Ç. Ñêàêóí (²âàíî-Ôðàíê³âñüê)
4. Îñîáëèâîñò³ ãåîìåò𳿠ë³âîãî øëóíî÷êà ó õâîðèõ ï³ñëÿ ïåðåíåñåíîãî ³íôàðêòó ì³îêàðäà çàëåæíî â³ä òàêòèêè ë³êóâàííÿÐ.Ð. Ãóòà, Í.Ñ. Áåê, Î.Ì. Ðàä÷åíêî (Ëüâ³â)
5. Êëèíè÷åñêèé ñëó÷àé òðîìáîýìáîëèè ëåãî÷íîé àðòåðèè ó áîëüíîãî íà ôîíå îáîñòðåíèÿ íåñïåöèôè÷åñêîãî ÿçâåííîãî êîëèòàÈ.Â. Êóçíåöîâ, Ì.Â. Êóëèêîâà, È.Â. Êàíäûáêî, À.Ã. Ãóêîâ, Ë.Â. Æóðàâëåâà (Õàðüêîâ)
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
39
25th
of
Sept
embe
r (W
edne
sday
)
6. Çâ’ÿçîê êàëüïðîòåêòèíó ç ïàðàìåòðàìè âóãëåâîäíîãî îáì³íó ó õâîðèõ íà ãîñòðèé ³íôàðêò ì³îêàðäà íà òë³ öóêðîâîãî ä³àáåòó 2-ãî òèïóÍ.Ã. Ðèíä³íà, Ì.². Æóðàâëüîâà, Ï.Ã. Êðàâ÷óí (Õàðê³â)
7. Ðîëü á³îìàðêåðà ÂÅÔÐ-Àâ ïðîãíîçóâàíí³ ðîçâèòêó áàãàòîñóäèííîãî óðàæåííÿ êîðîíàðíèõ àðòåð³é ó õâîðèõ íà ãîñòðèé ³íôàðêò ì³îêàðäà ç åëåâàö³ºþ ñåãìåíòà STÌ.Ï. Êîïèöÿ, ².Ì. Êóòÿ, Þ.Â. Ðîä³îíîâà, Í.Â. Òèòàðåíêî, ß.Â. óëüîâà, À.Â. Êîáåöü (Õàðê³â)
8. Òhe role of components ofextracellular matrix in the patients with acute myocardial infarction with and withoutdiabetes mellitus type 2M.Yu. Koteliukh (Kharkiv)
9. Ïðåäèêòîðè ñèñòîë³÷íî¿ äèñôóíêö³¿ ë³âîãî øëóíî÷êà ó õâîðèõ íà Q-³íôàðêò ì³îêàðäà, óñêëàäíåíèé ãîñòðîþ ñåðöåâîþ íåäîñòàòí³ñòþÂ.Ä. Ñèâîëàï, Í.². Êàïøèòàð (Çàïîð³ææÿ)
10. Øëÿõè ï³äâèùåííÿ åôåêòèâíîñò³ ë³êóâàííÿ òà ïðîô³ëàêòèêè ðåïåðôóç³éíîãî ñèíäðîìó ó õâîðèõ íà ãîñòðèé êîðîíàðíèé ñèíäðîì (³íôàðêò ì³îêàðäà), ÿêèì ïðîâåäåíî áàëîííó àíã³îïëàñòèêó òà ñòåíòóâàííÿ êîðîíàðíî¿ àðòåð³¿Ì.². Øâåä, ².Î. ßñòðåìñüêà, Ë.Â. Öóãëåâè÷ (Òåðíîï³ëü)
11. Èçó÷åíèå âîçìîæíîñòåé ðàííåãî íàçíà÷åíèÿ ïîëèïèë ó áîëüíûõ, ïåðåíåñøèõ ðàçíûå ôîðìû ÎÊÑÅ.Ñ. Ùóêèíà, Å.À. Êîâàëü (Äí³ïðî)
12. Ïðîãíîñòè÷íå çíà÷åííÿ îäíîíóêëåîòèäíîãî ïîë³ìîðô³çìó Ò786Ñ ãåíà åíäîòåë³àëüíî¿ NO-ñèíòàçè ï³ñëÿ ³í-ôàðêòó ì³îêàðäà ç ï³äéîìîì ñåãìåíòà STÎ.Â. Ïåòþí³íà, Ì.Ï. Êîïèöÿ, Î.ª. Áåðåç³í, Ä.Ï. Áàá³÷åâ (Õàðê³â)
13. Çâ’ÿçîê ì³æ ôàêòîðîì, ùî ³íã³áóº ì³ãðàö³þ ìàêðîôàã³â, òà òðèâîæíî-äåïðåñèâíèìè ñòàíàìè ïðè ³íôàðêò³ ì³îêàðäà ç åëåâàö³ºþ ñåãìåíòà STÎ.Â. Ïåòþí³íà, Ì.Ï. Êîïèöÿ, Î.Â. Ñêðèííèê (Õàðê³â)
²ØÅ̲×ÍÀ ÕÂÎÐÎÁÀ ÑÅÐÖßÌîäåðàòîðè: ïðîô. Î.À. Õàíþêîâ, ä.ì.í. Â.Â. Áóãàºíêî 1. Îö³íêà ÿêîñò³ æèòòÿ òà êðèòå𳿠åôåêòèâíîñò³ êîðîíàðíî¿ ðåâàñêóëÿðèçàö³¿ ó ïàö³ºíò³â ç³ ñòàá³ëüíîþ ²ÕÑ ³ çáå-
ðåæåíîþ ôðàêö³ºþ âèêèäó ë³âîãî øëóíî÷êàÞ.À. Áîðõàëåíêî, Î.É. Æàð³íîâ, Î.À. ªïàí÷³íöåâà, Á.Ì. Òîäóðîâ (Êè¿â)
2. Prognostic assessment of the stable coronary heart disease severity in patients with non-alcoholic steatohepatitisI.I. Vakalyuk, N.G. Virstyuk, V.I. Sovtus, O.F. Sovtus (Ivano-Frankivsk)
3. Åôåêòèâí³ñòü âêëþ÷åííÿ äî êîìïëåêñíî¿ òåðàﳿ ñòàá³ëüíî¿ ñòåíîêàð䳿 àëîïóðèíîëó ³ êâåðöåòèíóÀëü Ñàëàìà Ìóõàìåä Âàñåê Îáåéä, Î.Ì. óíãóëÿê, Í.À. Òóðóáàðîâà-Ëåóíîâà, ².Ò. Ðóñíàê (×åðí³âö³)
4. Ñòàí âíóòð³øíüîñåðöåâî¿ ãåìîäèíàì³êè òà ì³êðîöèðêóëÿö³¿ ó õâîðèõ íà õðîí³÷íó ³øåì³÷íó õâîðîáó ñåðöÿ ³ç ñóïóòí³ìè äèôóçíèìè çàõâîðþâàííÿìè ïå÷³íêèÑ.ª. Ìîñòîâèé, Î.Á. Äèííèê, Í.À. Ìàðóí÷èí (Êè¿â)
5. Ì³í³³íâàçèâíå áàãàòîñóäèííå êîðîíàðíå øóíòóâàííÿ â ðóòèíí³é ïðàêòèö³Â.Ì. Äåì’ÿíåíêî, Î.Ä. Áàáëÿê, Ä.ª. Áàáëÿê, ª.À. Ìåëüíèê, Ê.À. Ðåâåíêî, Î.Ñ. Ñòîãîâ (Êè¿â)
6. Òîëåðàíòí³ñòü äî ô³çè÷íîãî íàâàíòàæåííÿ ïàö³ºíò³â ç ³øåì³÷íîþ õâîðîáîþ ñåðöÿ â ïîºäíàíí³ ç õðîí³÷íèì îáñòðóêòèâíèì çàõâîðþâàííÿì ëåãåíüÎ.Â. Êíÿçºâà (Äí³ïðî)
7. Àtherosclerotic changes in coronary and cerebral vessels in patients with coronary heart diseaseY.S. Kushnir, K. Perepelytsia (Dnipro)
8. Ðersonalized approach to antiplatelet therapy, depending on the functional activity of platelets and c807t polymorphism of itga2 in patients with hypertension and coronary artery diseaseV.Z. Netiazhenko, A.V. Liakhotska, O.N. Plenova (Kyiv)
9. Îñîáëèâîñò³ ôîðìóâàííÿ ã³ïåðòðîô³¿ ë³âîãî øëóíî÷êà ó õâîðèõ íà ³øåì³÷íó õâîðîáó ñåðöÿ òà öóêðîâèé ä³à-áåò 2-ãî òèïóÌ.Â. Ìàéîðîâà, Î.Â. Øàïàðåíêî, Ê.Ë. Ãàì³ñîí³ÿ (Õàðê³â)
10. Òhe interrelationship between the coronary heart disease’s course and community-acquired pneumonia (the retrospective analysis data)N.S. Mykhailovska, Ò.Î. Kulynych, V.A. Morguntsov (Zaporizhzhia)
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
40
26 â
åðåñ
íÿ
(÷åò
âåð)
11. Îïòèì³çàö³ÿ ðåàá³ë³òàö³¿ òà â³äíîâíîãî ë³êóâàííÿ õâîðèõ íà ³øåì³÷íó õâîðîáó ñåðöÿ øëÿõîì êîðåêö³¿ êîìïî-íåíò âíóòð³øíüî¿ êàðòèíè çäîðîâ’ÿÐ.Â. Íåñòåðàê (²âàíî-Ôðàíê³âñüê)
12. Ìîæëèâîñò³ îïòèì³çàö³¿ ë³êóâàííÿ õâîðèõ íà ³øåì³÷íó õâîðîáó ñåðöÿÂ.Î. Ðîìàíîâà, Í.Â. Êóçüì³íîâà, Â.Ê. Ѻðêîâà, Ë.Î. Ðîìàíîâà (³ííèöÿ)
13. Long-term prognosis and risk factors for major adverse cardiac events in patients with ischemic chronic heart failure with mid-range ejection fractionV.D. Syvolap, D.A. Lashkul (Zaporizhzhia)
×ÅÒÂÅÐ, 26 ÂÅÐÅÑÍß(ÎÁÃÎÂÎÐÅÍÍß ÄÎÏβÄÅÉ Ç 13:00 ÄÎ 14:00)
ÑÅÐÖÅÂÀ ÍÅÄÎÑÒÀÒͲÑÒÜÌîäåðàòîðè: ïðîô. ².Å. Ìàëèíîâñüêà, ïðîô. Î.Ã. Íåñóêàé, ê.ì.í. Í.À. Òêà÷ 1. Ïîêàçíèêè åõîêàðä³îãðàô³¿ ó õâîðèõ ç ïåðåíåñåíèì Q-³íôàðêòîì ì³îêàðäà òà äåêîìïåíñîâàíîþ ñåðöåâîþ
íåäîñòàòí³ñòþ â ïðîöåñ³ ë³êóâàííÿ ÿíòàðíîþ êèñëîòîþ òà ïðåïàðàòàìè àðã³í³íó².Ï. Âàêàëþê, Õ.Â. Ëåâàíäîâñüêà (²âàíî-Ôðàíê³âñüê)
2. Áåçáîëüîâà ³øåì³ÿ ì³îêàðäà â îñ³á ïîõèëîãî â³êó ç ³çîëüîâàíîþ ñèñòîë³÷íîþ àðòåð³àëüíîþ ã³ïåðòåí糺þ, óñêëàäíåíîþ õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþÑ.Î. Øåéêî, Í.Î. Êîëá, À.Ì. Âàñèëåíêî (Äí³ïðî)
3. Ôàêòîðè ³ìóíîçàïàëüíî¿ àêòèâàö³¿ òà åíäîòåë³àëüíà äèñôóíêö³ÿ ó õâîðèõ ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàò-í³ñòþ, êîìîðá³äíîþ ³ç ã³ïîòèðåîçîì (ïîïåðåäíº äîñë³äæåííÿ)².Ã. Êóïíîâèöüêà, Þ.². Ìèêóëà (²âàíî-Ôðàíê³âñüê)
4. Ïðåäèêòîðíå çíà÷åííÿ çàë³çîäåô³öèòó òà àíå쳿 ó õâîðèõ ³ç õðîí³÷íîþ ñåðöåâîþ íåäîñòàòí³ñòþ ïðè ³øåì³÷-í³é õâîðîá³ ñåðöÿÍ.Ã. Ðèíä³íà, Ï.Ã. Êðàâ÷óí (Õàðê³â)
5. ʳëüê³ñíà òà ÿê³ñíà õàðàêòåðèñòèêà õâîðèõ ç íåêîðîíàðîãåííîþ ïàòîëî㳺þ, ùî ïðîõîäèëè ë³êóâàííÿ ó ³í-íèöüêîìó ðåã³îíàëüíîìó êàðä³îëîã³÷íîìó öåíòð³Ë.Ï. Ñîëåéêî, Î.Â. Ñîëåéêî, À.ª. Äàíèëü÷óê (³ííèöÿ)
ÀÐÒÅвÀËÜÍÀ òÏÅÐÒÅÍDzßÌîäåðàòîðè: ïðîô. Ò.Â. Êîëåñíèê, ä.ì.í. Ë.À. ̳ùåíêî, ïðîô. Ã.Ä. Ðàä÷åíêî 1. Dependence of cardiovascular risk factors on the vascular endothelium damage in patients with comorbidity
of arterial hypertension and subclinical hypothyroidismO.M. Bilovol, V.D. Nemtsova, V.V. Zlatkina, I.A. Ilchenko (Kharkiv)
2. ßê³ñòü æèòòÿ ïàö³ºíò³â ç àðòåð³àëüíîþ ã³ïåðòåí糺þ â çàëåæíîñò³ â³ä êë³í³÷íèõ ãðóï õðîí³÷íîãî îáñòðóêòèâíî-ãî çàõâîðþâàííÿ ëåãåíüÒ.Ç. Áóðòíÿê (Äí³ïðî)
3. Âïëèâ ³íäèâ³äóàëüíîãî íàâ÷àííÿ îñíîâàì ìåäè÷íèõ çíàíü íà îñíîâí³ ôàêòîðè ñåðöåâî-ñóäèííîãî ðèçèêóÃ.Ñ. ²ñàºâà, Ë.À. кçí³ê, Ì.Ì. Âîâ÷åíêî, Î.Î. Áóðÿêîâñüêà (Õàðê³â)
4. Âïëèâ ïîðóøåíü ñíó ó ïàö³ºíò³â ç ïîºäíàííÿì ã³ïåðòîí³÷íî¿ õâîðîáè òà öóêðîâîãî ä³àáåòó 2-ãî òèïó íà ïåðå-á³ã çàõâîðþâàííÿÃ.Ñ. ²ñàºâà, Î.Î. Áóðÿêîâñüêà (Õàðê³â)
5. Îñîáëèâîñò³ äîáîâîãî ïðîô³ëþ ÀÒ òà ñòðóêòóðíî-ôóíêö³îíàëüíîãî ñòàíó ñåðöÿ ó õâîðèõ íà àðòåð³àëüíó ã³-ïåðòåíç³þ ó ïîºäíàíí³ ç ïîäàãðîþÎ.Ì. Ëàçàðåíêî, Ã.Ï. Êóçüì³íà (Äí³ïðî)
6. Îñîáëèâîñò³ êîãí³òèâíèõ ôóíêö³é ó õâîðèõ ç ã³ïåðòîí³÷íîþ õâîðîáîþ òà ï³äâèùåíèì ³íäåêñîì ìàñè ò³ëàÂ.À. Ñêèá÷èê, Î.Ñ. Ïåëåøêî (Ëüâ³â)
7. Ïîøèðåí³ñòü àðòåð³àëüíî¿ ã³ïåðòåí糿 ó ä³òåé ï³äë³òêîâîãî â³êó ïðîìèñëîâîãî ðåã³îíó Êðèâîð³ææÿ Ñ.Î. Øåéêî, Ñ.Â. Þðêîâà (Äí³ïðî)
8. Îìàíëèâà êîíòðîëüîâàíà àðòåð³àëüíà ã³ïåðòåíç³ÿ: êîãí³òèâí³ ôóíêö³¿ òà ÿê³ñòü æèòòÿÂ.Þ. Êðîòîâà, Ò.À. Õîìàçþê (Äí³ïðî)
9. Ñòàí àíòèêîàãóëÿíòíîãî ãåìîñòàçó ó õâîðèõ íà ã³ïåðòîí³÷íó õâîðîáó â ïîºäíàíí³ ç îæèð³ííÿì òà íåàëêîãîëü-íîþ æèðîâîþ õâîðîáîþ ïå÷³íêèÍ.Ì. Áàæåíîâà (Êè¿â)
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
41
26th
of
Sept
embe
r (T
hurs
day)
10. Âçàºìîçâ’ÿçîê êë³í³÷íèõ ïîêàçíèê³â êðîâ³ òà ð-ñåëåêòèíó ó õâîðèõ ç àðòåð³àëüíîþ ã³ïåðòåí糺þ òà öóêðîâèì ä³àáåòîì 2-ãî òèïóÀ.Î. Á³ëü÷åíêî (Õàðê³â)
11. Ó÷àñòü ãë³ï³êàíó-4 ó ñåðöåâî-ñóäèííîìó ðåìîäåëþâàíí³ ó õâîðèõ íà àðòåð³àëüíó ã³ïåðòåíç³þ òà öóêðîâèé ä³àáåò 2-ãî òèïóÎ.Ì. Á³ëîâîë, Î. Àëü-Òðàâíåõ, ².². Êíÿçüêîâà (Õàðê³â)
12. The influence of dyslipidaemia correction on kidney hemodynamics and calcium metabolism in patients with essential hypertension and osteoarthritisT.A. Rogachova, L.V. Zhuravlyova (Kharkiv)
13. Âçàºìîçâ’ÿçîê ñèðîâàòêîâîãî ð³âíÿ íåñôàòèíó-1 òà áåçáîëüîâî¿ ³øå쳿 ì³îêàðäà ó õâîðèõ íà ã³ïåðòîí³÷íó õâî-ðîáóÑ.Â. ²âàí÷åíêî, Î.Ì. Êîâàëüîâà (Õàðê³â)
14. Êîðåêö³ÿ ïîðóøåíü ïðîòèçãîðòàëüíîãî ïîòåíö³àëó êðîâ³ ïðè ã³ïåðòîí³÷í³é õâîðîá³ â ïîºäíàíí³ ç õðîí³÷íèì îáñòðóêòèâíèì çàõâîðþâàííÿì ëåãåíüÑ.Î. Ñàìîéëîâà, Â.Ç. Íåòÿæåíêî, Î.Ì. Ïëºíîâà (Êè¿â)
15. гâåíü àëüäîñòåðîíó òà ïðóæíî-åëàñòè÷í³ âëàñòèâîñò³ àðòåð³é â çàëåæíîñò³ â³ä êîíòðîëþ Àà ó ïàö³ºíò³â ³ç õðî-í³÷íîþ õâîðîáîþ íèðîêÂ.Â. Ñåìåíîâ, Î.Â. Êóðÿòà (Äí³ïðî)
16. Âïëèâ ð³âí³â àäèïîöèòàðíèõ ìåä³àòîð³â àïåë³íó-12 òà îáåñòàòèíó ó õâîðèõ ç ã³ïåðòîí³÷íîþ õâîðîáîþ òà öó-êðîâèì ä³àáåòîì 2-ãî òèïó çàëåæíî â³ä ñòóïåíÿ òÿæêîñò³ àðòåð³àëüíî¿ ã³ïåðòåí糿Î.Ñ. Òàáà÷åíêî, Î.Þ. Áîðçîâà, Î.Ñ. ªðìàê (Õàðê³â)
17. Îñîáëèâîñò³ ë³êóâàííÿ ïîäàãðè ó õâîðèõ íà àðòåð³àëüíó ã³ïåðòåíç³þÂ.ª. Êîíäðàòþê, Þ.Ï. Ñèíèöÿ, Î.Ì. Òàðàñåíêî (Êè¿â)
ÍÅÊÎÐÎÍÀÐͲ ÕÂÎÐÎÁÈ ÑÅÐÖßÌîäåðàòîðè: ä.ì.í. Ä.Â. Ðÿáåíêî, ä.ì.í. Ñ.Ì. Êîæóõîâ, ê.ì.í. Ñ.Â. ×åðíþê 1. The contribution of proinflammatory markers into the formation of cardiomyopathy in patients with type 2 diabetes
mellitus and overweightN.V. Sokolnikova, L.V. Zhuravlyova (Kharkiv)
2. Êë³í³÷íèé âèïàäîê ìàëîñèìïòîìíî¿ ã³ãàíòñüêî¿ ì³êñîìè ë³âîãî ïåðåäñåðäÿÌ.². Øâåä, Í.Ì. Êîâáàñà, Ê.Á. ϳæèöüêà, ².Î. ßñòðåìñüêà (Òåðíîï³ëü)
3. ijàãíîñòè÷íå çíà÷åííÿ âèçíà÷åííÿ ôàêòîð³â ðèçèêó çà øêàëîþ SILC ó õâîðèõ íà ì³îêàðäèò ç ïîðóøåííÿì ðèòìó ³ ïðîâ³äíîñò³Ê.Â. Ìèíäç³â, Î.². Êîöþáà, Í.². ßðåìà, Í.Â. Òêà÷óê, Ê.Â. Âåðåùàã³íà (Òåðíîï³ëü)
ÌÅÒÀÁÎ˲×Ͳ ÏÎÐÓØÅÍÍß ÏÐÈ ÑÅÐÖÅÂÎ-ÑÓÄÈÍÍÈÕ ÇÀÕÂÎÐÞÂÀÍÍßÕÌîäåðàòîðè: ïðîô. Î.². ̳ò÷åíêî, ïðîô. Ò.Â. Òàëàºâà, ê.ì.í. Â.Þ. Ðîìàíîâ1. Ôóíêö³ÿ åíäîòåë³þ, ïîêàçíèêè ë³ï³äíîãî ñïåêòðà òà ³íñóë³íîðåçèñòåíòí³ñòü ó õâîðèõ íà ³øåì³÷íó õâîðîáó
ñåðöÿ â ïîºäíàíí³ ç íåàëêîãîëüíîþ æèðîâîþ õâîðîáîþ ïå÷³íêè òà ¿õ äèíàì³êà ï³ä âïëèâîì óðñîäåçîêñèõî-볺âî¿ êèñëîòèÌ.Ì. Ãðå÷àíèê, ².Ï. Áîãîâ³íà, Í.Ì. Ãðå÷àíèê, Ä.Ë. ×âîðà (Äí³ïðî)
2. Êë³í³êî-ïðîãíîñòè÷íå çíà÷åííÿ ã³ïåðòðèãë³öåðèäå쳿 ó õâîðèõ íà ³øåì³÷íó õâîðîáó ñåðöÿ ç ìåòàáîë³÷íèì ñèíäðîìîìÎ.ß. Êîðîëþê (Ëüâ³â)
3. Âïëèâ òåðàﳿ ³ç âêëþ÷åííÿì L-àðã³í³íó òà á³ñôîñôîíàò³â íà êë³í³÷íèé ïåðåá³ã ³øåì³÷íî¿ õâîðîáè ñåðöÿ, êî-ìîðá³äíî¿ ç ïîñòìåíîïàóçàëüíèì îñòåîïîðîçîìÍ.Ñ. Ìèõàéëîâñüêà, ².Î. Ñòåöþê (Çàïîð³ææÿ)
4. Âïëèâ ìåòàáîë³÷íî¿ òåðàﳿ íà ë³ï³äíèé ñïåêòð êðîâ³ ó õâîðèõ íà îñòåîàðòðèò, ïîºäíàíèé ç ³øåì³÷íîþ õâîðî-áîþ ñåðöÿÑ.². Ñì³ÿí, Ð.ß. Áîäíàð, Ë.Ï. Áîäíàð (Òåðíîï³ëü)
5. Ôóíêö³îíàëüíèé ðåçåðâ íèðîê ó õâîðèõ íà àðòåð³àëüíó ã³ïåðòåíç³þ â çàëåæíîñò³ â³ä ôóíêö³¿ ùèòîïîä³áíî¿ çàëîçè².Ï. Ãàðì³ø (Äí³ïðî)
6. Îñîáëèâîñò³ êîíòðîëþ àðòåð³àëüíîãî òèñêó ó ïàö³ºíò³â ç àðòåð³àëüíîþ ã³ïåðòåí糺þ òà ìîðá³äíèì îæèð³ííÿì ï³ä âïëèâîì áàð³àòðè÷íîãî ë³êóâàííÿ é àíòèã³ïåðòåíçèâíî¿ òåðàﳿÀ.Â. Íàäþê, Ò.Â. Êîëåñíèê, Ð.Â. Äóêà, À.À. Êîñîâà (Äí³ïðî)
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
42
ÀÂÒÎÐÑÜÊÈÉ ÏÎÊÀÆ×ÈÊ
Ambrosova T.M. 41Andreieva Y.O. 40Ashcheulova T.V. 41Gilyova Ya.V. 39Honchar O.V. 39, 41Kadykova O. 40Kolesnik E.L. 41Kolesnik T.V. 41Kopytsya M.P. 39Kosova H.A. 41Koteliukh M.Yu. 40Kovalyova O.M. 41Kravchun P.G. 40Matyash N.M. 41Molotiagin D. 40Mykhailovska N.S. 40Nadiuk A.V. 41Nickening G. 8Oliinyk T.V. 40Pasiieshvili T.M. 41Petyunina O.V. 39Rodionova Yu.V. 39Tytarenko N.V. 39Vyshnevska I.R. 39Zelena I.I. 41Zhelezniakova N.M. 41Àáäóðàõìàíîâ Ç.Ì. 37Àáðàìåíêî ².Â. 40Àêêàÿ Å. 33Àëüì³ç Ï.Î. 32Àìåë³íà Ò.Ì. 40Àìîñîâà Ê.Ì. 20, 22, 25, 27Àíäð³ºâñüêà Ñ.Î. 12, 26Àíäð³éö³â Ç.Ñ. 33Àïàíàñåíêî Ã.Ë. 38Àðòåìåíêî Â.Î. 27Àñîíîâ À.Î. 16Áàá³é Ë.Ì. 38Áàáëÿê Î.Ä. 16, 21Áàáî÷ê³íà À.Ð. 33Áàçèêà Î.Ä. 40Áàíàõ Ì. 28Áàðçàê Í.Ñ. 40, 41Áàóåð Ï. 25Áàöàê Á.Â. 36Áåâçþê Ë.Â. 39Áåðåç³í Î.ª. 25, 37Áåðêîâè÷ À. 33Áåø Ä.². 39Áåøëÿãà Â.Ì. 14, 15Á³ëèé Ä.Î. 19, 40Á³ëîâîë Î.Ì. 41Á³ëîóñ Í.². 40Á³ëü÷åíêî Î.Â. 23, 32Áîãîâ³íà Î.Ï. 40Áîéêî Â.Â. 40Áîéêî Î.². 39Áîðîâèê Ê.Ì. 39Áîðîäàé À.Î. 15Áîðõàëåíêî Þ.À. 40
Áðèíçà Ì.Ñ. 32, 39Áóäêî Î.Î. 36Áóæåíêî À.². 17Áóðòíÿê Ò.Ç. 41Áóðÿê Ð.Â. 18Áóðÿêîâñêàÿ À.À. 41Âàâ³ëîâà Ë.Ë. 33Âàðáàíåöü Ñ.Â. 37Âàñèëåíêî À.Ì. 12, 25, 34Âàñèëåíêî Â.À. 25, 34Âàñèëüºâà Ë.². 30Âåðáîâñüêà Î.Ñ. 33ºðêî Í.Ï. 25Âèøíåâñüêà ².Ð. 40³ðíà Ì.Ì. 28Âëàä³ì³ðîâ Î.À. 38Âîâ÷åíêî Ì.Ì. 28Âîâ÷åíêî Ì.Í. 41Âîëêîâ Ä.ª. 32, 33Âîëîøèíà Î.Â. 19Âîðîíêîâ Ë.Ã. 25, 38, 40Âîðîõòà Þ.Ì. 14Ãàâðèëåíêî Ò.². 16, 40Ãàâðèø Î.Ñ. 26Ãàâðîíñüêà Ò.Ì. 16Ãàëàøêî Ê.Þ. 39Ãàëü÷èíñüêà Â.Þ. 28Ãàðêàâåíêî Î.Ã. 39Ãåëåòþê Þ.Ë. 41Ãåðàñèì÷óê Ñ.Ã. 19Ãåòüìàí Ò.Â. 11Ãèë¸âà ß.Â. 39Ãèùàê Ò.Â. 16óááñ Ñ. 30óíãóëÿê Î.Ì. 17óðåø É.É. 36ó÷óí Â.Ñ. 17Ãîë³êîâà ².Ï. 22, 26Ãîëóáîâñüêà Þ.ª. 16Ãîí÷àð Î.Î. 26Ãîí÷àðü À.Â. 39Ãîðáà÷îâà Â.Â. 17, 38Ãðå÷àíèê Ì.Ì. 40Ãðå÷àíèê Í.Ì. 40Ãðå÷êî Ñ.². 33Ãðèíåíêî Ò.Â. 26Ãð³áåíþê Î.Â. 41Ãðóáÿê Ë.Ì. 14Ãóê Â.Ï. 17Ãóê Î.À. 36Ãóëÿºâà Ì.Â. 13Ãóð’ºâà Î.Ñ. 37Äàâèäîâà Þ.Â. 13Äàâèä÷óê Î. 25Äàí³ëåâè÷ Ò.Ä. 17Äàðîõà Ñ. 30Äåì’ÿíåíêî Â.Ì. 16, 21Äåì’ÿí÷óê Â. 25Äåíèñþê Â.². 33Äåíèñþê Î.Â. 33
Äåÿê Ñ.². 15ijäêîâñüêèé Â.Ñ. 17ijòê³âñüêèé ².Î. 37Äìèòåðêî Ó.À. 41Äîâãàíè÷ Í.Â. 29Äîëæåíêî Ì.Ì. 12, 13,
14, 25, 38Äîðîí³í Î.Â. 32Äîðîõ³íà Ã.Ì. 17Äîñåíêî Â.ª. 26, 38Äðåâèöüêà Ò.². 26Äóáíîâ³íñüêà Ò.Â. 26Äóáðîâ Ñ.Î. 34Äóäíèê À.ª. 38, 40Äüîëîã Ì.Â. 20Äÿ÷åíêî Â.Ë. 37Äÿ÷åíêî Î.Î. 17ªìåöü Ã.². 37ªìåöü ².Ì. 36, 37ªíà Ë.Ì. 27ªïàí÷³íöåâà Î.À. 25, 40ªðìàê Î.Ñ. 39ªñêå À. 20ªô³ìåíêî Ä.Ñ. 19ªô³ìåíêî Î.Î. 13Æàäàí À.Â. 15, 37Æàð³íîâ Î.É. 9, 15, 25, 27, 40Æàð³íîâà Â.Þ. 38Æåáåëü Â.Ì. 38Æåêîâ ².². 37Æåë³áà Î.Ì. 15Æèâèëî ².Î. 30Æèòèíñüêèé ª. 25Æóðàâëüîâà Ë.Â. 41Çàáîëîòíà Ò.Â. 16Çàé÷åíêî À.Â. 27Çàëåâñüêèé Â.Ï. 9Çàëüöáåðã Ñ. 33Çàðåìáà ª.Õ. 28, 37Çàðåìáà Î.Â. 28, 37Çàðåìáà-Ôåä÷èøèí Î.Â. 28Çåðá³íî Ä.Ä. 36, 39Çäðîºâñüêèé Ò. 38dzí÷åíêî Þ.Â. 11Çîëîòàðüîâà Ò.Â. 39Çóáîâñüêèé Ä.Ñ. 17Èñàåâà À.Ñ. 41²âàí³â À.Þ. 14²âàí³â Þ.À. 13, 14, 15, 29²âàíêîâà À.Â. 39²âàíîâ Â.Ï. 27, 39²âàí÷åíêî Ñ.Â. 41²âàí÷óê Ï.Ð. 39, 40²ëü÷åíêî ².À. 41²ëü÷èøèíà Î.ß. 19²ëþøèíà Ã.ß. 12²ðê³í Î.². 9, 12, 19, 27, 34²ñàºâà Ã.Ñ. 28Êàçüì³ðóê Â.Ì. 33Êàïëàí Ï.Î. 22
Êàðïåíêî Þ.². 32Êàðïëÿê Â.Ì. 28, 37Êàõëå Ï. 33Êâàøà Î.Î. 38Êèðè÷åíêî À.Ã. 17Êèðè÷åíêî Ð.Ì. 36Êèñèëåâè÷ Ë.Ô. 19Êèÿê Ã.Þ. 38ʳíîøåíêî Ê.Þ. 37Êëåêîò Î.Î. 28Êëèìåíêî Î.Î. 26Êîáåëü À.Â. 39Êîáèëÿêà Â.Þ. 19Êîâàëåâñüêà Î.À. 15Êîâàëåíêî Â.Ì. 14, 15, 35Êîâàëü Î.À. 10, 19, 22Êîâàëü Ñ.Ì. 23, 37Êîâàëüîâ Î.Ñ. 40Êîâàëüîâà Ì.Î. 27Êîæèíà Ã.Ì. 23Êîæóõîâ Ñ.Ì. 25, 28Êîçëþê À.Ñ. 29, 36Êîëá Í.Î. 41Êîëåñíèê Å.Ë. 41Êîëåñíèê Ì.Þ. 14, 15, 39Êîëåñíèê Ò.Â. 12, 23, 26, 27, 41Êîëåñí³êîâà Î.Â. 27Êîëîñ Ë.À. 16Êîíäðàòþê Â.ª. 41Êîíîòîï÷èê Ñ.Â. 14Êîïèöà Í.Ï. 39Êîïèöÿ Ì.Ï. 39, 40Êîðíàöüêèé Â.Ì. 17, 23Êîðîñò³é Â.². 23Êîñîâà Ã.À. 41Êîöþáà Î.². 34Êðàâ÷åíêî Â.². 37Êðàâ÷åíêî Ê.Ñ. 41Êðàâ÷óê Á.Á. 32Êðàñíÿêîâ ².Ä. 33Êðåìçåð Î.Î. 25Êðèêóíîâ Î.À. 9, 14, 15, 36Êðè÷êåâè÷ Â.À. 26Êðóøèíñüêà Ç.Ã. 15Êðóøèíñüêà Í.À. 37Êðÿ÷îê ².À. 36Êóçíåöîâ ².Â. 40Êóçíåöîâà Ñ.Ì. 13Êóçíºöîâà Ë.Â. 16Êóçüì³íîâà Í.Â. 39, 40, 41Êóëèê Ë. 30Êóíä³íà Â.Â. 15Êóí³ñ Ì. 33Êóðñ³íà Í.Â. 40Êóðÿòà Î.Â. 22, 23, 39Êóòÿ ².Ì. 39, 40Êóöü Â.Î. 15Êó÷ìåíêî Î.Á. 19, 26Êóøí³ð Þ.Ñ. 39Ëàçàðºâà Ê.Ï. 22
ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÕX ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ ÕX UKRAINIAN NATIONAL CONGRESS OF CARDIOLOGY ÍÀÖ²ÎÍÀËÜÍÈÉ ÊÎÍÃÐÅÑ ÊÀÐIJÎËÎò ÓÊÐÀ¯ÍÈ
43
Ëàçîðèøèíåöü Â.Â. 9, 15, 21Ëåâèöüêà Ë.Â. 38, 41Ëåâèöüêìé ².Á. 38Ëåîí³äîâà Â.². 39Ëèçîãóá Ñ.Â. 11, 34Ëèìàíñüêèé Î.Â. 38Ëèïîâåöüêà Ñ.É. 34Ëèñåíêî Ã.Ô. 22˳ïêàí Í.Ã. 38, 40˳ôàíòüºâà Í.Î. 15Ëîçèíñüêà Í.Â. 15Ëóòàé Ì.². 21, 22, 26, 28Ëóòàé ß.Ì. 19, 34, 38Ëó÷èíåöü Î.Ô. 18, 36Ìàçóð Î.À. 37Ìàçóð Ñ.Ã. 13Ìàêàðîâà ².². 15Ìàêîâ³é÷óê ².Î. 39Ìàëèíîâñüêà ².Å. 19Ìàíüêîâñüêà ².Ì. 26Ìàðàðåíêî Î.À. 19Ìàð³ºâñüêèé ².Â. 36Ìàðêîâåö À.Â. 35Ìàðóøêî Ò.Â. 16Ìàðóøêî Þ.Â. 16Ìàòîâà Î.Î. 23, 26Ìàòîõíþê Ì. 38Ìàòþõ Ê.Ì. 39Ìàòþõà Ë.Ô. 12Ìåäâ³äü Â.². 13Ìåëàìóä Ê.Ñ. 23Ìåëåíü Þ.Ï. 40Ìåëüíèê ª.À. 16, 21Ìèòðîõ³íà Î.Ñ. 40Ìèõàéëîâñüêà Í.Ñ. 41Ìèõàéëîâñüêèé ß.Ì. 39̳íÿéëåíêî Ë.ª. 41̳ò÷åíêî Î.². 12, 27, 28̳õàëºâ Ê.Î. 12, 25̳õàëºâà Ò.Â. 26̳ùåíêî Ë.À. 12, 14, 23, 25̳ùåíêî Ò.Ñ. 14Ìîãèëüíèöüêèé ª.Â. 11Ìî³ñåºíêî Î.². 22Ìîêðèê ².Þ. 35Ìîðîç Ì.Ñ. 28Ìðî÷åê À.Ã. 20Ìóäðóê ².Â. 39Ìóçèêà Í.Î. 33Ìóõàììàä Ìóõàììàä 40Ìõ³òàðÿí Ë.Ñ. 26, 38, 40Íàäþê À.Â. 41Íàéäà Ñ.À. 17Íàñò³íà Î.Ì. 40Íàòðóñ Ë.Â. 25Íåâìåðæèöüêà Ë.Î. 9, 18Íåìöîâà Â.Ä. 41Íåñóêàé Î.Ã. 8, 9, 12, 24, 36Íåòÿæåíêî Â.Ç. 14, 19ͳøêóìàé Î.². 22Íîâåðêî ².Â. 15, 37Íîéìàí Ò. 33Íîñàð Â.². 26
Íîñåíêî Í.Ì. 14, 23, 36Îâðàõ Ò.Ã. 18Îí³ùåíêî Î.Â. 40Îðèí÷àê Ì.À. 28Îðèùèí Í.Ä. 15, 29Îñîâñüêà Í.Þ. 12, 14, 15Îñüîäëî Â.². 17Ïàâåëêî Ì.Ì. 38Ïàâëèê Í.Ñ. 16Ïàíòàç³ Î. 25Ïàíüê³â Â.². 13Ïàðàö³é Î.Ç. 34Ïàðõîìåíêî Î.Ì. 19, 34, 38Ïåòêàíè÷ Ì.Ì. 33Ïåòþíåâà Ë.Ë. 28Ïåòþí³íà Î.Â. 40Ϻòêîâ Î.Â. 40Ïèâîâàð Ñ.Ì. 22, 38ϳâòîðàê Ê.Â. 12ϳäãàéíà Ë.Â. 16, 21ϳäãàéíà Î.À. 16Ïîâîðîçíþê Â.Â. 22Ïîãóðåëüñüêà Î.Ï. 38Ïîçíÿê Þ.Â. 18Ïîë³âåíîê ².Â. 40Ïîë³ùóê Ì.ª. 13Ïîëÿíñüêà Î.Ñ. 40Ïîíè÷ Í. 25Ïîíîìàðüîâà Ã.Â. 40Ïîïîâ Â.Â. 33Ïîòàáàøí³é Â.À. 25, 32Ïîòàøîâ Ñ.Â. 14, 15Ïðàâîñóäîâè÷ Ñ.Î. 31Ïðîíîçà-Ñòåáëþê Ê.Â. 17Ïóãà÷ Ò.Â. 22Ïóêàñ Î.Ñ. 37Ðàäåöüêà Ë.Â. 34Ðàä÷åíêî Ã.Ä. 11, 15,
23, 25, 30, 36Ðàê Í.Î. 37Ðàñïóò³íà Ë.Â. 27Ðàñïóòíÿê Î.Â. 16Ðåâåíêî Ê.À. 16, 21Ðåâåíüêî ².Ë. 14, 23Ðåêîâåöü Î.Ë. 37Ðåçíèê Ë.À. 41Ðèáàê À.Þ. 22Ðèá÷èíñüêèé Ñ.Â. 18Ðèæêîâà Í.Î. 16Ðèíãà÷ Í.Î. 38Ðèíä³íà Í.Ã. 39гøêî Ì.Â.Ðîäèîíîâà Þ.Â. 39Ðîä³îíîâà Þ.Â. 39Ðîìàíåíêî Ñ.Â. 22Ðîìàíîâ Â.Þ. 28Ðîìàíîâà Â.Î. 40Ðîìàíîâà Î.Ì. 11, 31, 32Ðóäåíêî À.Â. 27Ðóäåíêî Â.À. 21Ðóäåíêî Ê.Â. 9, 36Ðóäåíêî Í.Ì. 36, 37Ðóäåíêî Ñ.À. 27
Ðóäåíêî Þ.Â. 22, 25Ðóäèê Þ.Ñ. 22, 38Ðóä³ê Ì.Â. 15Ðóñíàê À.Î. 9, 33Ðÿáåíêî Ä.Â. 23, 36Ñàâ³öüêà Þ.Â. 18Ñàâ÷åíêî ².Ï. 34Ñàâ÷óê Î.Â. 40Ñàíåð Õ. 38Ñàòèð Ì.Â. 15Ñâèðèäþê Î.ª. 14Ñåáîâ Ä.Ì. 22Ñåìåíîâ Â.Â. 19, 22, 23Ñåðáåíþê Ê.². 23Ñåðåäþê Í.Ì. 33Ñåð³ê Ñ.À. 22Ñåðüîã³íà Î.Ï. 19Ѻðêîâà Â.Ê. 40Ñèäîðåíêî Ã.Â. 40Ñèíèöÿ Þ.Ï. 41Ñè÷îâ Î.Ñ. 9, 11, 14, 15, 30ѳðåíêî Þ.Ì. 9, 10, 27,
29, 30, 36ѳ÷êàðóê ².Ì. 22Ñêàêóí Î.Ç. 33Ñêà÷êîâà Í.À. 13Ñêèá÷èê Â.À. 40Ñê³áî Þ.Ì. 40Ñêîðîìíà À.Ñ. 19Ñëîáîä³í Ò.Ì. 14Ñìèðíîâà ².Ï. 38Ñìîëàíêà ².². 29Ñí³ãóðñüêà ².Î. 37Ñîêîëîâ Ì.Þ. 19, 20, 39Ñîêîëîâ Þ.Ì. 19, 20, 21Ñîêîëîâà Ë.Ê. 8, 23, 24Ñîêîëüí³êîâà Í.Â. 41Ñîëåéêî Ë.Ï. 40, 41Ñîëºéêî Î.Â. 40, 41Ñîëîâ’ÿí Ã.Ì. 11Ñîëîíîâè÷ À.Ñ. 18Ñîïêî Î.Î. 38Ñîðîê³âñüêèé Ì.Ñ. 16Ñð³áíà Î.Â. 33, 38Ñòàðæèíñüêà Î.Ì. 38Ñòåáëþê Â.Â. 17Ñòåïàí³øèíà ß.À. 36Ñòåïóðà À.Î. 19Ñòåöþê ².Î. 41Ñòè÷èíñüêèé Î.Ñ. 32Ñòîãîâà Î.Â. 36Ñòóêîâ Þ.Þ. 19Ñóìàíîâà È.À. 39Ñóõîâà Ñ.Ì. 20Òàëàºâà Ò.Â. 22, 26Òàðàïîí ².Â. 19Òàðàñîâà Â.Ê. 26Òàòàð÷óê Ò.Ô. 12Òàùóê Â.Ê. 19, 22, 27,
33, 34, 39Òàùóê Ì.Â. 39, 40Òåðåøêåâè÷ Ë.Ï. 19
Òåðåùåíêî Í.Ì. 19Òèòàðåíêî Í.Â. 39Òèùåíêî ª.Â. 40Ò³ùåíêî Í.Â. 40Òêà÷ Ë.². 21Òêà÷ Í.À. 25Òîâñòóõà Â.Â. 26Òîäóðîâ Á.Ì. 25, 35, 37, 40Òîìàùóê Í.Á. 13Òîðáàñ Î.Î. 37Òðåãóáîâà Ì.Î. 36Òðåìáîâåöüêà Î.Ì. 36Òðåôàíåíêî ².Â. 33Òð³ùèíñüêà Ì.À. 32Òðóíîâà Ë.À. 40Ôåäîðåíêî Î.À. 35Ôåäüê³â Ñ.Â. 14, 15, 22Ôåñåíêî Â.². 25, 32Ô³òöå ². 36Ôëîì³í Þ.Â. 13Ôðîëîâ Î.². 11Ôóðñà Î.Ì. 35Õàâîðò Ø.Ã. 29Õàäæàÿ Í.Â. 17Õàéí À. 33Õàíþêîâ Î.Î. 9Õàòàëà Ð. 31Õîìåíêî Þ.Î. 38Õîõëîâ À.Â. 37Õóäçèê Ì. 32Öâèê À.Ñ. 18Öåë³ê Í.ª. 41Öåëóéêî Â.É. 20, 23, 25,
32, 36, 37Ö³âåíêî Â.Ì. 39×àñíîéò À. 32×åðåäíè÷åíêî Ì.Ç. 11×åðåíüêî Ò.Ì. 41×åðíþê Ñ.Â. 16, 35×åðíÿãà-Ðîéêî Ó.Ï. 16×åðïàê Á.Â. 37Øàá³ëüÿíîâà Ë.Î. 39Øàòàéëî Â.Ï. 22Øâåä Ì.². 34, 38Øâåöü À.Â. 17Øåéêî Ñ.Î. 12, 41Øåðåìåò Ì.Þ. 23Øèìàíêî Ì.Â. 37Øêëÿíêà ².Â. 18Øòåëüìàõ Â.Î. 39Øóìàêîâ Â.Î. 19. 38Ùåãëîâ Ä.Â. 14Þøêî Ê.Î. 23ßáëó÷àíñüêèé Ì.². 39, 41ßâäîøíÿê Õ.Â. 39ßãåíñüêèé À.Â. 10, 22, 33, 38 ßêîâëºâà Ë.Ì. 14ßêóøêî Ë.Â. 16ßëîâåíêî Ì.². 18ßðåìà Í.². 34ßðèíê³íà Î.À. 29ßðîø Â.Î. 27